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Abstract
The studies described in this thesis were concerned with the role of
sex steroids in the control of the differentiation of ovarian granulosa
cells. This process is driven by FSH, but is subject to the influence of
locally produced factors which are thought to be critical in determining
the fate of a follicle. Androgens and oestrogens were known to augment
the action of FSH on granulosa cell steroidogenesis, with androgens being
the more potent. However, little was known about their mechanism of
action, or their effects at the levels of gene expression and protein
synthesis. Therefore, a rat granulosa cell culture model was modified and
validated to study the role of sex steroids in the control of expression of
structurally and functionally important granulosa cell proteins and genes
during FSH-stimulated differentiation.
It was found that FSH caused marked changes in the synthesis of a
number of prominent cellular and secreted proteins in vitro, one of
which was identified by immunoprecipitation as vinculin, a cytoskeletal
protein, and another as fibronectin, an extracellular matrix protein.
Synthesis of both these proteins was reduced in response to FSH. The
expression of mRNA encoding another cytoskeletal protein, actin, was
also found to be reduced by FSH treatment in vitro. All of these effects of
FSH, which are consistent with observed changes in morphology during
granulosa cell differentiation in vitro, were strongly augmented by
oestrogen and androgen. However, FSH was found to be without effect
on actin mRNA levels in vivo. It was concluded that the changes in
morphology reflected in these results are probably an artefact of the in
vitro approach, and so do not provide a suitable model for the study of
the role of steroids in ovarian physiology.
A novel aspect of granulosa cell function which was thought to
accompany their differentiation was production of inhibin. Little was
known about the control of granulosa cell inhibin production, and so the
viii
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effects of gonadotrophins and steroids on the expression of mRNA
encoding the three inhibin subunits were investigated. FSH stimulated
expression of mRNA encoding all three inhibin subunits in rat granulosa
cells in vivo and in vitro. When administered after treatment with FSH,
hCG suppressed levels of inhibin subunit mRNA. The relationship
between inhibin gene expression and expression of other correlates of
granulosa cell differentiation was studied in order to provide a context for
these results. Expression of mRNA encoding the LH receptor and the
aromatase enzyme was, like the inhibin subunits, increased by FSH and
reduced by hCG following FSH treatment, suggesting that all these genes
are increasingly expressed during follicle development, and lost at
luteinization. The mRNA encoding the side-chain cleavage enzyme,
however, was only moderately increased by FSH treatment, but greatly
increased by hCG treatment, consistent with its function in the corpus
luteum. Since the pattern of expression of all these markers followed
qualitatively the same pattern in vivo and in vitro, the control of inhibin
subunit gene expression by FSH and steroids in vitro could then be
studied in detail. Both androgen and oestrogen augmented the
stimulation by FSH of inhibin gene expression in a dose-dependent
fashion. Furthermore, it was found that oestrogen, but not androgen, was
able to stimulate the expression of the mRNA encoding the inhibin a-
and PB-subunits, in the absence of FSH.
In order that the control of inhibin gene expression could be studied
in a quantitative and systematic manner, an attempt was made to
develop a sensitive and quantitative solution hybridisation assay for
inhibin-a mRNA. Basic developmental work was carried out, but more
validation was required before this assay could be used routinely. During
the development of this assay, a low molecular weight RNA species was
detected which hybridised to the inhibin-a sense probe, suggesting that it
may be an endogenous antisense inhibin-a RNA. It was speculated that
this could be involved in the regulation of expression of this gene, but
further work would be required to determine its function.
The mode of action of androgens and oestrogens in granulosa cells
was also investigated by studying the expression of mRNA encoding their
receptors. Androgen receptor mRNA was readily detected in granulosa
Abstract x
cells, and its abundance was unaffected by treatment with
gonadotrophins. Oestrogen receptor mRNA was also detected in ovarian
RNA, but was undetectable in granulosa cells. However, a smaller
transcript which hybridised to the oestrogen receptor probe was detected
in granulosa cells. The levels of this species were increased by treatment
of animals with FSH, and reduced by treatment with hCG following
treatment with FSH. Although the function of this molecule is
unknown, it is speculated that it may encode an oestrogen-binding
protein which may act to regulate levels of free oestrogen in the cell.
It was concluded that oestrogen and androgen interact with FSH to
stimulate all aspects of granulosa cell differentiation studied, and that
their different potencies can be accounted for in part by different levels of
expression of their receptors. However, the ability of oestrogen to
stimulate inhibin gene expression in the absence of FSH suggests some
difference in their mechanisms of action. Since thecal androgen synthesis
is known to be stimulated by inhibin and may be inhibited by oestrogen,
it is speculated that this effect of oestrogen may act to maintain supply of
androgen substrate for oestrogen synthesis in the presence of high local
levels of oestrogen present during preovulatory follicular development.
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Chapter 1 Literature Review
1 Introduction
In mammals, the ovary has two functions, firstly to release viable
gametes at the appropriate time to allow fertilization, and secondly to
secrete steroids which influence sexual behaviour around the time of
ovulation and prepare the female for pregnancy and lactation. These
functions are really inseparable, since steroids not only affect sexual
behaviour and organs such as mammary glands and uterus, but also play
a pivotal role in the control of ovarian function.
There are two major levels at which control is exerted over the
growth and development of ovarian follicles during the normal ovarian
cycle. In cyclic animals, the normal development of ovarian follicles,
ovulation and luteal function are primarily under the endocrine control
of the pituitary gonadotrophins follicle-stimulating hormone (FSH) and
luteinizing hormone (LH), and secondarily under paracrine control by
factors produced within the ovary. It is of great significance that the
ovarian follicle is not simply the passive target organ for pituitary
hormones, but is able to modify the production of, and its own response
to those hormones through local and endocrine action of steroid and
peptide factors. It must be stressed that the use of terms such as "primary"
and "secondary" is not meant to indicate greater or lesser importance of
one level of control over another, since both mechanisms are necessary
for normal follicle development.
This project has focussed on the interactions of steroid and peptide
factors in the local control of ovarian function. In this review, I will
attempt to provide the background to the ovary and its endocrine control,
and the events which occur during the ovarian cycle, before describing in
1
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detail the cell biology of the ovarian follicle and its control at the
paracrine level.
2 Structure and Cellular Composition of the Ovary
The mammalian ovaries are paired organs situated in the peritoneal
cavity. Their exact position and shape varies between species, but they are
generally roughly bean-shaped and approximately equal in size. The
ovaries are attached to the broad ligament by a mesentery called the
mesovarium, through which the ovarian blood vessels, lymphatics and
sympathetic nerves pass before joining the ovary at the ovarian hilus.
The ovarian arteries are spiral and form extensive connections with the
ovarian veins in the hilar region. The ovary is surrounded by a capsule,
or bursa, and the extent to which it encloses the ovary varies between
species. In rats and mice, the bursa almost completely encloses the ovary,
with very little connection with the peritoneum. In pigs and sheep, the
bursa is open to the peritoneum, and in humans it is virtually absent
(Harrison, 1962). The ovary itself is covered with a continuous smooth
epithelium, called the germinal epithelium. During embryonic
development, this epithelium proliferates to give rise to the underlying
cortex, in which the germ cells are embedded (Franchi et al. 1962). In the
cortex of the ovary, a number of cell types and structures can be seen.
Apart from the oocytes and the associated cells of the follicle which are
described in detail below, the cortical stroma contains connective tissue,
fibroblasts, blood and lymphatic vessels and macrophages, as well as
secretory cells known as interstitial cells. Primary interstitial cells are
steroidogenic cells present only for a short time during fetal life, which
are not gonadotrophin-responsive and appear to be involved in the
conversion of placental progestogens to androgens (Erickson et al. 1985).
There are also androgen-producing interstitial cells in the hilar region of
the ovary, but their function is unknown. The third type of steroidogenic
interstitial cell is the secondary interstitial cell. These cells are thought to
be derived from the theca-lutein cells of regressed corpora lutea and are
functionally indistinguishable from theca cells (Erickson et al. 1985).
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During foetal life the germ cells in the ovary proliferate by mitosis to
form the oogonia, and enter the first meiotic division. Once meiosis has
begun, the germ cells are termed primary oocytes, and they will not
proliferate any further. As a result, the number of germ cells in the ovary
is fixed by the time of birth, and are not replaced as they are released.
Before birth most of these oocytes become surrounded by spindle-shaped
cells, which are the precursors for the granulosa cells, to form primordial
follicles, which are distributed in the ovarian cortex, just under the
germinal epithelium. These granulosa cell precursors form gap junctions
with the oocyte. This unit is enclosed from the surrounding stroma by a
basement membrane, the membrana propria. With the formation of the
primordial follicle, the oocytes arrest in diplotene of the first meiotic
prophase, before spindle formation, and at this stage of their growth are
unable to proceed any further. Although little is known about the
influence of the oocyte on the development of the follicle, it is an
essential component since follicles do not form in their absence
(Buccione et al. 1990).
The majority of the oocytes in the ovary from around the time of
birth are present in primordial follicles, but every day of reproductive life,
a number of follicles begins to grow. The spindle-shaped cells
surrounding the oocyte become cuboidal and begin to proliferate, and are
then termed granulosa cells. The oocyte, still arrested in diplotene,
approximately doubles in size, and an opaque layer between the
granulosa cells and the oocyte, called the zona pellucida is formed from
glycoproteins secreted by the oocyte (Philpott et al. 1987; Lira et al. 1990).
The granulosa cells maintain their close contact with the oocyte by
forming cytoplasmic projections which extend through the zona
pellucida to form gap junctions with the oocyte plasma membrane. The
granulosa cells act to promote the growth of the oocyte, by passing
nutrients such as nucleotides and lactate to the oocyte (Heller & Schultz,
1980). Granulosa cells function in a specific manner in their effects on
oocyte growth, since other cell types are unable to stimulate oocyte
growth (Buccione et al. 1990). Stromal cells condense around the
membrana propria and develop cytoplasmic organelles characteristic of
steroid-secretory cells, to form the theca layer. This layer, unlike the
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granulosa cell layer, is highly vascular. The follicle is now termed a
primary follicle. It is at this stage that the oocyte stops growing, although
it continues to produce RNA and protein (Lintern-Moore & Moore, 1979).
The growth of the oocyte is associated with development of the ability of
the oocyte to resume meiosis, since reinitiation of meiosis occurs
spontaneously in oocytes isolated from follicles at this stage (Eppig &
Downs, 1984). They do not resume meiosis, however, until just before
ovulation, and it is thought that the oocyte is held in this state of meiotic
arrest by factors produced by the granulosa cells. Cyclic adenosine
3',5'-monophosphate (cAMP) is able to maintain oocytes in meiotic
arrest, and it is thought that granulosa cells, stimulated by FSH, may pass
v
cAMP to the oocyte through gap junctions (Eppig & Downs, 1984). Purine
factors such as hypoxanthine, which is present in high concentration in
follicular fluid, are also implicated in the maintenance of oocyte meiotic
arrest by maintaining high levels of cAMP within the oocyte (Downs &
Eppig, 1987; Downs et al. 1989).
As the follicle continues to grow, the theca layer differentiates into
the theca externa, a fibrous wall to the follicle, and the theca interna,
which is a highly vascular steroidogenic layer. The granulosa cells secrete
a viscous fluid containing proteoglycans, which eventually coalesces to
become the follicular fluid which forms the follicular antrum. At this
point, two types of granulosa cell can be distinguished. Those granulosa
cells which are in direct contact with the oocye are called the cumulus
oophorus, or cumulus granulosa cells, whereas those which lie between
the basement membrane and the antrum are known as mural granulosa
cells. Up to this stage, follicular growth is relatively independent of
gonadotrophins, since follicles will grow to the early antral stage in
hypophysectomized animals (Hirshfield, 1985), although this does not
mean that these follicles are not gonadotrophin-responsive (Greenwald
& Terranova, 1988). In the absence of gonadotrophins, many follicles
become atretic, and healthy follicles will proceed no further than the early
antral stage.
The follicle is the functional unit of the ovary, with growing follicles
functioning independently of each other. The selection of the oocyte or
oocytes to be ovulated in a given cycle is exerted on the follicle as a whole.
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3 Role of Pituitary Hormones in Follicular Development
The anterior pituitary secretes two gonadotrophic glycoprotein
hormones, follicle-stimulating hormone (FSH) and luteinizing hormone
(LH). FSH and LH are both heterodimeric glycoproteins, consisting of an
a-subunit of 89 amino acids with two glycosylation sites, common to both
hormones (and also common to thyroid-stimulating hormone [TSH] and
chorionic gonadotrophin [CG]), and a [3-subunit 115 of amino acids, which
confers specificity. The (3-subunits of the two hormones are identical at
only seven amino acids, and the FSH (3-subunit has two glycosylation
sites, whereas the LH (3-subunit has only one. The molecular weight of
FSH is 32,600 Da, and that of LH is 34,000 Da (Johnson & Everitt, 1988).
3.1 Function of FSH
Follicle-stimulating hormone, as the name suggests, stimulates
growth of ovarian follicles in vivo. Administration of this hormone in
vivo leads to marked growth of follicles (Goldenberg et al. 1973;
Goldenberg et al. 1972; Simpson et al. 1941; Greep et al. 1942), and this has
been shown to be due to an increase in the proliferation of the granulosa
cells (Roy & Greenwald, 1991; Gougeon & Testart, 1990). The receptor for
FSH is present only on granulosa cells of follicles from the large preantral
stage onwards, and is not present in the cells of primordial follicles or old
\/
corpora lutea (Oxberry & Greenwald, 1982; Camp et al. 1991). FSH does not
stimulate granulosa cells to grow in vitro (Skinner et al. 1987; Hammond
& English, 1987; Dorrington et al. 1988), suggesting that this effect of FSH
is mediated through an intermediate in vivo (see below). However,
through generation of intracellular cAMP (see below), FSH directly causes
granulosa cells to differentiate. The major characteristic of this
differentiation is the development of steroidogenic activity. FSH
stimulates immature granulosa cells, which secrete little or no steroids, to
produce progestogens (Hillier et al. 1978; Thanki & Channing, 1978;
Richards et al. 1979; Moon, 1981; Carson et al. 1979) and in particular to
aromatize androgens to oestrogens (Dorrington et al. 1975; Moon et al.
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1978; Gore Langton & Dorrington, 1981; Hillier & deZwart, 1982). The
molecular basis of this aspect of granulosa cell differentiation is discussed
below. Another characteristic of granulosa cells which have been induced
to differentiate in response to FSH is the expression of receptors for LH
(Zeleznik et al. 1974; Richards et al. 1976; Richards et al. 1979; Erickson et
al. 1979; Sheela Rani et al. 1981), which is also linked to the cAMP second
messenger system (see below). This is of great importance, since
granulosa cells in an advanced stage of differentiation are able to respond
to LH in the same way as FSH when levels of FSH are low. FSH also
stimulates production of its own receptor (Richards et al. 1976; Ireland &
Richards, 1978), further adding to the sensitivity of these cells to
gonadotrophin stimulation. Granulosa cells also produce a number of
important proteins in response to FSH, including proteoglycans (Ax &
V
Ryan, 1979; Yanagishita et al. 1981), which contribute to the formation of
follicular fluid; inhibin and follistatin (Bicsak et al. 1986; Michel et al.
1991b; Hillier et al. 1989b; Michel et al. 1990), which are probably involved
in the control of FSH secretion (see below) and may also be local
regulators of follicular function (see below); plasminogen activators
(Canipari & Strickland, 1986; Ny et al. 1987; O'Connell et al. 1987; Galway
et al. 1990), which are important in ovulation (see below); and a variety of
growth factors and their receptors (Adashi et al. 1985a; Hsueh, 1986;
Hillier, 1990; Adashi et al. 1991), which may be involved in the control of
follicle development and tissue remodelling during the major changes in
structure of the follicle during the ovarian cycle (see below).
Differentiation of granulosa cells in vitro is also accompanied by
profound morphological changes. Upon stimulation with FSH, cultured
granulosa cells become rounded and aggregate (Soto et al. 1986), due to
cytoskeletal reorganization. Stress fibres are dismantled (Amsterdam &
Rotmensch, 1987), and production of the major components of stress
fibres, actin and a-actinin, falls (Ben Ze'ev & Amsterdam, 1987;
>y v/'
Amsterdam & Rotmensch, 1987; Anderson et al. 1988). Production of
y/ y
fibronectin (Skinner et al. 1985; Skinner & Dorrington, 1984), which is an
extracellular matrix protein, and vinculin, which is involved in linking
stress fibres to fibronectin, is also suppressed during FSH-induced
differentiation (Ben Ze'ev & Amsterdam, 1986; Amsterdam &
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Rotmensch, 1987; Ben Ze'ev & Amsterdam, 1987). FSH also stimulates
the formation of gap junctions between granulosa cells (Lindner et al.
1977; Ben Ze'ev & Amsterdam, 1987), allowing them to pass nutrients
between each other and to the oocyte, which becomes increasingly
important as the follicle grows, since the granulosa cell layer has no direct
blood supply. The formation of gap junctions between granulosa cells
allows other molecules to be passed throughout the granulosa layer. In
particular, cAMP produced in response to gonadotrophins can be passed
through gap junctions, so that cells devoid of gonadotrophin receptors
can still respond through coupling with their neighbours (Lawrence et al.
1978).
Therefore, FSH acts on granulosa cells not only to drive the growth
of the follicle and production of steroid and protein hormones, but also to
increase the sensitivity of the granulosa cells to gonadotrophins through
increased expression of their receptors, functional coupling via gap
junctions as well as through production of steroids and protein factors
which, as discussed below, also act to increase the sensitivity of the follicle
to gonadotrophins.
3.2 Function of LH
LH administered in vivo in the absence of FSH leads to the growth
of follicles (Simpson et al. 1941; Greep et al. 1942). This effect is not so
marked as the effect of FSH, and is largely due to thecal hypertrophy
(Erickson et al. 1985). When administered in conjunction with FSH,
however, LH triggers ovulation and subsequent formation and
maintenance of corpora lutea (Greep et al. 1942; Lostroh & Johnson, 1966;
Smith & Bradbury, 1966), hence its name.
Until late follicular development, receptors for LH are limited to the
theca compartment of the follicle, where LH acts to stimulate the
production of a number of factors, in particular androgens and
progestogens (Erickson et al. 1985; Erickson & Ryan, 1976; McNatty et al.
1980; Tsang et al. 1979b). LH therefore acts in the developing follicle to
stimulate the theca cells to provide the granulosa cells with androgen
substrate for the synthesis of oestrogens. As the follicle grows, its
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granulosa cells mature in response to FSH, and express receptors for LH.
Such granulosa cells respond to low levels of LH by producing oestrogen,
progesterone, inhibin and other factors, in the same way as they do to
FSH (Hillier, 1985; Hsueh et al. 1984). High levels of LH cause ovulation
and luteinisation of granulosa cells. These granulosa-lutein cells then
secrete progesterone in response to LH (Moor, 1974).
3.3 Signal Transduction
Gonadotrophins bind to specific membrane receptors, which are
members of a large family of structurally related membrane receptors.
Members of this family are large, single chain polypeptides with seven
regions of hydrophobic residues, separated by short stretches of
hydrophilic amino acids. The hydrophobic regions of the receptors span
the cell membrane, and the hydrophilic regions connect these
membrane-spanning regions, forming intracellular and extracellular
loops (Johnson & Dhanasekaran, 1989). The hormone recognition site of
the receptor resides in the long extracellular amino terminus. The
LH/hCG receptor has been studied in some detail, and its cDNA recently
cloned (Bernard et al. 1990; Minegishi et al. 1990; McFarland et al. 1989).
The molecular weight of the ovarian LH receptor has been reported to be
between 85kDa and 93kDa in its monomeric glycosylated form (Minegishi
et al. 1989; Rosemblit et al. 1988) and between 59kDa and 62kDa when
^ /
deglycosylated (Minegishi et al. 1989; Petaja Repo et al. 1991). The
glycosylation of the hormone-binding domain may be involved in the
interaction of the receptor with the ligand(Dufau et al. 1989; Minegishi et
al. 1989), although this has recently been disputed (Petaja Repo et al. 1991).
Certainly, the glycosylation of the ligand (LH or hCG) is important to its
binding (Petaja Repo et al. 1991; Sairam et al. 1990). It has also been
reported that the receptor exists in the membrane as a dimer (Dufau et al.
1989; Zhang & Menon, 1989). As well as activation of adenylate cyclase,
binding of ligand to the LH receptor leads to phosphorylation by protein
■
kinase A (Dufau et al. 1989; Minegishi et al. 1989), and this may be
involved in the striking down-regulation of the receptor by LH
(Rosemblit et al. 1988). Less is known about the FSH receptor, but since it
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has recently been cloned, no doubt more information will soon be
available. Based on its cDNA sequence, the FSH receptor has a predicted
deglycosylated molecular weight of approximately 75kDa, with a long (348
amino acids) extracellular hormone-binding domain which is potentially
glycosylated in three positions (Sprengel et at. 1990). The FSH receptor
bears high sequence homology with the LH/hCG receptor, as would be
expected from the similarity of the ligands, especially in the
transmembrane regions.
Both receptors are functionally coupled to G-proteins (Reichert &
Dattatreyamurty, 1989), and the intracellular loops are thought to be the
site of this interaction (Johnson & Dhanasekaran, 1989). G-proteins
consist of three subunits, designated a, [3 and y in descending order of
molecular weight. It is the a-subunit which appears functionally to be the
most important component of the G-proteins, although little is known
about the functions of the other subunits other than that they serve to
anchor the inactivated a-subunit to the cell membrane. The a-subunit
contains a region in its carboxy terminus which binds to a part of the
receptor to which it is coupled, probably by one of the intracellular loops
of the receptor (Johnson & Dhanasekaran, 1989). Antibodies to this region
of the G-protein a-subunit are capable of uncoupling the G-protein from its
receptor (Spiegel et at. 1990; Milligan et al. 1990). Another region of the a-
subunit binds GDP in its inactivated state, but upon agonist binding to the
receptor, the receptor catalyses the exchange of bound GDP for GTP, the
predominant form of guanosine phosphate in the cell, is bound instead.
This results in dissociation of the a-subunit from the other subunits, and
in this free state the a-subunit exerts its action on intracellular second
messenger metabolism. The a-subunit possesses intrinsic GTPase activity,
and converts its bound GTP to GDP, returning the protein to its inactive
membrane-bound form (Johnson & Dhanasekaran, 1989).
G-protein a-subunits exist in a number of forms which stimulate or
inhibit production of intracellular second messengers or ion channel
opening, depending on their type. The type of G-protein a-subunit
coupled to gonadotrophin receptors is a stimulatory (denoted as) protein,
which activates the membrane-bound enzyme adenylate cyclase (Spiegel
et al. 1988). This enzyme converts adenosine diphosphate (ADP) to cAMP,
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which acts as the second messenger mediating the actions of both FSH
and LH. cAMP exerts its effects through activation of cAMP-dependent
protein kinases (protein kinase A). Protein kinase A consists of four
subunits; two regulatory cAMP-binding subunits, and two catalytic
subunits (Taylor et at. 1990). Binding of cAMP to the regulatory subunits
allows phosphorylation of a variety of proteins, resulting in acute effects,
for example on steroidogenesis, and also longer term effects on gene
expression. The exact mechanism whereby activation of protein kinase A
leads to changes in gene expression is not fully understood. A
transcription factor known as cAMP response element-binding protein
(CREB) has been identified, which binds as a dimer to an enhancer
element known to mediate cAMP responsive gene expression, the cAMP
response element (CRE), and stimulates transcription from genes under
the regulation of a CRE (Montminy et at. 1990). It is likely that protein
kinase A directly or indirectly activates CREB, leading to expression of
gonadotrophin-responsive genes in ovarian cells.
LH, presumably through LH receptor activation of a different
G-protein intermediate, is also capable of stimulating release of inositol
phosphates and diacylglycerol from thecal and granulosa cell membranes,
and is therefore also able to activate protein kinase-C (Davis et al. 1983;
Davis et al. 1984; Davis et al. 1986a; Dimino et al. 1987). The contribution
of this second messenger pathway in the mediation of LH effects is not
clear.
3.4 Control of Gonadotrophin Secretion
FSH and LH are released in response to stimulation of the
gonadotrophs by the hypothalamic decapeptide, gonadotrophin-releasing
hormone (GnRH). This factor is synthesized in the cell bodies of
neurones situated mainly in the medial preoptic area and the arcuate and
paraventricular nuclei of the hypothalamus, and transported to their
terminals in the median eminence. GnRH is then released into the
hypophysial portal vein in a pulsatile fashion and delivered to the
anterior pituitary by the blood (Johnson & Everitt, 1988). The nature of
the receptor for GnRH is still obscure, but it is likely to be another
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member of the seven transmembrane domain G-protein coupled receptor
family. GnRH acts to stimulate release of gonadotrophins acutely, and
also to stimulate expression of the genes encoding gonadotrophin (3-
subunits. GnRH also acts to increase numbers of its own receptor (the so-
called self-priming effect). These effects are mediated through a calcium-
dependent mechanism, probably through activation of protein kinase C
(Conn, 1989).
LH is released from intracellular stores in pulses in response to
pulses of GnRH, whereas FSH release is more dependent upon its rate of
synthesis, and is therefore released more or less continuously (McNeilly,
1988).
The secretion of gonadotrophins is under control at the level of both
pituitary and hypothalamus. Circulating steroid and protein factors
produced by the ovary exert both negative (especially on FSH) and
positive feedback on the secretion of gonadotrophins. The major steroid
involved in the control of FSH secretion is oestradiol, although high
concentrations of progesterone exert similar suppressive effects at the
pituitary. At low circulating levels of oestradiol, FSH secretion is rapidly
inhibited. This action of oestradiol is mainly exerted at the pituitary,
where it acts to inhibit transcription of both the a-subunit and
u/
particularly the (3-subunit of FSH (Phillips et al. 1988). The suppression of
secretion of FSH by oestradiol or progesterone is very rapid and profound,
and can be accounted for entirely by this suppression of FSH p-subunit
mRNA synthesis. Although steroids inhibit transcription of the a-
subunit, LH levels remain fairly constant while FSH levels fall (Baird,
1991), because secretion of FSH is more dependent upon its rate of
synthesis than LH (see above).
Although low concentrations of oestradiol acutely suppress FSH
secretion, longer exposure to high concentrations results in a massive
release of LH, and to a lesser extent FSH. It is this surge of LH which
triggers ovulation. The mechanism of oestrogen positive feedback
involves action both at the pituitary, where it progressively enhances
sensitivity to GnRH over the late follicular phase (Johnson & Everitt,
1988) due to increased GnRH receptor numbers (Laws et al. 1990), and the
hypothalamus, where it increases GnRH pulse frequency at the time of
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the LH surge, probably by an indirect action on non-GnRH-secreting
neurones (Fink, 1988). Progesterone is able to prevent the LH surge in
response to oestradiol (Johnson & Everitt, 1988), partly by its negative
effects on FSH synthesis at the pituitary, and partly by slowing GnRH
pulse frequency at the hypothalamus (Ramirez et al. 1985), explaining
why the large amounts of oestradiol secreted throughout the primate
luteal phase fail to elicit a surge of LH.
A number of proteins potentially produced in the ovary may also be
involved in the control of FSH secretion. Inhibin (see below) has been
shown in a number of species to suppress FSH synthesis and secretion by
cultured pituitary cells (Robertson et al. 1986; Farnworth et al. 1988), and
immunoneutralization of inhibin in vivo results in an increase in
plasma FSH levels and increased ovulation rate in rats, pigs and sheep
(Mann et al. 1989a; Rivier & Vale, 1989; Findlay et al. 1989; Wrathall et al.
1990; Brown et al. 1990). Inhibin appears to exert this effect by reducing the
increase in FSH (3-subunit mRNA in response to GnRH (Carroll et al.
1989), probably by blocking the ability of GnRH to up-regulate its own
receptor (Braden et al. 1990; Busbridge et al. 1990; Wang et al. 1989c).
However, a direct cause-effect relationship between secretion of inhibin
by the ovary and falling plasma FSH levels has not been shown. It may be
that inhibin does inhibit FSH release in vivo, but in humans and sheep
at least, it is probably not responsible for the decline in plasma FSH seen
in the mid-late follicular phase (Baird, 1991). There is less evidence for
the involvement of activin in the control of FSH secretion. This protein
has been shown to stimulate FSH secretion by cultured pituitary cells
(Schwall et al. 1988; Mason et al. 1989), by increasing levels and stability of
FSH-(3 mRNA (Attardi & Miklos, 1990; Carroll et al. 1991), but to date
there is no evidence for the secretion of this protein into the blood. The
diverse sites of production of activin, and the discovery that follistatin,
another gonadal protein capable of suppressing pituitary FSH secretion
v y
(Ying et al. 1987; DePaolo et al. 1991), is a binding protein for activin
(Nakamura et al. 1990), seem to argue against an endocrine role for
ovarian activin in the control of FSH secretion. One very recent report
has shown that injection of activin causes an increase in plasma FSH
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levels in rats (Rivier & Vale, 1991), so the question of the systemic role of
activin in the control of FSH secretion remains open.
4 The ovarian cycle
The mammalian ovarian cycle consists of a repeated process of
follicle recruitment, selection, ovulation and corpus luteum formation
and regression. The human menstrual cycle can be split into two
functional phases, follicular and luteal. The follicular phase is the part of
the cycle during which small follicles are stimulated to grow in response
to an initial rise in FSH levels and tonic LH levels. As this phase
progresses, the appropriate number of follicles which begin to secrete
oestrogen are "selected", while others become atretic. During this phase
tonic LH levels are maintained and FSH levels gradually fall as oestrogen
secretion by the dominant follicle(s) rises. The transition from the
follicular phase to the luteal phase is marked by a surge of gonadotrophin
from the pituitary, followed some hours later by ovulation. The ovulated
follicle becomes the corpus luteum, which in humans secretes
progesterone, oestradiol and inhibin. The lifespan of this gland in a non-
fertile cycle is the length of the ensuing luteal phase. After regression of
the corpus luteum, gonadotrophin levels rise again, triggering another
cycle. The events of the cycle are governed by the secretion of
gonadotrophins by the pituitary, and the resulting secretion of steroids
and other factors, which exert feedback control over gonadotrophin
secretion. Hence, the cyclicity of the process is an intrinsic property of the
interaction between the ovary and the pituitary (and hypothalamus), and
in humans and other non-seasonal species is not imposed by the central
nervous system.
The relative durations of the two phases of the cycle and the number
of eggs ovulated in each cycle vary between species. Species can be
classified very roughly into three groups on the basis of the relative
lengths of the follicular and luteal phases of their cycles. The first group
of species, which includes humans and most other primates, have
follicular and luteal phases of approximately the same length.
Development of small follicles does not begin in these species until the
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corpus luteum regresses. This may be because the corpus luteum in these
species secretes oestrogen and inhibin as well as progesterone (Baird, 1991;
Bassett et al. 1990), resulting in suppression of gonadotrophin secretion
from the pituitary. As a result, the follicle must go through the whole
process of gonadotrophin-dependent development after regression of the
corpus luteum.
Some other species, such as pigs, guinea pigs, cows and sheep, have a
luteal phase roughly equivalent to that of the human, but their follicular
phase is much shorter. This is probably because their corpora lutea secrete
no oestrogen or inhibin (Greenwald, 1979; Mann et al. 1989b; Henderson
& Franchimont, 1983). Consequently, levels of gonadotrophin (in
particular FSH) are much higher during the luteal phase in these species.
This allows follicle development to occur while the corpus luteum is still
present.
The third group of mammals which includes rats, mice and
hamsters, corpora lutea are not functional (i.e. secrete little progesterone)
and will regress in 2-3 days, unless coitus has taken place. Follicular
development is triggered in rats by a secondary surge of FSH occurring on
the morning of oestrus, at about the same time as ovulation (Barraclough
& Wise, 1979). As a result, rats have very short oestrous cycles of four to
five days. A functional luteal phase of a length comparable to that of
long-cycle species can be induced by mating a female of one of these
species with an infertile male. This induced luteal phase is known as
pseudopregnancy. In rabbits and cats, even ovulation does not take place
without physical stimulation of the cervix, and these species appear to
have permanent follicular phases, with repeated waves of antral
follicular development and atresia occurring until mating, which triggers
an LH surge, leading to ovulation followed by a luteal phase.
The difference in the relative lengths of follicular and luteal phases
between primates and other mammals is probably related to their
different types of ovarian cycle. Primates such as humans have menstrual
cycles in which the endometrium is shed at the end of the luteal phase of
every infertile cycle. Consequently, the endometrium must be fully
regenerated by the time an embryo reaches the uterus to implant, placing
a minimum limit on the interval between ovulations. This may be the
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reason for extending the follicular phase by suppression of
gonadotrophin secretion during the luteal phase (Baird, 1991).
4.1 Recruitment of Secondary Follicles
As described above, there is a steady trickle of follicles beginning to
grow in response to unknown cues and independently of gonadotrophins
throughout life. It has been shown that pregnant mare serum
gonadotrophin (PMSG), which has both FSH and LH activity, has no
effect on the growth of follicles until they have developed a distinct theca
layer (Goldenberg et al. 1973). By the time these follicles begin to develop
an antrum, their granulosa cells have developed receptors for FSH, and
their theca cells have developed LH receptors (Oxberry & Greenwald,
1982; Uilenbroek & Richards, 1979). Shortly after the LH surge, FSH levels
peak for a second time in many species including the rat and sheep
(McNeilly, 1988; Butcher et al. 1974; Pant et al. 1977). This is thought to be
due to a drop in secretion of oestradiol and inhibin by the preovulatory
follicle which occurs after the LH surge in these species (Watanabe et al.
1990; Campbell et al. 1990; Barraclough & Wise, 1979). Since these factors
inhibit FSH secretion, it is freed from negative feedback soon after the LH
surge. This rise in FSH levels is responsible for the recruitment of the
small antral follicles present at that time. In most species, therefore, the
development of follicles in a cycle begins at the beginning of the luteal
phase of the previous cycle. In primates, the situation is rather different.
Because the primate corpus luteum secretes oestradiol and inhibin as
well as progesterone, there is no relaxation of negative feedback on the
pituitary until regression of the corpus luteum. At this point, FSH levels
do rise, and the next wave of small follicles is recruited.
Theca and particularly granulosa cells of these follicles proliferate,
and the theca begin to synthesize androgens in response to tonic levels of
LH (see below). In the mid to late follicular phase, however, most of these
developing follicles will degenerate, or become atretic. A number of
follicles, depending on the species, do not become atretic, and are destined
to ovulate.
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As the recruited follicle increases in size, the granulosa cells within a
follicle are not all at exactly the same stage of differentiation. The
expression of steroidogenic enzymes is greatest in the granulosa cells
closest to the basement membrane (Goldschmit et at. 1989; Zlotkin et at.
1986; Tabarowski & Szoltys, 1987; Rune & Heger, 1987). The expression of
LH receptors follows the same pattern (Oxberry & Greenwald, 1982;
Richards et at. 1987); the binding capacity of the granulosa cells forming
the wall of the follicle is tenfold greater than that of the cumulus cells
(Lawrence et at. 1980). Conversely, proliferation of granulosa cells as
determined by tritiated thymidine uptake is greatest in the cells lining the
antrum and surrounding the oocyte (Hirshfield, 1986). Interestingly,
expression of mRNA encoding IGF-I, which is implicated in the control
of granulosa cell proliferation (see below), is also greatest in the cells
*/
lining the antrum (Oliver et at. 1989). Despite the presence of gap
junctions coupling cells in the granulosa layer, therefore, it does not
function entirely as a syncitium. There appears to be a gradient of
differentiation, at its highest near the thecal layer and the blood supply,
and a gradient of proliferation in the opposite direction. It is likely that
this is due to better access in the region nearest the basement membrane
to FSH and other factors from the blood, and to regulatory factors such as
androgen from the theca. Although cAMP produced by FSH-stimulated
(or LH-stimulated) cells can be passed between cells through gap
junctions, it appears that it does not penetrate the most distant cells,
probably gradually being broken down by phosphodiesterases en route.
4.2 Selection of Dominant Follicles
As the follicle develops, the steroidogenic capacity of its granulosa
cells increases in response to FSH. Secretion of inhibin by granulosa cells
is also stimulated by FSH. As a result, towards the end of the follicular
phase of the cycle, concentrations of oestradiol and inhibin in the blood
increase which feed back to the pituitary, to suppress the secretion of FSH.
Therefore, at this stage of the cycle, large numbers of growing follicles are
exposed to declining trophic support. Many of these follicles are unable to
withstand this, and become atretic. However, those follicles which are
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most advanced are able to continue growing despite lower FSH exposure.
Such follicles are termed dominant, and the number of follicles selected
in a cycle varies with different species. There is strong evidence that a key
factor in the selection of a follicle is its capacity for synthesizing oestrogen.
This ability of a follicle to continue developing despite falling FSH
levels is thought to be due to a reduced threshold concentration of FSH
required by that follicle for continued growth (Baird, 1987). Since all
follicles are exposed to the same concentration of FSH from the blood, it
seems likely that this increased sensitivity to FSH is due to the influence
of locally produced substances. The relative importance of a number of
substances which have been implicated in this mechanism is discussed in
detail below. In addition, one of the most important effects of FSH is the
induction during the second half of the follicular phase of receptors for
LH on the granulosa cell membranes. This receptor, like the FSH
receptor, is also coupled to the cAMP signalling system. Therefore, in
follicles containing mature granulosa cells possessing LH receptors, tonic
levels of LH are able to make up for falling FSH levels.
4.3 Ovulation
As the dominant follicle increases in size, its capacity for oestrogen
secretion increases, and levels of oestradiol in the blood increase to a
level at which its effects on the pituitary are positive. This leads to a
massive release of both FSH and, more importantly, LH. This surge of LH
stimulates production of progesterone (Moor, 1974) and prostaglandins
(Morioka et al. 1989; Wong et al. 1989) by the granulosa cells of the
preovulatory follicle, both of which are involved in the processes which
lead to ovulation. Progesterone promotes ovulation in perifused ovaries
(Baranczuk & Fainstat, 1976; Greenwald, 1977; Tsafriri et al. 1987), and it
has been suggested that it does so by interfering with collagen synthesis in
the follicle wall (Tjugum et al. 1984). Prostaglandins have also been
shown to induce ovulation (Strickland & Beers, 1976), and indomethacin,
an inhibitor of prostaglandin synthesis, is able to block this effect
(Canipari & Strickland, 1986). The action of prostaglandins may be exerted
at several levels. Prostaglandins produced in response to the
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gonadotrophin surge lead to increased blood flow to the follicle,
accompanied by increased vascular permeability (Brannstrom & Janson,
1991) leading to increased follicular fluid volume. The last phase of
preovulatory follicle growth is not due to cell proliferation, but increased
follicular fluid volume (Brannstrom & Janson, 1991). Prostaglandins also
affect contractility of smooth muscle in the theca externa layer (Morioka
et al. 1989), although the involvement of muscle contractility in
/
ovulation is uncertain (Brannstrom & Janson, 1991). It is clear, however,
that the production of proteases in the follicle is involved in follicular
rupture. The major proteolytic enzymes produced by granulosa and theca
cells, as well as oocytes, are plasminogen activators (Curry et al. 1989;
Cajander, 1989). Production of plasminogen activators (especially tissue-
type plasminogen activator) is stimulated by both gonadotrophins
(Galway et al. 1990; Liu et al. 1987a; Canipari & Strickland, 1986), and is
maximal at around the time of ovulation (Canipari & Strickland, 1985)
and the enzyme is most abundant in the apical region of the follicle,
where the stigma forms (Liu et al. 1987a). Expression of collagenases is
also stimulated by human chorionic gonadotrophin (hCG) (Reich et al.
1991). These enzymes are believed to play an important part in follicle
rupture by degrading connective tissue in the follicle wall, a hypothesis
which is supported by the observation that administration of antibodies
to plasminogen activator partially blocks ovulation (Tsafriri et al. 1989a).
Prostaglandins also stimulate granulosa cell plasminogen activator
synthesis (Canipari & Strickland, 1986), and it has been suggested that the
gonadotrophin stimulation of plasminogen production is actually
mediated through prostaglandin synthesis and autocrine action (Canipari
& Strickland, 1986). Progesterone is also involved in the synthesis of
plasminogen activator, by augmenting the effects of gonadotrophins (Ny
et al. 1985).
Just prior to ovulation, gap junctions between the cumulus cells and
between the oocyte and the cumulus cells break down (Lindner et al.
1977), and the cumulus mass expands, due to intercellular accumulation
of hyaluronic acid (Eppig, 1991). This may allow the cumulus-oocyte
complex to float freely in the antrum, allowing its expulsion when the
follicle ruptures. This breakdown of communication between the oocyte
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and the granulosa cells and between the cumulus cells and the mural
granulosa cells is followed by reinitiation of meiosis by the oocyte,
probably due to the removal of inhibitory factors such as cAMP or
purines produced by the granulosa cells (see above), or possibly due to
removal of electrical coupling of the oocyte and granulosa cells (Lindner
et at. 1977).
4.4 The Corpus Luteum
Following ovulation, the follicle collapses, the basement membrane
fragments (Yoshinaga Hirabayashi et al. 1990) and the cells of the follicle
wall fill the antrum, to form the corpus luteum. To support the cells in
this more solid structure, blood vessels invade the cell mass. The corpus
luteum secretes progesterone, and in primates, oestradiol and inhibin as
well (Savard et al. 1965; McLachlan et al. 1987; Fraser et al. 1989). The
function of this is to provide a secretory endometrium to support
pregnancy in the event of conception and implantation, until the
placenta has developed sufficiently to take over. Accordingly, the
granulosa cells of the former follicle enlarge and accumulate cytoplasmic
lipid droplets and large numbers of mitochondria, which are the
characteristics of active steroid-secretory cells. This is the final stage of the
differentiation of the granulosa cells, and is known as luteinisation. The
granulosa-lutein cells lose their responsiveness to FSH, due to a loss of
FSH receptors (Lee & Takahashi, 1977; Oxberry & Greenwald, 1982;
Richards et al. 1976; Camp et al. 1991), but remain responsive to LFL The
theca-lutein cells also secrete progesterone in response to LH. In some
species such as rats and mice, another pituitary hormone, prolactin, also
stimulates luteal steroidogenesis (Hilliard, 1973), but its luteotrophic
action is less clear in other species. The steroidogenic capacity of the luteal
cells is at its greatest at the beginning of the luteal phase and declines
thereafter, although their LH responsiveness may increase (Fisch et al.
1989). Progesterone concentrations continue to rise during the luteal
phase however, and this discrepancy has been explained by the increasing
vascularisation of the corpus luteum during the first half of the luteal
phase (Niswender et al. 1976). During the second half of the luteal phase
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of an infertile cycle, progesterone secretion by the corpus luteum falls
until the gland regresses altogether. The longevity of the corpus luteum
depends upon the species, from a luteal phase accounting for most of the
cycle in sheep and pigs, to no true luteal phase at all, unless coitus has
taken place, in the rat (Barraclough & Wise, 1979). However, in a
particular species, the lifespan of the corpus luteum is fixed, and in an
infertile cycle the luteal cells die after that time has elapsed. The
regression of the corpus luteum appears not to be dependent upon LH
levels, but rather it seems to be an inherent property of the corpus
luteum which has been suggested to be a form of "programmed" cell
death (Zeleznik, 1991; Hurwitz & Adashi, 1992; Kaynard et al. 1992). If
pregnancy is established, however, chorionic gonadotrophin (CG) is
secreted by the placenta of some species such as the human. This
hormone acts on the same receptor as LH, and is able to "rescue" the
corpus luteum and prolong its lifespan. Why CG is able to rescue the
corpus luteum when LH is not is not yet clear, but is probably related to
the greater half-life of CG (Rizkallah et al. 1969), and the slower
internalisation of CG-receptor complexes by luteal cells (Mock &
Niswender, 1983).
5 Ovarian steroidogenesis
Steroid hormones are produced from cholesterol by the action of a
variety of separate enzymes, each catalyzing specific reactions. Three
classes of steroid hormone are produced in the ovary; progestogens,
androgens and oestrogens. Pathways of steroidogenesis in the ovary are
summarised in Fig.1.1. The specific steroids produced and how much is
produced depends not only on the enzymes present, but also on the
availability of substrates. The enzymes are expressed in a cell-specific
manner, and their expression is under the direct influence of
gonadotropins and locally produced paracrine factors.
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Fig. 1.1. Pathways of steroid synthesis in the ovary.
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5.1 The Biochemistry of Steroidogenesis
5.1.1 Uptake of Cholesterol
Cholesterol is the compound from which all other steroids are
synthesized. Steroidogenic cells are capable of synthesizing cholesterol
from acetyl coenzyme A, via a pathway in which the rate-limiting step is
catalyzed by 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG
CoA reductase). However, given an adequate supply, the preferred source
of cholesterol is in the form of blood-borne lipoproteins. Cholesterol is
delivered to the ovary in the blood either as low density lipoproteins
(LDL) or high density lipoproteins (HDL). The relative amounts of LDL
and HDL used as sources of cholesterol varies between species; in
humans LDL is the preferred source, whereas in rats cholesterol is mainly
taken up from HDL (Miller, 1988; Gwynne & Strauss, 1982).
LDL is taken up by receptor-mediated endocytosis at the microvilli of
steroidogenic cells, and the lipoprotein degraded in lysosomes. LDL
receptors are recycled to the plasma membrane. The mechanism by which
cholesterol is taken up from HDL is less clear. It is thought that the HDL
associates with a recognition site on the plasma membrane (Ghosh &
Menon, 1986), but rather than being internalized, the HDL may release its
cholesterol, through the action of lipases present on the surface of the
cell, which then passes into the cell.
Cholesterol is stored within the cell in lipid droplets, esterified to
fatty acids. The synthesis of cholesterol esters is catalyzed by acyl
coenzyme A: cholesterol acyltransferase (ACAT), and their breakdown, to
yield free cholesterol for metabolism to steroids, is catalyzed by
cholesterol esterase. During active steroidogenesis, cholesterol is
mobilized from stored cholesterol esters, and transported to the
mitochondria, where the first stage of steroidogenesis takes place. The
transport of cholesterol to the mitochondria remains obscure, but it
probably involves sterol-carrier protein (SCP2), although other factors
are likely to be involved, including fatty acid-binding protein and other as
yet unidentified factors (Strauss & Miller, 1991; Holt et al. 1991).
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5.1.2 Steroidogenic P450 Enzymes
Three members of the cytochrome P450 enzyme superfamily are
involved in ovarian steroidogenesis. All mammalian members of this
group of enzymes are membrane-bound proteins with a haem prosthetic
group, and they require transport of electrons from NADPH via
intermediates, including one flavoprotein, for their action (Strauss &
Miller, 1991; Takemori & Kominami, 1984).
Cholesterol side-chain cleavage cytochrome P450 (P450scc) is a 50kDa
mitochondrial enzyme which catalyzes the initial, rate-limiting step in
the synthesis of all steroids, which is the removal of six carbon atoms
from the side-chain of cholesterol to produce pregnenolone, a steroid
with 21 carbon atoms (C-21 steroid). Electrons from NADPH are passed
via the flavoprotein ferredoxin reductase (also known as adrenodoxin
reductase) to an iron-sulphur protein ferredoxin (also known as
adrenodoxin) associated with ferredoxin reductase. The reduced
ferredoxin dissociates from ferredoxin reductase and binds to P450scc,
passing its electrons to the haem group of P450scc. Ferredoxin then is
shuttled back to ferredoxin reductase. The reaction takes place in three
steps; two hydroxylations at carbons 20 and 22, followed by cleavage of the
bond between those atoms. Hence, the reaction requires three pairs of
electrons, and therefore three cycles of reduction and oxidation of
ferredoxin.
All following stages of ovarian steroidogenesis take place in the
smooth endoplasmic reticulum. The synthesis of androgens (C-19
steroids) from progestogens takes place in two steps, which are both
catalyzed by a 50kDa cytochrome P450 enzyme, 17a-hydroxylase/C17,20-
lyase (P450cl7). First, the carbon atom at position 17 is hydroxylated and
second, the bond between that carbon and the carbon atom at position 20
is broken. As for the side-chain cleavage step, electrons must be provided
by NADPH via a flavoprotein. Electrons for the first step are passed to
P450cl7 by P450 reductase, and for the second step either by P450 reductase
or cytochrome bs (Takemori & Kominami, 1984). P450cl7 can utilize
either pregnenolone (a A 5-progestogen) or progesterone (a
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A4-progestogen) as a substrate, to yield dehydroepiandrosterone (DHEA)
or androstenedione, respectively. However, pregnenolone is the
preferred substrate (Zuber et al. 1986).
The third major cytochrome P450 in the ovarian steroidogenic
pathway is the 55kDa aromatase enzyme (P450arom), which catalyzes the
conversion of C-19 androgens to C-18 oestrogens. The reaction takes place
in three steps. The methyl group at position 19 is hydroxylated twice,
which causes it to be lost, and the carbon atom at position 3 is
hydroxylated, leading to aromatization of the A ring. Three pairs of
electrons, again derived from NADPH, are supplied by P450 reductase
(Osawa et al. 1987). There are two major substrates for this enzyme in the
ovary; androstenedione and its 17p-hydroxylated counterpart,
testosterone. Action of aromatase on these steroids yields estrone and
17(3-oestradiol, respectively. Aromatase is not able to use 5a-
dihydrotestosterone (DHT), the most potent androgen in many tissues
(Johnson & Everitt, 1988), as a substrate, and DHT can act as a competetive
aromatase inhibitor (Hillier et al. 1980a; Hillier et al. 1980b).
5.1.3 Steroid Dehydrogenases
The conversion of A5-steroids to A4-steroids is catalyzed by the 46kDa
enzyme 3(3-hydroxysteroid dehydrogenase/A5'4 isomerase (3(3-HSD),
which also carries out 3|3-hydroxylation. The enzyme is localized to the
endoplasmic reticulum (Miller, 1988) in close proximity to the
mitochondria, where pregnenolone is produced by the side-chain
cleavage complex. This pregnenolone is converted by 3|3-HSD to
progesterone, using electrons donated directly by NADH or NADPH.
Other substrates in the ovary include 17-hydroxypregnenolone,
dehydroepiandrosterone and androstenediol, which are converted to 17-
hydroxyprogesterone, androstenedione and testosterone, respectively.
This step is not rate-limiting, since ovarian cells are capable of converting
large amounts of pregnenolone to progesterone in the absence of trophic
stimulation (Strauss & Miller, 1991).
The only readily reversible reaction in ovarian steroidogenesis is the
interconversion of the 17-ketone group of dehydroepiandrosterone,
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androstenedione and estrone and the 17-hydroxyl group of
androstenediol, testosterone and oestradiol, respectively. Because of this,
the enzyme catalyzing this step is variously called 17(3-hydroxysteroid
dehydrogenase (17(3-HSD), 17-ketosteroid reductase or 17-oxidoreductase.
This enzyme is present in both theca and granulosa cells, and appears to
be constitutively expressed (Bogovich & Richards, 1984).
5.1.4 Other Ovarian Enzymes of Steroid Metabolism
y
Granulosa cells posess 20a-hydroxylase activity (Davoren & Hsueh,
1986), which converts progesterone to the relatively inactive progestogen,
20a-hydroxyprogesterone. They also posess 5a-reductase (Moon &
Duleba, 1982; Makris & Ryan, 1980; Nimrod, 1977a), which converts
testosterone to DHT. The significance of these enzymes in ovarian
steroidogenesis is uncertain, but since 20a-progesterone is converted to
androgen in the ovary (Goldring & Orly, 1985), it could be that the reason
for the production of this progestogen is to provide substrate for
androgen synthesis without the hormonal activity of progesterone.
5.2 The "Two Cell, Two Gonadotrophin" Theory
The present model of ovarian oestrogen synthesis was initially based
on the observations that both FSH and LH (Fevold, 1941) and both
granulosa cells and theca interna cells (Falck, 1959) are required for the
synthesis of oestrogen by the ovary. In 1962, based on studies in the horse,
Short proposed a "two-cell" theory whereby granulosa cells synthesize
progesterone, which is then aromatized to oestrogens in the theca. For a
long time, the theca were considered to be the major site of oestrogen
synthesis (Ryan & Petro, 1966; Goldenberg et al. 1973; Makris & Ryan,
1975), although granulosa cells were shown to possess aromatase activity,
as well as 17(3-HSD and 3J3-HSD (Bjersing, 1967). In later studies it began to
emerge that granulosa cells produce oestrogen from exogenous androgen
precursor in response to FSH (Dorrington et al. 1975; Tsang et al. 1987),
and that in many species the granulosa cells are in fact the major, if not
sole, ovarian source of oestrogen (Hillier et al. 1981). Conversely, it was
Chapter 1 Literature Review 26
demonstrated that theca cells secrete androgens under the influence of
LH in culture, whereas granulosa cells are unable to synthesize androgens
(Tsang et al. 1979b; Tsang et al. 1987), consistent with earlier evidence that
granulosa cells display very little 17a-hydroxylase activity (Bjersing, 1967).
The "two-cell, two-gonadotrophin" model of ovarian oestrogen synthesis
which has now gained almost universal acceptance states that LH and
FSH stimulate progesterone synthesis in the theca and granulosa cells,
respectively, which then acts as a substrate for LH-stimulated androgen
synthesis in the theca cells. Thecal androgen diffuses across the basement
membrane to the granulosa cell layer, where FSH stimulates its
conversion to oestrogen. This theory is summarised in Fig.1.2.
Numerous studies in several species have now confirmed by
immunocytochemistry (Yoshinaga Hirabayashi et al. 1987; Sasano et al.
1989a; Sasano et al. 1989b; Rodgers et al. 1986a) and by using cDNA probes
to P450cl7 mRNA (Voutilainen et al. 1986) that thecal and interstitial
cells are the only ovarian cells which express this enzyme. The synthesis
of androgens by thecal cells in culture is stimulated by LH and cAMP
analogues (Tsang et al. 1979b; Roberts & Skinner, 1990b), and this is
associated with an increase in expression of the mRNA and the protein
for P450cl7 (Magoffin, 1989; McAllister et al. 1989). Furthermore,
immunocytochemical studies (Ishimura et al. 1989; Sasano et al. 1989b;
Naganuma et al. 1990) and the use of cDNA probes for P450arom
(McAllister et al. 1989; Hickey et al. 1990) have confirmed that the
expression of aromatase is restricted to the granulosa cell layer, and that
its expression is stimulated by FSH or artificial elevation of intracellular
cAMP levels (Steinkampf et al. 1987).
Both cell types express P450scc (Zlotkin et al. 1986; McAllister et al.
1989) and are able to synthesize pregnenolone and progesterone in
culture (Roberts & Skinner, 1990b; Hsueh et al. 1984). Secretion of
progestogens and expression of P450scc protein and its mRNA correlate
well, and are stimulated by FSH in granulosa cells, by LH in theca cells
and by cAMP analogues in both cell types (Trzeciak et al. 1986; McMasters
et al. 1987; Goldring et al. 1987; Magoffin, 1989; McAllister et al. 1989;
Oonk et al. 1990; Urban et al. 1991). However, since a partial barrier
between the blood and the granulosa cell layer exists which may limit
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LH BM FSH LH
Fig. 1.2. The "Two-Cell, Two-Gonadotrophin" theory of ovarian steroidogenesis.
LH, acting on the theca cells, stimulates expression of the cytochrome P450
enzymes side-chain cleavage (SCC) and 17a-hydroxylase (17a), leading to androgen
production. Androgen diffuses across the basement membrane (BM) to the
granulosa cell layer, where it is converted to oestrogen under the influence of FSH,
by cytochrome P450 aromatase (arom). As the granulosa cells mature, they develop
receptors for LH, and so oestrogen synthesis also comes under the control of LH.
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access of granulosa cells to lipoproteins (Shalgi et al. 1973), it is uncertain
whether granulosa cells within the follicle synthesize much C-21 steroid
to act as precursor for androgen and oestrogen synthesis. As noted above,
however, granulosa cells may synthesize cholesterol from acetate by the
action of HMG CoA reductase.
Other components of the steroidogenic machinery are affected by
FSH and LH which, together with increased expression of P450 enzymes,
increase the steroidogenic capacity of the cells. Thecal 3|3-HSD activity and
mRNA levels have been shown to increase in response to hCG
stimulation in the rat and pig (Martel et al. 1990b; Chedrese et al. 1990;
Martel et al. 1990a), and granulosa cell 3J3-HSD activity is stimulated by
FSH (Hsueh et al. 1984). Levels of this enzyme mirror those of P450scc,
with expression being higher in thecal cells than granulosa cells (Dupont
et al. 1990), and highest in the corpus luteum (Zhao et al. 1991; Couet et al.
1990).
Stimulation of steroidogenic P450 enzymes by gonadotrophins is
associated with some increase in the expression of their associated
electron transport proteins, reflecting an increase in the number of
mitochondria (Rodgers et al. 1986b). Expression of ferredoxin in human
preovulatory granulosa cells is increased by hCG, FSH and cAMP
analogues (Voutilainen et al. 1988). It has also been shown in the rat that
follicular ferredoxin mRNA levels rise in response to an ovulatory dose
of hCG, albeit transiently (Hedin et al. 1987b). In the same study, no
change in P450 reductase expression was observed. Studies in the cow
have shown that ferredoxin mRNA levels are at their highest in the
corpus luteum (Rodgers et al. 1987b). The relationship between
expression of steroidogenic P450 enzymes and their electron donors is not
yet clear, presumably because these proteins are generic electron transport
components involved in all P450-mediated processes.
Also, the dynamics of cholesterol synthesis and uptake, and
accumulation and breakdown of intracellular cholesterol ester stores are
affected by gonadotrophins. LDL receptor expression is stimulated in
mature human granulosa cells by hCG and cAMP (Golos et al. 1986; Golos
et al. 1987; Golos & Strauss, 1987). In the bovine ovary LDL receptor
expression is highest in the corpus luteum (Rodgers et al. 1987b), when
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the highest level of steroidogenesis is seen. HMG CoA reductase
expression is also stimulated by cAMP in the bovine corpus luteum
(Rodgers et al. 1987a), and transiently in the rat follicle following hCG
stimulation (Hedin et al. 1987b). The dynamics of cholesterol ester
synthesis and hydrolysis are affected by gonadotrophin stimulation.
However, these effects may not be direct, but due to removal of
intracellular feedback effects of oxysterol (Strauss & Miller, 1991).
These observations generally correlate well with the fluctuations in
the expression of the three key enzymes in the ovary during the cycle.
P450cl7 and P450scc expression can be detected in the theca layer of atretic
as well as healthy follicles from the early antral stage onwards (Zlotkin et
al. 1986; Rodgers et al. 1986a; Hedin et al. 1987b). Aromatase is not
expressed in granulosa cells of small follicles, but is expressed in large
antral follicles (Hickey et al. 1988; Ishimura et al. 1989; Sasano et al. 1989b).
There is some disagreement concerning the exact stage at which P450scc is
first expressed in granulosa cells, but it is clear that it is not expressed in
these cells until at least the late preovulatory stage (Rodgers et al. 1986a;
Zlotkin et al. 1986; Le Goascogne et al. 1989). At the LH surge, P450scc
increases still further (Doody et al. 1990; Hedin et al. 1987b), and there is
evidence that this enzyme is expressed constitutively in the corpus
luteum (Oonk et al. 1990; Hedin et al. 1987b). Androgen production is
rapidly suppressed at the LH surge, probably due to increased progestogen
production which inhibits P450cl7 activity (Eckstein et al. 1985; Johnson,
1988), and in most species, with the exception of the human and other
primates (Doody et al. 1990) this is followed by a decline in P450cl7
mRNA and protein (Ishimura et al. 1990; Hedin et al. 1987b; Rodgers et al.
1986b). P450arom is present in low abundance in the corpus luteum of
many species, including ones which do not secrete oestrogen during the
luteal phase (Yoshinaga Hirabayashi et al. 1990; Hickey et al. 1988). It is
therefore likely that in these species the corpus luteum does not secrete
oestrogen due to lack of androgen substrate, rather than absence of
aromatase. In human ovaries, P450arom mRNA is more abundant in the
corpus luteum than in preovulatory follicles (Doody et al. 1990). This is
surprising, since plasma oestradiol levels are at their highest during the
late follicular phase. This may be due to the large amounts of
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progesterone produced in the luteal phase, which may inhibit P450cl7,
limiting production of androgen substrate (Eckstein et al. 1985; Johnson,
1988).
6 Local Control of Follicle Development
All follicles are exposed to the same blood levels of gonadotrophins,
and yet most which begin to grow become atretic, while others become
dominant and ovulate. This strongly suggests that factors other than
gonadotrophins act locally to bring about this difference in the fate of
follicles. The critical factors determining the fate of a follicle are believed
to be the responsiveness of its granulosa cells to FSH and their ability to
respond to LH i.e. their degree of differentiation. Therefore, a great deal of
research has been carried out into the effects of various locally produced
steroids, proteins and other factors on granulosa cell differentiation.
6.1 Role of Steroids
Since the most conspicuous secretory productsof follicular cells are
steroids, their role for these factors in the local control of granulosa cell
differentiation has been studied in some detail.
6.1.1 Mechanism of Action of Steroids
Steroid action, according to current concepts, is mediated by specific
receptors which belong to a family of transcription factors. Following
cloning and sequence comparison, it has been found that steroid receptors
belong to a large family of nuclear hormone receptors which includes the
receptors for thyroid hormones, vitamin D3, and retinoic acid, as well as
some proteins for which no ligand has yet been found (Evans, 1988;
Parker, 1988). These nuclear hormone receptors have a highly modular
structure, with distinct domains fulfilling discrete functions (see Fig.1.3)
which have been elegantly characterised by mutagenesis (Kumar et al.
\S
1986; Jenster et al. 1991) and generation of chimaeric receptor proteins
(Green & Chambon, 1987; Green & Chambon, 1989). The most highly
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H2N III LIGAND COOH
Fig. 1.3. General structure of members of the nuclear hormone receptor
superfamily, including steroid receptors. "DNA" denotes the DNA-binding
domain, and "LIGAND" denotes the ligand-binding domain.
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conserved domain of these receptors is the DNA-binding domain, which
is rich in cysteine residues (Green & Chambon, 1986). These residues act
to coordinate zinc ions, forming secondary structures known as zinc
fingers (Evans & Hollenberg, 1988; Berg, 1990), similar to those found in
some other transcription factors (Struhl, 1989; Harrison, 1991; Miller et al.
1985). Steroid receptors possess two zinc fingers which are capable of
binding to specific short palindromic DNA sequences in the genome
known as hormone response elements (HREs) (Ham et al. 1988; Beato et
al. 1989; Umesono & Evans, 1989), which act as enhancers (Ptashne, 1988).
Binding of a steroid receptor to its HRE leads to enhancement of
transcription of the downstream gene, by interacting with other
transcription factors at the gene promoter (Schule et al. 1988a; Schule et
al. 1988b; Beato, 1989; Klein Hitpass et al. 1990), and/or by causing a
change in chromatin structure such that these other factors may bind
(Spelsberg et al. 1989; Beato, 1989). The carboxy-terminal steroid-binding
domain is less highly conserved between members of this family, and the
degree of homology between receptors roughly reflects the difference in
structure of their ligands (Evans, 1988). This region is thought to act to
repress the transcriptional activation activity of the receptor in the
V-
absence of hormone (Webster et al. 1988; Hollenberg et al. 1987; Godowski
et al. 1987), and to be involved in dimerisation of occupied receptors
(Fawell et al. 1990). The function of the N-terminal region of these
receptors, which is highly variable in size and sequence, is not clear, but it
is required for the full activity of the receptor (Bocquel et al. 1989; Lees et
al. 1989).
Except for the glucocorticoid receptor (Gustafsson et al. 1989;
Gustafsson et al. 1987), steroid receptors are located predominantly in the
nuclei of target cells (Martin & Sheridan, 1986; Gasc & Baulieu, 1986;
King, 1987), and are bound to a number of proteins in their inactive state,
in particular a 90kDa heat-shock protein (hsp90) (Ziemiecki et al. 1986;
Joab et al. 1984). This protein is thought to prevent activation of the
receptor in the absence of steroid (Cadepond et al. 1991), by binding to
several sites of the receptor (Carson Jurica et al. 1989; Chambraud et al.
1990), including the DNA-binding domain (Baulieu, 1987; Smith et al.
1990a), and preventing dimerisation of receptors (DeMarzo et al. 1991).
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Upon ligand binding, the receptor becomes activated, or "transformed",
by a process involving dissociation of hsp90 (Denis & Gustafsson, 1989;
Nakao & Moudgil, 1989; DeMarzo et at. 1991), and receptor dimerisation
(Tsai et at. 1989; O'Malley, 1990). Activation of steroid receptors is also
thought to involve phosphorylation of the receptor (Auricchio, 1989; Orti
et at. 1992), although the significance of this is still not fully clear. In this
active state, hormone-receptor complexes bind as dimers, via their zinc-
finger domains, to their HREs and enhance transcription of hormone-
responsive genes (Beato, 1989).
6.1.2 Oestrogens
The involvement of oestrogen in the local as well as endocrine
control of follicle development has long been suspected. Injection of
oestrogen to rats reduces the number of follicles undergoing atresia
(Ingram, 1959a; Ingram, 1959b; Harman et at. 1975b; Richards, 1975),
increases proliferation of granulosa cells (Goldenberg et at. 1972), and
augments the stimulation of ovarian weight and follicle development
caused by FSH (Simpson et at. 1941; Goldenberg et at. 1972; Richards,
1975). The increased responsiveness to FSH is accompanied by an increase
in the number of receptors for FSH in the granulosa cells of oestrogen-
treated animals. Furthermore, administration of specific antibodies to
oestradiol or the antioestrogen clomiphene inhibits the effects of FSH and
LH on follicle development and ovarian weight (Harman et at. 1975a;
Reiter et at. 1972). Indeed the most widely used granulosa cell culture
model makes use of the effect of oestrogen when administered in vivo
on the proliferation of rat granulosa cells to increase yields of granulosa
cells (Dorrington et at. 1975; Sanders & Midgley, 1982; Hsueh et at. 1984).
Oestrogen administered in vivo also increases communication between
granulosa cells via increased homologous gap junction formation (Merk
et at. 1972).
In addition to its effects on granulosa cell proliferation, which is
probably an indirect effect (see above), a number of the effects of FSH on
the differentiation of granulosa cells have been shown to be augmented
by simultaneous administration of oestrogens. Oestrogen augments the
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induction of aromatase activity stimulated by FSH (Merk et al. 1972;
Daniel & Armstrong, 1983; Adashi & Hsueh, 1982), thereby stimulating its
own synthesis. It also augments the stimulation by FSH of progesterone
production by cultured granulosa cells (Welsh et al. 1983; Fortune &
Hansel, 1979; Ratoosh & Richards, 1985), although it is inhibitory in
several species at high concentrations (Thanki & Channing, 1976;
Shemesh & Ailenberg, 1977; Bieszczad et al. 1982), probably due to direct
inhibition of the 3p-HSD enzyme (Veldhuis et al. 1983). The stimulation
of progesterone production is due to increased levels of P450scc protein
(Toaff et al. 1983), although oestradiol appears to have no effect on basal
or FSH-stimulated levels of P450scc mRNA in pig granulosa cells (Urban
et al. 1990; Urban et al. 1991). The other major marker for FSH-stimulated
differentiation of granulosa cells is the acquisition of LH receptors, and
this too has been shown to be augmented by oestrogens (Richards et al.
1976; Sheela Rani et al. 1981; Knecht et al. 1985). These effects of oestrogen
appear to be specific, since they can be blocked with specific antioestrogens
(Veldhuis et al. 1986b; Olsson & Granberg, 1990), and the effects of FSH or
cAMP analogues can be inhibited with antioestrogens (Knecht et al. 1985;
Kessel & Hsueh, 1987), presumably by blocking the action of endogenous
oestrogen produced in response to FSH. Interestingly, oestrogensappear to
have no effect on the ability of FSH to increase numbers of its own
receptor, although oestrogen treatment alone does increase numbers of
FSH receptors (Richards et al. 1976). It has also been suggested that FSH
stimulation of proteoglycan production is under the modulatory
influence of oestrogen (Schweitzer et al. 1981), although in another study
no effect was seen (Yanagishita et al. 1981).
The augmentation by oestrogen of a number of FSH-stimulated
parameters of granulosa cell function is probably mediated, at least in
part, at the level of cAMP generation or breakdown. Both in vitro and in
vivo, oestrogens have been shown to amplify the levels of cAMP
generated in granulosa cells in response to FSH (Richards et al. 1979;
Jonassen et al. 1982). This is presumably the basis for the augmentation of
the effects of FSH by oestradiol. The mechanism by which oestrogens
enhance FSH-stimulated cAMP generation has not been extensively
studied, but it does not seem to involve an increase in FSH receptor
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numbers, nor inhibition of cAMP breakdown by phosphodiesterases
(Richards et al. 1979). Also, oestrogen is capable of augmenting the effects
of forskolin, cholera toxin and 8-bromo-cAMP on LH receptor, FSH
receptor and cAMP accumulation in cultured granulosa cells (Knecht et
al. 1985; Knecht et al. 1984). The effect of oestrogen on cAMP
accumulation is seen only after some time in culture (Knecht et al. 1984),
suggesting that oestrogen does inhibit breakdown of cAMP. The effects of
oestrogen on gonadotrophin-stimulated cAMP production are fairly
modest in comparison to the very marked augmentation of progesterone,
oestrogen and LH receptor production (Hudson et al. 1987; Adashi &
Hsueh, 1982; Knecht et al. 1984; Knecht et al. 1985), suggesting that
another mechanism may be involved, although the response to cAMP
levels may not of course be linear.
Because of this rather generalized effect of oestrogen, many effects of
FSH are augmented by oestrogen. Such effects include expression of a
regulatory subunit (RII(3) of protein kinase A. The precise significance of
this finding is not known, since the pattern of expression of the other
subunits of protein kinase A does not follow the same pattern (Richards
et al. 1987), but it may indicate an increased intracellular capacity to
respond to cAMP. Increased sensitivity to FSH in generating intracellular
cAMP, coupled to an increased ability to respond to that messenger, may
constitute a highly efficient mechanism whereby the threshold level of
FSH required for the continued development of the follicle could be
reduced by oestrogen. However, increased levels of RII do not increase
sensitivity of cells to cAMP (Richards & Hedin, 1988), and one would
expect that increased levels of this protein, which suppresses the activity
of the catalytic subunits of protein kinase A, would lead to reduced rather
than increased cAMP responsiveness.
Oestrogen may also have paracrine effects on thecal androgen
production. Studies in pigs (Tsang et al. 1979a; Tonetta & Hernandez,
1989) and rats (Leung & Armstrong, 1979; Magoffin & Erickson, 1982)
have shown that oestrogens strongly inhibit androgen production,
although a study using cow theca cells showed a stimulatory effect of
oestrogen (Roberts & Skinner, 1990a). The inhibitory action of oestrogen
on androgen production is not exerted through altered generation of
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cAMP by theca cells (Morley et al. 1989; Hunter & Armstrong, 1987), and is
probably due to direct inhibition of the P450cl7 enzyme (Leung &
Armstrong, 1979; Magoffin & Erickson, 1982; Gower & Cooke, 1983).
In order that oestrogens may exert their effects, conventional ideas
would dictate that they do so via interaction with specific oestrogen
receptors. Specific, high affinity binding sites for oestrogens have been
identified in the ovaries of rats and hamsters (Kim & Greenwald, 1987;
Saiduddin & Zassenhaus, 1977), most of which appear to be in the
granulosa cells (Richards, 1975; Kudolo et al. 1984b; Kudolo et al. 1984a).
These high affinity binding sites are located in the nucleus of these cells
(Kudolo et al. 1984b; Richards, 1975), and specific nuclear uptake of
intracellularly produced oestradiol has been demonstrated in cultured rat
granulosa cells (Wolfson et al. 1990). Furthermore, the abundance of
nuclear binding sites for oestrogen is increased by treatment of animals
with oestrogen, unchanged by treatment with FSH or progesterone, and
reduced by treatment with LH or androgen (Richards, 1975; Saiduddin &
Zassenhaus, 1978). However, immunocytochemical studies are scarce and
contradictory on the existence of typical oestrogen receptors in granulosa
cells. In monkey ovaries, oestrogen receptor has been detected only in the
germinal epithelium (Hild Petito et al. 1988), whereas in human ovaries,
positive staining for the oestrogen receptor has been found in the
granulosa cells of large antral follicles prior to the LH surge (Iwai et al.
1990). Studies using nucleic acid probes have failed to detect oestrogen
receptor mRNA in mouse granulosa cells (Hillier et al. 1989a).
Intriguingly, several studies have indicated that there are oestrogen
receptor-related molecules present in granulosa cells, as there are in
✓ /
several other tissues (Ataya et al. 1988; Giguere et al. 1988). Kudolo et al.
(1984b) reported a second oestrogen-binding species in the cytoplasm of
rat granulosa cells. This protein has a much lower affinity for oestradiol
than does the nuclear species (46nM, compared to 0.6nM Kj), and also
binds androgens and progestogens (although with lower affinity than for
oestradiol). Also, the amount of cytoplasmic oestrogen binding is
elevated after treatment of animals with FSH and LH (Kudolo et al. 1987).
Oestrogen receptor-related mRNA has also been detected in high
abundance in mouse ovary using RNA probes complementary to the
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region of the oestrogen receptor mRNA which encodes the steroid
binding domain of the receptor (Hillier et al. 1989a). This smaller (-1.5
kilobases, compared to -6.5 kilobases) message is confined to the
granulosa cells, is not detected with RNA probes corresponding to other
regions of the authentic oestrogen receptor mRNA, and appears not to be
affected by gonadotrophin treatment. Furthermore, this species is not
generated from the oestrogen receptor gene by alternative splicing, since
it hybridizes less strongly to the oestrogen receptor RNA probe than does
the authentic uterine oestrogen receptor mRNA. The function of these
species is uncertain, but they could be intracellular oestrogen-binding
proteins which control the levels of free oestrogen within the cell.
Meanwhile the existence of true oestrogen receptors in granulosa cells
remains in doubt.
6.2.3 Androgens
Androgens produced by the theca and interstitial cells do not simply
act as a substrate from which granulosa cells synthesize oestrogens, but
also have a hormonal role in the local control of follicular development.
Initial evidence suggested that androgens promote atresia, and so an
action of androgen antagonistic to that of oestrogen was proposed.
Administration of androgens to hypophysectomized animals in vivo
does lead to a reduction in ovarian weight and wholesale atresia of
follicles (Hillier & Ross, 1979). In addition, it is now clear that androgens
are capable of modulating the action of FSH on granulosa cells in much
the same way as oestrogens. However, the function of androgens in vivo
is not certain, since administration of antiandrogens does not disrupt rat
oestrous cycles (Neumann et al. 1970) nor does it affect FSH
responsiveness in rats (Zeleznik et al. 1979), and androgen resistant mice
have normal cycles (Lyon & Glenister, 1974). On the other hand,
intraovarian implants of antiandrogen reduce progesterone secretion by
granulosa cells in subsequent culture (Schomberg et al. 1978).
Many studies have now shown that FSH-stimulated progesterone
and oestradiol synthesis by granulosa cells in vitro is greatly enhanced by
the addition of androgens to the medium. This is true for granulosa cells
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isolated from small follicles in the rat (Hudson et al. 1987; Nimrod, 1977a;
Nimrod, 1981; Lucky et al. 1977; Armstrong & Dorrington, 1976; Duleba et
al. 1984), pig (Spicer & Hammond, 1988b), cow (Luck et al. 1990;
Henderson & Franchimont, 1983), sheep (Moor et al. 1975) and monkey
(Harlow et al. 1986; Shaw et al. 1989). Androgens also augment
gonadotrophin-stimulated progesterone production in mature granulosa
cells (Zeleznik et al. 1979; Quirk & Fortune, 1983; Corredor & Flickinger,
1983; Haney & Schomberg, 1978). Oestrogen production stimulated by
FSH or cAMP analogues is also augmented by androgens (Daniel &
Armstrong, 1980; Hillier & deZwart, 1982; Shaw et al. 1989). The
possibility that these effects may be mediated by oestrogen following
aromatization of the androgen has been ruled out by several pieces of
evidence. Firstly, androgens such as testosterone and androstenedione are
far more potent than oestrogen in the augmentation of FSH-stimulated
steroid production (Hillier et al. 1985; Armstrong & Dorrington, 1976;
Duleba et al. 1985). Secondly, nonaromatizable androgens such as 5a-
dihydrotestosterone (DHT) are very nearly as potent as testosterone in
this respect (Hillier & deZwart, 1981; Hillier et al. 1988; Spicer &
Hammond, 1988b). Thirdly, the effect of androgens can be blocked with a
specific antiandrogen, whereas that of oestrogen cannot (Duleba et al.
1985; Spicer & Hammond, 1988b; Hudson et al. 1987; Hillier & deZwart,
1982). Conversely, the effects of oestrogen can be blocked with
antioestrogen (Veldhuis et al. 1986b; Knecht et al. 1985), while those of
androgen cannot (Daniel & Armstrong, 1983). For more mature
granulosa cells (i.e. from larger follicles), androgen may in fact be
inhibitory (Polan et al. 1986; Hillier et al. 1988). Androgens also enhance
many other of the effects of FSH associated with granulosa cell
differentiation, including the development of LH responsiveness (Shaw
et al. 1989), inhibin production (Hillier et al. 1989b; Michel et al. 1991b;
Henderson & Franchimont, 1981; Henderson & Franchimont, 1983),
proteoglycan production (Yanagishita et al. 1981) and plasminogen
activator secretion (Wang & Leung, 1987 a; Jia et al. 1990).
The mechanism by which androgens exert their modulatory effects
on FSH-stimulated granulosa cell differentiation is not fully understood.
Androgens, like oestrogens, are capable of enhancing levels of cAMP
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generated in response to FSH (Hillier & deZwart, 1982; Knecht et at. 1984;
Goff et al. 1979). However, Nimrod (1977b) observed no change in cAMP
generation or breakdown associated with androgen augmentation of
FSH-stimulated progestogen production relative to FSH alone.
Furthermore, like oestrogens, androgens can augment the stimulation of
progesterone and oestrogen synthesis brought about by the cAMP
analogue, 8-bromo cAMP and also by cholera toxin (Hillier & deZwart,
1982; Nimrod, 1977b; Knecht et al. 1984). As is the case for oestrogen,
androgens enhance FSH-stimulated steroidogenesis to a much greater
degree than cAMP accumulation (Hillier & deZwart, 1982; Welsh et al.
1982), so there may be other mechanisms involved, such as modification
of the temporal pattern of, or sensitivity to, cAMP generation.
The demonstration that androgen effects on granulosa cells can be
blocked with specific antiandrogens (Duleba et al. 1985; Hudson & Hillier,
1985; Spicer & Hammond, 1988b; Hudson et al. 1987; Hillier & deZwart,
1982) suggests that these effects are receptor-mediated. High affinity (Kj 2-
3nM) binding sites specific for testosterone and distinct from androgen-
binding protein have been found in rat (Schreiber et al. 1976) and human
(Milwidsky et al. 1980) ovaries. Furthermore, nuclear uptake of labelled
testosterone has been demonstrated in rat ovaries (Zeleznik et al. 1979;
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Schreiber & Ross, 1976), which can be inhibited by antiandrogen (Zeleznik
et al. 1979). These binding sites have a greater affinity for testosterone
than other androgens. Indeed, the affinity of the rat ovarian androgen
"receptor" is no greater for DHT than for oestradiol (Schreiber et al. 1976).
These characteristics may explain why testosterone is more potent than
DHT in augmenting the actions of FSH (Hillier & deZwart, 1982), but does
not explain why DHT is more potent than oestradiol in this respect
(Hudson et al. 1987). The cellular distribution of ovarian androgen
receptor is still not clear since, as with oestrogen receptor studies, recent
immunocytochemical studies have been inconclusive. In the rat ovary,
Takeda et al. (1990) found weak positive staining for androgen receptor
only in granulosa-lutein cells, whereas in the monkey ovary, staining has
been observed in virtually every cell type in the ovary (Hild Petito et al.
1991). It appears likely that the effects of androgens on granulosa cells are
receptor-mediated, but until the existence of conventional androgen
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receptors in these cells is unequivocally demonstrated, the mechanism of
androgen action remains unknown.
6.1.4 Progestogens
As well as androgens and oestrogens, progestogens, in particular
progesterone, have also been implicated in the local control of follicular
and luteal function, although the evidence to support such a role is less
clear-cut than for androgens and oestrogens. Regression or removal of
the corpus luteum is followed by commencement of antral follicular
growth (Goodman & Hodgen, 1979; Baird et al. 1984; Mills & Stopper,
1989), although large preantral and even small antral follicles continue to
develop in the presence of an active corpus luteum (McNatty et al. 1983;
Baird et al. 1984; Zeleznik et al. 1980). Also, antral follicular growth is
inhibited by administration of exogenous progesterone to intact animals
(Buffler & Roser, 1974; Greenwald, 1977). These observations have led to a
hypothesis that progesterone exerts an inhibitory influence upon follicle
development (Mills & Stopper, 1989; Goodman & Hodgen, 1983), at least
during the luteal phase. However, these results have been explained in
terms of negative feedback of gonadotrophin secretion by progesterone,
rather than direct effects of progesterone on the ovary (Taya et al. 1981;
Garza & Terranova, 1984). This explanation is supported by the finding
that exogenous gonadotrophin is able to stimulate follicle growth in
V'
ovaries containing an active corpus luteum (Zeleznik & Resko, 1980). In
fact, it has been shown that the effect of hCG on the growth of small
follicles is augmented by elevated serum progesterone levels brought
about by the use of progesterone implants in intact animals (Bogovich et
al. 1981; Richards & Bogovich, 1982; Bogovich & Richards, 1982), although
the serum levels of progesterone attained by this method were very high.
In hypophysectomized rats, treatment with progesterone alone caused no
change in the morphology of the ovary in a number of studies (Richards,
1975; Saiduddin & Zassenhaus, 1978; Smith & Bradbury, 1966), although it
has been shown to inhibit follicular growth brought about by oestrogen
(Smith & Bradbury, 1966; Payne et al. 1956) and gonadotrophin (Chiras &
Greenwald, 1978).
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In vitro studies on the direct effects of progesterone on ovarian cells
have yielded scarcely more conclusive results. Stimulatory effects of
progesterone (or a synthetic analogue, R5020) on cultured granulosa cells
have been observed, with respect to gonadotrophin-stimulated
progesterone production (Ruiz de Galarreta et al. 1985; Fanjul et al. 1983)
and plasminogen activator (Wang & Leung, 1987a), both markers of
advanced granulosa cell development. These effects can be blocked by the
antiprogestin RU486 (Wang & Leung, 1987a), and cannot be blocked with
an antiandrogen (Fanjul et al. 1983). The effect of R5020 on FSH-
stimulated progesterone production was very modest and exerted only at
very high doses, but its augmentation of LH action was much greater
(Fanjul et al. 1983), supporting the notion that progesterone begins to be
important only in the later stages of granulosa cell development. Studies
on cultured hamster ovaries suggest that progesterone may also promote
ovulation (Baranczuk & Fainstat, 1976), possibly by interfering with
synthesis of connective tissue, leading to thinning of the follicle wall
(Tjugum et al. 1984). Inhibitory effects of progesterone on cultured
granulosa cells have also been observed. Progesterone inhibits FSH-
stimulated oestrogen production in cultured rat granulosa cells (Schreiber
et al. 1980; Schreiber et al. 1981; Fortune & Vincent, 1983) and rabbit
follicles (Bahr et al. 1980), although in a study by Daniel and Armstrong
(1980), no effect of progesterone on oestrogen synthesis was observed.
Progesterone also inhibits induction of LH receptors in rat granulosa cells
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(Schreiber et al. 1982), and may (Henderson & Franchimont, 1981) or may
not (Michel et al. 1991b) inhibit inhibin production in mature cow and
pig granulosa cells, respectively. It has been pointed out that, since rather
high concentrations of progesterone are required to exert significant
effects, and since high concentrations of progesterone do not develop in
the follicle until preovulatory development (McNatty et al. 1975) by
which time aromatase activity and LH receptors are already induced,
these effects of progesterone can be of little importance (Hillier, 1985).
Data regarding the effects of progesterone on thecal cells is very
scarce. Androgen production by pig thecal cells is affected by progesterone
depending on the size of the follicles from which they were obtained,
being inhibited in cells from medium-sized follicles, and stimulated in
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cells from large follicles (Tonetta & Hernandez, 1989). Androgen
production by thecal cells from medium-sized pig follicles is moderately
enhanced by incubation in granulosa cell-conditioned medium
(Lischinsky & Armstrong, 1983). It was found that substitution of
progesterone and pregnenolone in the concentrations present in the
conditioned medium was able to elicit a response in thecal cells
equivalent to that elicited by granulosa cell-conditioned medium. The
authors suggested on the basis of these results that granulosa cells pass
progestogens to the thecal cells, which act as androgen substrate. This may
not be the only way in which progestogens affect thecal androgen
production, since P450scc immunostaining in thecal cells of small rat
follicles is increased by administration of the antiprogestin RU486 (Le
Goascogne et al. 1989).
The mechanism of direct actions of progesterone on granulosa cells
is not known. It has been suggested that its effects on oestrogen
production are exerted subsequent to cAMP generation (Schreiber et al.
1981), which may explain why progesterone can exert inhibitory effects at
the same time as augmenting (albeit modestly) FSH-stimulated cfAMP
production (Goff et al. 1979). It has been suggested that some effects of
high concentrations of progesterone and R5020 may be mediated through
the androgen receptor (Hillier, 1985), since R5020 has been shown to
exhibit androgenic actions in some tissues (Bardin & Catterall, 1981), and
since progesterone can be converted to 5a-reduced androgen within the
ovary (Inaba et al. 1978). However, the fact that the action of progesterone
can be blocked with antiprogestins (Wang & Leung, 1987a), and not with
antiandrogens (Fanjul et al. 1983) suggests that these actions are mediated
through the progesterone receptor, at least in part. Moderately high
affinity binding sites for progesterone have been identified in whole
ovary extracts of the rat (Fujii Hanamoto et al. 1985; Schreiber & Hsueh,
1979; Schreiber et al. 1983) and human (Milwidsky et al. 1980), and in rat
granulosa cells (Schreiber & Erickson, 1979; Naess, 1981). The levels and
affinity of these receptors appears to vary with the oestrous cycle (Fujii
Hanamoto et al. 1985), but the significance of the change in affinity is
unclear. More recently, immunocytochemical studies have established
that in human and monkey ovaries, progesterone receptor is present in
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theca cells, interstitial cells and stroma throughout the menstrual cycle,
but only appears in granulosa cells after the LH surge (Iwai et al. 1990;
Hild Petito et al. 1988).
The available evidence, therefore points to there being little effect of
progesterone in the early stages of follicle development, when there is
little progesterone or progesterone receptor present in any case. This
steroid may well be important in ovulation, and in autoregulation of
progesterone production in the corpus luteum. The seemingly
contradictory stimulatory and inhibitory effects of progesterone on
different parameters may reflect the well known complexity with which
progesterone interacts with oestrogen (Mester & Baulieu, 1984). The
known effect of oestrogen on induction of progesterone receptors in other
tissues may explain the observed pattern of progesterone receptor in
granulosa cells of preovulatory (oestrogenic) follicles (Iwai et al. 1990;
Hild Petito et al. 1988).
6.1.5 Catecholoestrogens
Another class of steroids which may have intraovarian functions
are the catecholoestrogens. These steroids are formed by hydroxylation of
oestrogens at the 2- or 4-positions by oestrogen-2/4-hydroxylases. In the
uterus the major product is 4-hydroxyoestradiol (4-OH-E2), and in the
conceptus and ovary 2-hydroxyoestradiol (2-OH-E2) is produced in larger
quantities. It has been suggested that these steroids participate in
implantation and establishment of pregnancy (Chakraborty et al. 1989;
Paria et al. 1990). Catecholoestrogens have been detected in nanomolar
concentrations in human and horse follicular fluid (Dehennin et al. 1984;
Spicer & Hammond, 1989b), and in porcine follicles the enzyme
oestrogen-2-hydroxylase is abundant in both theca and granulosa cells,
although not in corpora lutea (Spicer & Hammond, 1989b). Furthermore,
the capacity of granulosa cells to metabolize E2 to 2-OH-E2 increases with
follicular development (Eppig & Downs, 1984). It has been shown that
2-OH-E2 is capable of stimulating basal, gonadotrophin-stimulated and
catecholamine-stimulated progesterone production by rat and pig
granulosa cells (Hudson & Hillier, 1985; Hudson et al. 1987; Spicer &
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Hammond, 1987b; Spicer & Hammond, 1987a), at the level of P450scc
mRNA expression (Spicer et al. 1990). It has also been demonstrated that
2-OH-E2 inhibits proliferation of pig granulosa cells (Spicer & Hammond,
1989a). Further evidence for a local function of 2-OH-E2 came from the
finding that it is also able to inhibit androgen production by pig thecal
cells (Morley et al. 1989). It was found that pregnenolone accumulation
was enhanced, while production of androstenedione and 17a-
hydroxyprogesterone was reduced, suggesting that 2-OH-E2 acts directly
on the P450cl7 enzyme in much the same way as does oestradiol. The
mechanism by which 2-OH-E2 exerts its effects on granulosa cells is
unclear, although it is known that it acts, at least in part, at a site distal to
cAMP generation, since it augments progesterone production stimulated
not only by gonadotrophins, but also by cAMP analogues (Morley et al.
1989). The action of 2-OH-E2 is distinct from that of oestradiol, since its
potency is greater than that of oestradiol (Hudson et al. 1987; Spicer &
Hammond, 1987a). 2-OH-E2 does not bind to a- or p-adrenergic receptors,
although it is able to increase numbers of P-adrenergic receptors in
granulosa cells (Spicer & Hammond, 1988a). However, the effects of
2-OH-E2 can be blocked with an antiandrogen, SCH16423
(hydroxyflutamide), suggesting that 2-OH-E2 acts in a similar fashion to
androgens (Hudson et al. 1987; Spicer & Hammond, 1988b). Altogether,
these findings point to a local role for catecholoestrogens in the control of
follicular development, but their exact importance is not yet known.
6.2 Role of Peptide Factors
6.2.1 IGFs
Of all the growth factors implicated in the local control of follicle
development, the insulin-like growth factors (IGFs), or somatomedins,
have been most extensively studied. IGFs (types I and II) are single chain
polypeptides which have close homology with insulin (Froesch et al.
1985), and IGFs and insulin cross react to varying degrees with one
another's receptors, which are present in most cells (Rechler & Nissley,
1985). IGFs produced by the liver in response to growth hormone (GH) act
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as endocrine hormones acting upon various tissues (Slack, 1989).
However, IGFs are not only produced by the liver, but also in other
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tissues where they exert their actions locally (Adashi et at. 1985a;
Daughaday & Rotwein, 1989). The rat and pig ovary produces
predominantly IGF type I (IGF-I, somatomedin-C), and of all adult tissues
studied, only the uterus and liver produce more (Murphy et al. 1987). The
fact that IGF-I concentrations much higher than those in plasma have
been found in human follicular fluid (Geisthovel et al. 1989b; Rabinovici
et al. 1990a) suggested an ovarian site of production. It has now been
shown in the rat (Hernandez et al. 1989; Oliver et al. 1989) and pig
(Hammond et al. 1985; Hsu & Hammond, 1987a) that the granulosa cells
are the principal site of ovarian IGF-I gene expression and protein
synthesis. In vivo, the expression of the IGF-I gene is confined to the
granulosa cells of healthy antral follicles, and is greatest in the cumulus
cells and the cells lining the antrum (Oliver et al. 1989). Although the
hormonal regulation of IGF-I expression in granulosa cells has not been
extensively studied, pig granulosa cell IGF-I production has been reported
to be stimulated by FSH, LH, GH and oestradiol, via the cAMP second
messenger pathway (Hsu & Hammond, 1987b; Hsu & Hammond, 1987a).
IGF-I production by porcine granulosa cells is also modulated by a
number of other growth factors (Mondschein et al. 1988; Mondschein &
Hammond, 1988), and may actually be inhibited by FSH (Mondschein &
Hammond, 1988). Receptors for IGF-I have been demonstrated in rat
(Adashi et al. 1986a; Adashi et al. 1986d), sheep (Monget et al. 1989), pig
(Veldhuis & Furlanetto, 1985) and human (Gates et al. 1987) granulosa
cells, and in rat theca cells (Hernandez et al. 1988; Cara et al. 1990; Cara &
Rosenfield, 1988). Expression of granulosa cell IGF-I receptors is also
stimulated by FSH, LH and GH in vivo and in vitro (Adashi et al. 1988b;
Adashi et al. 1986a), again through cAMP production.
The intraovarian function of IGF-I is not fully understood since,
although it promotes proliferation of granulosa cells in some species (see
above), it also augments the effects of FSH on a number of the
differentiated functions of granulosa cells without any effect on
proliferation (Adashi et al. 1985a). IGF-I augments FSH-stimulated
progesterone production by cultured rat (Adashi et al. 1985b; Davoren et
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al. 1985; Hutchinson et al. 1988), cow (Schams et al. 1988) and pig
(Veldhuis & Furlanetto, 1985; Maruo et al. 1988) granulosa cells, due to
increased levels of P450scc mRNA (Veldhuis et al. 1986a; Urban et al.
1990) and protein (Veldhuis & Rodgers, 1987; Veldhuis et al. 1986b). FSH-
stimulated oestrogen synthesis is also stimulated by IGF-I (Davoren et al.
1985; Dorrington et al. 1987; Hutchinson et al. 1988), accompanied by an
increase in P450arom gene expression (Steinkampf et al. 1988). These
effects on steroidogenesis are associated with a stimulation of LDL
metabolism and receptor expression (Veldhuis et al. 1987; Veldhuis &
Rodgers, 1987). Other correlates of granulosa cell differentiation which are
stimulated by IGF-I include LH receptor induction (Maruo et al. 1988),
inhibin production (Bicsak et al. 1986; Zhang et al. 1987a; LaPolt et al.
1990b; Michel et al. 1991b) and proteoglycan secretion (Adashi et al. 1986d).
These effects appear to be mediated by specific IGF-I receptors since
insulin and IGF-II are far less potent than IGF-I (Veldhuis et al. 1987;
Maruo et al. 1988; Veldhuis et al. 1986b). IGF-I also has profound effects
on thecal steroidogenesis. Both basal and LH-stimulated androgen
production are enhanced by IGF-I (Barbieri et al. 1983; Hernandez et al.
1988; Cara & Rosenfield, 1988; Magoffin et al. 1990); indeed the effect of
IGF-I on thecal androgen synthesis is greater than that of LH, and the
combination of LH and IGF-I stimulates androgen synthesis
synergistically (Hillier et al. 1991a; Hillier et al. 1991b). Thecal LH binding
is also enhanced by IGF-I (Cara et al. 1990).
The effects of IGF-I in enhancing gonadotrophin-stimulated
granulosa cell differentiation appear to be mediated partly at the level of
cAMP generation or breakdown, since IGF-I treatment of cultured
granulosa cells has been shown to increase accumulation of cAMP
(Davoren et al. 1985; Adashi et al. 1986c). However, the fact that
stimulation of cells with maximally effective doses of cAMP analogues
can be further augmented by IGF-I (Adashi et al. 1986b; Veldhuis &
Furlanetto, 1985) suggests that it may also increase cellular
responsiveness to cAMP. IGF-I action is mediated through a receptor
which has tyrosine kinase activity (Yarden & Ullrich, 1988; Rechler &
Nissley, 1985), but the nature of the proteins phosphorylated in response
to IGF-I binding is unknown. It is conceivable that the IGF-I receptor
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phosphorylates some component or components of the cAMP response
and metabolism mechanisms.
Although IGF-I is the major, if not only, IGF produced by rat and pig
granulosa cells, theca cells express the IGF-II gene (Flernandez et al.
1990b). In humans, IGF-II is found in follicular fluid (Ramasharma et al.
1986), and there is evidence that granulosa cells produce IGF-II, and that
its expression is stimulated by FSH, LH, GH and agents which stimulate
the cAMP second messenger system (Voutilainen & Miller, 1987b;
Ramasharma & Li, 1987). It has been confirmed that human granulosa
cells express the IGF-II and not the IGF-I gene (Geisthovel et al. 1989a), but
this does not explain the high concentrations of IGF-I in human follicular
fluid (Geisthovel et al. 1989b; Rabinovici et al. 1990a).
Attempts to understand the function of IGFs within the ovary have
been considerably complicated by the expression of IGF-binding proteins
(IGF-BPs) in ovarian cells. Unlike insulin, the vast majority of IGFs that
are transported in the blood are bound to IGF-BPs, which affect the
presentation of IGFs to their receptors, but there are at least six types of
IGF-BPs, which may have different modulatory effects on IGF effects
(Rosenfeld et al. 1990; Shimasaki et al. 1991). Human granulosa cells
produce IGF-BP-1 mRNA and protein (Jalkanen et al. 1989; Koistinen et
al. 1990; Suikkari et al. 1989). Very recently, Nakatani et al (1991b) have
studied the expression of four IGF-BPs (types 1,2,3 and 4) in the rat ovary
by in situ hybridisation. They found no IGF-BP-1 mRNA anywhere in the
ovary, in agreement with studies on pig granulosa cells (Mondschein et
al. 1990). However, the other three IGF-BPs were found to be expressed in
a highly compartmentalised pattern. IGF-BP-2 was expressed only in
thecal and interstitial cells, in agreement with Ricciarelli et al (1991),
being expressed more in larger follicles. IGF-BP-3 mRNA was found only
in corpora lutea, and IGF-BP-4 mRNA was detected only in the granulosa
cells of atretic follicles, with the expression being greatest in follicles in
more advanced stages of atresia. The authors assumed the IGF-BPs to be
inhibitory (with some justification) and were led to suggest that since
luteal cells and granulosa cells of atretic follicles are not proliferating,
their expression of IGF-BPs might be acting to block the mitogenic actions
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of IGFs. Increased granulosa cell IGF-BP production is also associated with
atresia in the sheep (Monget et al. 1989).
Both stimulatory and inhibitory effects of IGF-BPs on IGF action
have been shown (Adashi et al. 1991), but to date, the evidence suggests
that IGF-BPs inhibit the actions of IGFs on granulosa cells. In fact, the
porcine IGF-BP-3 was isolated and cloned on the basis of its ability to
inhibit FSH-stimulated oestradiol production by cultured rat granulosa
cells (Ui et al. 1989; Shimasaki et al. 1989a). Two IGF-BPs, types 2 and 3,
inhibit granulosa cell steroidogenesis stimulated in vitro by FSH or a
cAMP analogue (but, paradoxically, not by LH), without any effect on
cAMP production, and also inhibit proliferation (Bicsak et al. 1990). The
effects of the IGF-BPs were very similar to those of a specific antiserum to
IGF-I, suggesting that in the rat, IGF-BPs of granulosa or thecal origin are
capable of inhibiting granulosa cell function by binding to and
neutralising endogenous IGF-I.
6.2.2 EGF and TGFa
Epidermal growth factor (EGF) affects both proliferation and
differentiation of granulosa cells in several species. Granulosa cells of rats
and pigs have been shown to have specific EGF receptors (Jones et al.
1982; Buck & Schomberg, 1988), which are upregulated by treatment with
FSH in vivo (St Arnaud et al. 1983; Siebers et al. 1985) and in vitro (Feng
et al. 1986; Feng et al. 1987; Buck & Schomberg, 1988). Autoradiographic
studies have also localised EGF receptors to thecal, interstitial and luteal
cells (Feng et al. 1987; Chabot et al. 1986). However, EGF does not appear
to be expressed in the ovary (Skinner & Coffey, 1988). Another protein,
transforming growth factor-a (TGFa), which shares about 40%
homology with EGF, and interacts with the same receptor as EGF
(Massague, 1985; Carpenter, 1987; Gill et al. 1987), has been shown to be
expressed in thecal cells (Kudlow et al. 1987; Skinner & Coffey, 1988; Lobb
et al. 1989). It seems likely, therefore, that the observed effects of EGF on
granulosa cells reflect the function of TGFa in vivo.
EGF is a potent mitogen for granulosa cells of a number of species in
vitro, including cows, pigs, humans and rabbits (Gospodarowicz &
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Bialecki, 1979; Mondschein et al. 1988; May et al. 1987; Tapanainen et al.
1987; Bendell et al. 1988; Skinner et al. 1987), although rat granulosa cells,
on which the effects of EGF have been studied most intensively, are
relatively insensitive to the mitogenic action of EGF (Zhang et al. 1987b;
y
Gospodarowicz & Bialecki, 1979). The stimulation of proliferation by EGF
depends upon the culture system and the presence of other factors
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(Mondschein & Hammond, 1988; May et al. 1990). As one would expect of
a factor which promotes proliferation, EGF generally inhibits granulosa
cell differentiation. In rats, EGF inhibits FSH-stimulated production of
oestradiol (Dorrington et al. 1987; Jones et al. 1982; Adashi et al. 1987;
Suzuki et al. 1987), inhibin (Bicsak et al. 1986; Zhang et al. 1987b; Zhang et
al. 1988a) and progesterone (Suzuki et al. 1987; Dodson & Schomberg,
1987) and LH receptor induction (Feng et al. 1986; Dodson & Schomberg,
1987). These effects are apparently due to a suppression of cAMP
production (Adashi et al. 1987; Dodson & Schomberg, 1987; Ben Ze'ev &
Amsterdam, 1987), although it is also able to inhibit the action of cAMP
analogues (Adashi et al. 1987; Zhang et al. 1987b). The effects of EGF are
similar in pigs, cows and humans (Steinkampf et al. 1988; Franchimont et
al. 1986; Mason et al. 1990; Michel et al. 1991b), except that progesterone
production by pig and human granulosa cells may be enhanced by EGF
(Tapanainen et al. 1987; Richardson et al. 1989; Urban et al. 1990). Also, in
pigs, EGF increases FSH receptor numbers (May et al. 1987) and stimulates
IGF-I and IGF-BP production (Mondschein et al. 1988; Mondschein &
Hammond, 1988; Mondschein et al. 1990). To date, the effects of TGFa
have been shown to be the same as those of EGF (Adashi & Resnick, 1986;
Skinner & Coffey, 1988; Tsafriri et al. 1989b).
6.2.3 The TGF[3 Family
As the name suggests, transforming growth factor (TGF) was
originally described on the basis of its ability reversibly to elicit
transformation of normal cells, similar to viral transformation, which is
characterised by cell proliferation uninhibited by cell contact and
independent of cell attachment (Massague, 1985). Upon fractionation,
TGF was found to consist of two components, one related to EGF and
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termed TGFa, and another which seemed to synergise with TGFa in
inducing transformation, termed TGFp. TGFP has now been found to
exist in three forms, TGFPi, TGFP2, and TGFP3, which are all
homodimers of ~12kDa subunits, linked by disulphide bridges.
Furthermore, there are also a number of proteins which are related to
TGF{3. These proteins share a number of structural features, such as their
distribution of cysteine residues involved in proteolytic processing of
precursors, and the fact that they are all active as homodimers.
Considerable impetus has been added to the study of inhibin and activin
by the recent discovery that they are members of this family (Mason et al.
1985; Derynck & Rhee, 1987). TGFp, inhibins and activins also share
significant homology with Mullerian duct Inhibiting Substance (MIS)
(Cate et al. 1986), which causes regression of the Mullerian duct during
the early embryonic differentiation of the testis, and a product of the
Drosophila decapentaplegic complex (Dpp), which is also involved in
early embryonic development (Padgett et al. 1987). With the exception of
the Drosophila protein, all these members of the TGFP family are
expressed within the ovary, including MIS (Takahashi et al. 1986;
Voutilainen & Miller, 1987a). All of these factors are clearly biologically
very important molecules, and comparison of their actions may provide
valuable insight into the biology of inhibin and activin and vice versa.
The regulation of ovarian TGFp expression has not been studied in
detail, but it is clear that theca cells of rats, pigs and cows at least produce
TGFp (Bendell & Dorrington, 1991; Skinner et al. 1987; Bendell &
Dorrington, 1988; Kim & Schomberg, 1989; Gangrade & May, 1990;
Hernandez et al. 1990a). Pig granulosa cells do not produce TGFp
(Gangrade & May, 1990; Kim & Schomberg, 1989) but rat granulosa cells
do, at least in vitro (Kim & Schomberg, 1989; Bendell & Dorrington, 1991),
and its production is stimulated by oestradiol (Bendell & Dorrington,
1991). In contrast to its expression, the effects of TGFP on ovarian cells,
especially granulosa cells, have been extensively studied. There is
considerable variation between the responses of rat and pig granulosa
cells to TGFp. In rats, TGFP augments several effects of FSH, including
production of oestradiol (Hutchinson et al. 1987; Ying et al. 1986; Adashi
& Resnick, 1986; Bendell & Dorrington, 1988; Adashi et al. 1989) inhibin
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(LaPolt et al. 1989; Zhang et al. 1988a; LaPolt et al. 1990b) and progesterone
(Dodson & Schomberg, 1987; Knecht et al. 1987) and also LH and EGF
receptor induction (Blair et al. 1988; Feng et al. 1986). These effects are
partly due to enhanced cAMP accumulation (Knecht et al. 1986; Blair et al.
1988), but also appear to increase responsiveness to cAMP or cAMP
analogues (Knecht et al. 1987; Feng et al. 1986; Adashi et al. 1989). They
also appear to be specific, since antibodies to TGFP have been used to
block its effects (Bendell & Dorrington, 1988; Blair et al. 1988). However,
TGFP inhibition of granulosa cell cAMP production and differentiation
stimulated by a high dose of FSH has also been observed in rat cells, but
only in the presence of insulin (Knecht et al. 1986; Knecht et al. 1987) or
EGF (Zhang et al. 1988a). In rats TGF(3 also stimulates proliferation of
granulosa cells, both alone (Dorrington et al. 1988) and in synergy with
FSH (Dorrington et al. 1988; Bendell & Dorrington, 1988), and the action
of FSH in stimulating proliferation (where it has been observed) can be
blocked with an antibody to TGFP (Bendell & Dorrington, 1991). Whereas
in rats TGFP is generally a stimulatory factor, in pigs it is the opposite.
TGFP inhibits FSH-stimulated porcine granulosa cell production of
inhibin (Michel et al. 1991b) and progesterone (Mondschein et al. 1988) as
well as proliferation (Mondschein et al. 1988; Gangrade & May, 1990). It
also inhibits EGF-stimulated IGF-I production (Mondschein et al. 1988;
Mondschein & Hammond, 1988) and basal IGF-BP secretion (Mondschein
et al. 1990), but enhances EGF-stimulated proliferation (May et al. 1988). In
the cow it also inhibits EGF-stimulated granulosa cell proliferation
(Skinner et al. 1987).
Data on the effects of TGFP on thecal cells are more clear, perhaps
because they are less abundant. In the rat, TGFp appears to stimulate
thecal progesterone production, while inhibiting androgen production
without affecting proliferation (Magoffin et al. 1989; Hernandez et al.
1990a). These effects were seen only in the presence of insulin or IGF-I. In
cow theca cells, TGFP inhibits proliferation, has no effect on androgen
production, and stimulates progesterone production (Roberts & Skinner,
1991).
Chapter 1 Literature Review 52
6.2.4 Inhibins and Activins
Inhibin is a heterodimeric glycoprotein consisting of an a-subunit
and one of two closely related (3-subunits, termed (3a and (3b- This protein
was purified from follicular fluids from a number of species, on the basis
of its ability to suppress FSH release from pituitary cells (Burger &
Igarashi, 1988) (see above). The smallest form of inhibin purified from
follicular fluid is a protein with a molecular weight of about 32kDa,
consisting of an a-subunit of 18-20kDa and a [3-subunit of 13-15kDa
(Leversha et al. 1987; Mason et al. 1985; Rivier et al. 1985; Miyamoto et al.
1985). Inhibin A denotes a dimer of an a- and a (3A-subunit, whereas
inhibin B is a dimer of an a- and a Ps-subunit. Both types have been
purified from porcine follicular fluid (Ling et al. 1985), and testicular
inhibin appears to be very similar (Vaughan et al. 1989; Grootenhuis et al.
1990).
However these are not the only combinations of inhibin subunits
which are produced by the gonads (Miyamoto et al. 1986). Some of the
forms which have been identified in follicular fluid are shown in Fig.1.4.
The a-subunit is synthesized as a 360 amino acid precursor, which is
processed in a number of proteolytic steps to form mature a-subunit, or
aC. Amino acids 18-60 comprise the "pro-" sequence, amino acids 61-226
the aN sequence, and amino acids 227-360 make up the mature aC. A
58kDa form of inhibin has been found in bovine follicular fluid, the
a-subunit of which was about 441<Da in size (Robertson et al. 1985; Forage
et al. 1986), corresponding to the uncleaved aN-aC molecule. In addition,
a 261<Da a-subunit has been purified from bovine follicular fluid which is
composed of the aC fragment, linked by disulphide bond(s) to the pro¬
peptide (Sugino et al. 1989), and is known as pro-aC. This molecule was
also found by Robertson et al. (1989), who also found the intervening aN
cleaved peptide. There is also evidence that free a- (Bicsak et al. 1988;
Knight et al. 1989; Schneyer et al. 1990) and (3- (Robertson et al. 1992)
subunit monomers are secreted by ovarian cells, although the
significance of this is not known. Much higher molecular
weight forms of inhibin have also been identified by Western
blotting, which appear to be composed of a large (~62kDa) (3-
subunit precursor, linked to a (3 dimers of different sizes
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Fig.1.4. Some forms of inhibins and activins found in the follicular fluid of several
species. Consensus figures for the molecular weights of subunits and dimers are
shown in kilodaltons (kDa). SS indicates that subunits are connected by disulphide
bonds, and an asterisk indicates that a subunit is glycosylated. Note that activin B has
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(Miyamoto et at. 1986). Very recently, Sugino et al. (1992) reported the
purification from bovine follicular fluid of several more high molecular
weight forms of inhibin, which appear to be composed of a (3-subunit
either 15kDa or 55kDa in size and an a-subunit of either 40kDa or 50kDa.
As well as peaks of protein which inhibited release of FSH from
pituitary cells, Ling et al. (1985) found that some porcine follicular fluid
fractions eluting from a column before inhibin contained an activity
which was capable of stimulating release of FSH. This activity was
subsequently found to be a dimer of two inhibin (3-subunits, one (3a and
one (3b (Ling et al. 1986b). Homodimers of (3A-subunits have also been
purified from porcine follicular fluid, having the same properties as
.
(3a-(3b dimers (Vale et al. 1986; Ling et alV1986a). These proteins, termed
activin A ((3a_Pa) aRd activin AB (Pa~Pb) have now been found to affect a
wide range of tissues, and where studied, their effects have always been
shown to be the opposite to those of inhibin.
Detection methods for the study of the hormonal regulation of
inhibin production originally relied on cultured pituitary cell bioassay, by
measuring FSH production (Erickson & Hsueh, 1978; Bicsak et al. 1986), or
"V
radioimmunoassays (RIA), using antibodies raised against synthetic
peptide fragments of the a-subunit (Rivier et al. 1987; Rivier et al. 1986).
Antibodies have also been used to study the distribution of inhibin
subunits by immunocytochemistry (Merchenthaler et al. 1987; Meunier et
al. 1988a). Data obtained by RIA are difficult to interpret, due to the wide
variety of possible combinations of inhibin subunits and subunit
fragments. Using oligonucleotides designed on the basis of partial protein
sequence data, cDNA encoding all three inhibin subunits has now been
cloned from rat ovary (Woodruff et al. 1987; Hsu & Hammond, 1987a),
pig ovary (Mason et al. 1985; Mayo et al. 1986), human ovary, testis and
placenta (Mason et al. 1986; Mason et al. 1989; Keinan et al. 1989; Feng et
al. 1989a; Mayo et al. 1986), and cow granulosa cell (Forage et al. 1986)
cDNA. These cDNA fragments have been used to study the regulation of
expression of inhibin subunits at the level of their mRNA. The inhibin
genes have also been cloned in the rat (Feng et al. 1989b; Albiston et al.
1990), sheep (Rodgers, 1991) and human (Albiston et al. 1990) and have
one intron each, situated in the region coding for the precursor
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sequences. The a- and [3b- genes have been mapped to human
chromosome 2 and mouse chromosome 1 and the |3a- gene to human
chromosome 7 and mouse chromosome 13 (Barton et at. 1989; Chenevix
Trench et al. 1990). The three subunit genes bear considerable homology
with one another, and are highly conserved between species (in fact, the
human, rat, cow and pig pA-subunit proteins are identical), suggesting
that they all evolved from a single ancestral gene.
Using various assays, it has been shown that the principal gonadal
sites of inhibin expression are the granulosa cells in the ovary and the
Sertoli cells in the testis. It has been shown by immunocytochemistry that
granulosa cells produce all three inhibin subunits (Meunier et al. 1988a),
and in situ hybridisation experiments have shown that the levels of
mRNA encoding each subunit correlate with changes in protein
expression (Meunier et al. 1988a; Rivier et al. 1989; Woodruff et al. 1989).
In rats, cows and sheep, the a-subunit is expressed in healthy follicles of
all sizes, but the p-subunits are only expressed in healthy antral follicles,
and not in atretic or preovulatory follicles (Rodgers et al. 1989; Woodruff
et al. 1988; Meunier et al. 1988a). In the primate, there is a recent report
that the Pb-subunit is expressed at an earlier stage of follicular
development than the a- or PA-subunits (Schwall et al. 1990). In the case
of species such as rats, cows and sheep, the corpus luteum does not
express inhibin (Mann et al. 1989b; Campbell et al. 1991; Torney et al. 1989;
Rodgers et al. 1989; Woodruff et al. 1988; Woodruff et al. 1989), although
some inhibin a-subunit and a-subunit mRNA has been detected in
newly formed rat corpus luteum (Cuevas et al. 1987; Meunier et al. 1988a).
In contrast, human and other primate corpora lutea do produce bioactive
inhibin and express inhibin subunits (Tsonis et al. 1987; Davis et al. 1987;
Hillier et al. 1989b; Smith & Fraser, 1991). In rat and cow theca interna
cells, there is evidence that there is some expression of the inhibin
a-subunit, although only at low levels (Meunier et al. 1988a; Rivier et al.
1989; Torney et al. 1989).
The expression of the inhibin genes in the ovary is under the
control of gonadotrophins, and varies during the ovarian cycle in
response to changes in levels of gonadotrophins. In humans and other
primates, serum inhibin levels follow roughly the same pattern as
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oestradiol. Levels of inhibin are low during the early follicular phase, and
rise during the late follicular phase to reach a peak just prior to the
midcycle gonadotrophin surge, when inhibin levels drop (McLachlan et
at. 1987; McLachlan et al. 1990; Reddi et at. 1990). When the corpus
luteum is established, inhibin levels rise again. With the regression of
the corpus luteum, inhibin levels fall along with those of progesterone
and oestradiol (McLachlan et al. 1987; Roseff et al. 1989; Smith et al. 1990c),
and this can be experimentally reproduced by luteectomy (Bassett et al.
1990) or infusion of a GnRH antagonist during the luteal phase (Fraser et
al. 1989). Similarly, inhibin levels can be maintained by "rescue" of the
corpus luteum with hCG in humans (Illingworth et al. 1990). The peak of
inhibin just before the surge is not so pronounced as, and occurs later
than, that of oestradiol. While oestradiol levels during the luteal phase
are elevated in these species, they never reach the levels seen just before
midcycle. However, inhibin levels in the blood are at their highest during
the luteal phase. Secretion of inhibin during the primate ovarian cycle
can be said to follow a pattern somewhere between that of oestradiol and
that of progesterone. In species such as rats, sheep and cows, the pattern of
inhibin secretion and gene expression follows a different pattern. In rats,
serum and follicular fluid inhibin levels begin to rise after the secondary
FSH surge in the morning of oestrus (Watanabe et al. 1990; Hasegawa et
al. 1989; Fujii et al. 1983). This can be mimicked by unilateral
ovariectomy, which causes an increase in serum FSH levels, which leads
to recruitment of more follicles, and increased expression of inhibin
subunit mRNA in these follicles (D'Agostino et al. 1989; Ackland et al.
1990). Inhibin levels increase steadily during dioestrus and metoestrus, to
reach a peak just before the gonadotrophin surge in the afternoon of
prooestrus. Thereafter, serum inhibin levels (Yohkaichiya et al. 1991;
Rivier et al. 1989; Watanabe et al. 1990) and expression of inhibin subunit
genes in preovulatory follicles (Meunier et al. 1988a; Woodruff et al. 1988)
decline sharply, although in smaller follicles inhibin expression remains
essentially unchanged. This fall in inhibin production can be shown to be
a response to the surge of LH, since treatment of animals with GnRH
antagonists blocks the drop in inhibin expression in the granulosa cells of
preovulatory follicles (Rivier et al. 1989; Woodruff et al. 1989). As with
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rats, sheep and cow follicles but not corpora lutea produce inhibin
(Campbell et al. 1991; Mann et al. 1989b), reflecting expression of inhibin
a- and PA-subunit mRNA (Rodgers et al. 1989). In these species, inhibin
expression is not confined to the largest follicles, and so does not entirely
follow the pattern of oestradiol secretion.
In vitro studies have now established that the production of inhibin
by rat (Bicsak et al. 1986; Suzuki et al. 1987; Zhang et al. 1987b; Bicsak et al.
1988), pig (Michel et al. 1991b) and primate (Hillier et al. 1989b) granulosa
cells is stimulated by FSH. Sheep and cow granulosa cell inhibin
production appears to be insensitive to FSH and LH (Henderson &
Franchimont, 1981; Campbell et al. 1991), although this could be due to
the degree of maturity of the granulosa cells or the culture system used.
LH has no effect on inhibin production by immature granulosa cells
(Zhang et al. 1988b; Hillier et al. 1989b), but it has a biphasic effect on
inhibin production by granulosa cells which have been exposed to FSH,
being stimulatory at low doses (Bicsak et al. 1986; Hillier et al. 1989b) and
inhibitory at high concentrations (Zhang et al. 1988b). Other factors also
affect granulosa cell inhibin production in vitro, including steroids (as
discussed above) and growth factors (see below). The control of inhibin
expression had not been fully investigated at the outset of this project,
and the effects of gonadotrophins and steroids on the expression of the
inhibin genes in rat granulosa cells are presented in Chapter 4.
Although inhibin and activin were originally postulated as
regulators of gonadotrophin secretion, and were purified on the basis of
these properties, it is becoming increasingly clear that these proteins, like
steroids, are not only produced in the ovary, but are also capable of acting
as paracrine or autocrine regulators of ovarian function. Few in vivo
studies have examined the effects of inhibin and activin at the level of
the ovary. Chari et al. (1985) reported that an inhibin-like component of
human follicular fluid (based on its ability to prevent the rise in serum
FSH in adult rats following ovariectomy) also had the property of
inhibiting gonadotrophin-stimulated oestradiol secretion when injected
into immature rats. Also, a study has been published recently, in which
inhibin or activin were injected into the space between the ovary and its
bursa in intact immature rats (Woodruff et al. 1990). The results were
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slightly confused by the effects of these treatments on gonadotrophin
secretion, but the effects observed were that inhibin stimulated follicle
development and uptake of tritiated thymidine into granulosa cells,
whereas activin caused atresia, decreased granulosa cell tritiated
thymidine uptake and partially antagonized the stimulatory effect of
PMSG on follicle development. Specific binding of both inhibin and
activin to granulosa cells was also demonstrated.
In rat granulosa cell cultures, inhibin appears to have little effect,
either slightly inhibiting FSH-stimulated cAMP generation, leading to a
reduction in aromatase activity and progesterone production (Ying et al.
1986), or having no effect at all (Hutchinson et al. 1987). Activin, in
contrast, has been convincingly shown to stimulate granulosa cell
function, augmenting the stimulation of cAMP formation (Xiao &
Findlay, 1991), LH receptor expression (Sugino et al. 1988a), aromatase
activity (Hutchinson et al. 1987; Xiao et al. 1990), progesterone production
(Sugino et al. 1988a; Xiao et al. 1990; Xiao & Findlay, 1991) and inhibin
gene expression (LaPolt et al. 1989) and production (Sugino et al. 1988a;
LaPolt et al. 1989; Xiao et al. 1990; Xiao & Findlay, 1991) brought about by
FSH or forskolin. Activin also increases the numbers of FSH receptors on
granulosa cells (Hasegawa et al. 1988). Some of the stimulatory effects of
activin on granulosa cells are mimicked by TGFj3 (Adashi & Resnick,
1986; Ying et al. 1986; Dodson & Schomberg, 1987; Hutchinson et al. 1987),
which is structurally related to activin (see above), but high affinity
binding sites for activin which have been demonstrated on cultured rat
granulosa cells (Sugino et al. 1988b; LaPolt et al. 1989; Woodruff et al.
1990) do not bind TGF(3 (Sugino et al. 1988b). Activin has also been shown
to stimulate proliferation of luteinizing human granulosa cells
(Rabinovici et al. 1990b) and to inhibit progesterone and oxytocin
production (both markers of luteinized function) by luteinizing cow
granulosa cells (Shukovski & Findlay, 1990), suggesting that while it
promotes early granulosa cell development, activin inhibits
luteinization.
Both inhibin and activin also modulate thecal cell androgen
production. Hsueh et al. (1987) showed that inhibin markedly augments
LH-stimulated androgen production by cultured rat thecal cells, and that
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the effects of activin were quite the opposite. This has recently been
shown to be the case for human thecal cells also (Hillier et al. 1991a;
Hillier et al. 1991b), both factors selectively regulating androgen
production, and only affecting progesterone production at high doses, and
without affecting cell division.
It has also suggested that inhibin acts as an inhibitor of oocyte
maturation (Tsafriri et al. 1989b; O et al. 1989), and oc-subunit fragments
may also facilitate ovulation (Findlay et al. 1990).
Although the gonads are the richest source of inhibin, the
expression of inhibin and related proteins is not limited to these tissues.
Using the highly sensitive and specific technique of SI nuclease
protection assay, Meunier et al. (1988b) demonstrated expression of
inhibin subunit mRNA in a wide variety of non-gonadal rat tissues,
including placenta, pituitary, adrenal, bone marrow, spleen, kidney, brain
and spinal cord. Expression of inhibin subunits in the adrenal cortex has
been confirmed, and found to be under the control of ACTH and
corticosteroids (Crawford et al. 1987; Haji et al. 1991). Likewise, placental
inhibin expression has been confirmed in the Japanese monkey (Nozaki
et al. 1990) and human (McLachlan et al. 1986; Petraglia et al. 1987), where
it is stimulated by hCG and cAMP analogues, and may be involved in the
local control of hCG secretion (Petraglia et al. 1987). Inhibin production by
the placenta in other species is still uncertain, since another study failed
to find mRNA encoding inhibin-a in the rat placenta (Davis et al. 1986c).
Unexpected sources of inhibin gene expression are the pituitary
gonadotroph cells, where a- and Pe-subunit mRNA and protein have
been detected, and found to be regulated by oestradiol (Roberts et al. 1989).
Furthermore, an antibody to activin-B suppresses basal FSH secretion in
cultured rat pituitary cells (Corrigan et al. 1991), suggesting that locally
produced activin is an autocrine regulator of FSH secretion. Activin-A
has also been detected using a specific radioimmunoassay in the rat brain
and human placenta, as well as the gonads and pituitary, although by far
the highest levels of activin detected were found in the gonads (Shintani
et al. 1991). A factor known as erythroid differentiation factor (EDF),
which induces the differentiation of erythrocytes from stem cells, has
y v
been found to be identical to activin A (Eto et al. 1987; Murata et al. 1988).
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This has been confirmed in studies which showed that recombinant
activin A has the same effects as EDF on blood cells (Yamashita et al. 1990;
Broxmeyer et al. 1988) and on the differentiation of nerve cells
(Hashimoto et al. 1990). Activins are also expressed during early
embryonic development at least in Xenopus (Thomsen et al. 1990) and
chicks (Mitrani et al. 1990), where they induce tissue differentiation (van
den Eijnden-Van Raaij et al. 1990; Smith et al. 1990b).
6.2.5 Follistatin
Another protein called follistatin, which like inhibin suppresses
FSH release from pituitary cells, has been purified from pig and cow
follicular fluid. This protein is a single-chain polypeptide sharing no
homology with inhibin, which exists in two forms with molecular
weights of 32kDa and 35kDa in pig follicular fluid (Ueno et al. 1987), and
three forms with molecular weights of 31kDa, 35kDa and 39kDa in cow
follicular fluid (Robertson et al. 1987). These proteins, without affecting
secretion of LH, suppress FSH secretion stimulated by GnRH or activin in
vivo (DePaolo et al. 1991) and in vitro (Ueno et al. 1987; Robertson et al.
1987), although with lower potency than inhibin (Ying et al. 1987;
Robertson et al. 1990; DePaolo et al. 1991). This effect is partly exerted by
reducing levels of FSH-P mRNA (Carroll et al. 1989), and partly by
inhibiting FSH release (Ying et al. 1987). The effects of inhibin and
follistatin on FSH secretion are parallel, additive and equal at maximally
effective doses (Ying et al. 1987), suggesting a common mechanism of
action. Following the cloning of cDNA and the genes (which consist of six
exons) encoding pig and rat follistatin, it was established that the size
variants are the result of alternate splicing, and not products of different
genes (Shimasaki et al. 1988; Michel et al. 1990; Shimasaki et al. 1989b). In
pig follicular fluid, the 35kDa protein is by far the more abundant (Ueno
et al. 1987; Michel et al. 1990), and it has been shown that the larger the
form of bovine follistatin, the more potent its suppression of FSH
secretion (Wang et al. 1990). However, a recent paper reported that of the
two forms of recombinant human follistatin generated by the authors, it
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was the smaller which was very much the more active, being as effective
at inhibiting FSH secretion as inhibin (Inouye et al. 1991).
An interesting property of follistatin is its ability to bind activin
(Nakamura et al. 1990), which may explain its ability to antagonize the
effects of activin in a large number of studies (Ying, 1989; Carroll et al.
1989; Xiao et al. 1990; Xiao & Findlay, 1991). Follistatin also suppresses
GnRFI-stimulated FSF1 secretion in the absence of activin, which cannot
be explained by this property, unless the action of GnRFl involves locally
produced activin (see above), which seems unlikely considering how
quickly LH secretion follows a pulse of GnRH (Lincoln et al. 1985).
Expression of follistatin and its mRNA in the rat ovary follows a
similar pattern to that of inhibin-a. Expression of follistatin mRNA is
confined to the granulosa cells of growing follicles from the early antral
stage onwards (Shimasaki et al. 1989b; Nakatani et al. 1991a). Follistatin
mRNA and protein levels increase with the size of the follicle, to a
maximum in the preovulatory follicle before the LH surge, after which
expression falls, lingering in the newly-formed corpus luteum but absent
by the time of luteal regression (Nakatani et al. 1991a). In vitro and in
vivo, follistatin production by granulosa cells is stimulated by FSH or
PMSG (Michel et al. 1990; Shimasaki et al. 1989b; Saito et al. 1991).
As with the other factors discussed above, expression of follistatin is
not limited to the ovary. The discovery of follistatin in the pituitary itself
(Kogawa et al. 1991; Michel et al. 1990) adds yet another layer of
complexity to the control of FSH secretion. Is FSH secretion modulated by
locally produced activin? If so, is that also subject to modulation by locally
produced follistatin? A study using the highly sensitive technique of SI
nuclease protection assay demonstrated follistatin expression in rat brain,
adrenal, thymus, pancreas, gut, kidney, heart, uterus, skeletal muscle and
lung as well as ovary, testis and pituitary. Another study confirmed by
Northern blotting the expression of follistatin in the ovary, kidney and
brain, but failed to detect the signal in other tissues (Shimasaki et al.
1989b). Follistatin is also expressed at the same time as activin during
development of Xenopus embryos (Tashiro et al. 1991).
There is little information available at the moment on the effects of
follistatin on ovarian cells. Follistatin appears to have no effect on
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progesterone secretion by cultured preovulatory follicles, or on the
maturation of their oocytes (Tsafriri et al. 1989b). However, two recent
studies have shown inhibitory effects of follistatin on the FSH-stimulated
secretion of inhibin and oestradiol by cultured rat granulosa cells (Xiao et
al. 1990), due to a suppression of cAMP accumulation (Xiao & Findlay,
1991).
6.2.6 GnRH
The hypothalamic decapeptide gonadotrophin-releasing hormone
(GnRH), in addition to its primary function of stimulating pituitary FSH
and LH release, has also unexpectedly been found to have direct actions
on granulosa cells, which have been studied in some detail. GnRH has
been detected in sheep and cow ovaries (Aten et al. 1987), and its mRNA
has been detected in rat ovary by the extremely sensitive technique of
reverse transcriptase-PCR (Oikawa et al. 1990). Furthermore, receptors for
GnRH have also been demonstrated on rat granulosa and theca cells
(Maruo et al. 1985; Hsueh & Schaeffer, 1985), and on the granulosa cells of
dominant human follicles (Latouche et al. 1989).
Treatment of immature granulosa cells with GnRH or a GnRH
agonist stimulates fibronectin secretion (Dorrington & Skinner, 1986),
while inhibiting FSH-stimulated progesterone (Knecht et al. 1982; Wang
& Leung, 1986; Suzuki et al. 1987; Wang et al. 1989b), oestradiol (Hsueh &
Schaeffer, 1985; Wang & Leung, 1986; Hillier et al. 1987; Suzuki et al. 1987)
and inhibin (Bicsak et al. 1986; Suzuki et al. 1987; LaPolt et al. 1990b)
production, and also FSH-stimulated LH receptor induction (Shinohara
et al. 1985a; Maruo et al. 1985; Knecht et al. 1982). In more mature cells,
GnRH or GnRH agonist stimulates progesterone (Kawai & Clark, 1985;
Eckstein et al. 1986; Wang & Leung, 1988; Wang & Leung, 1987b;
v-' y
plasminogen activator (Wang & Leung, 1986; Ny et al. 1987; Ohlsson et al.
1988) and prostaglandin (Kawai & Clark, 1985; Kawai & Clark, 1986; Wang
et al. 1989b) production. Many of these effects can be blocked with specific
GnRH antagonists (Wang & Leung, 1986; Bicsak et al. 1986; Ny et al. 1987;
LaPolt et al. 1990b), suggesting a specific effect of GnRH, mediated via
specific receptors. The main reason why GnRH has attracted so much
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attention as an intraovarian regulatory peptide when very little is known
about the regulation of its production and reception in the ovary is that it
inhibits differentiation of granulosa cells through the protein kinase C
pathway. GnRH causes a rapid increase in granulosa cell inositol
trisphosphate (Davis et al. 1986b; Wang & Leung, 1988), diacylglycerol
(Davis et al. 1986b) and Ca2+ (Davis et al. 1986b; Wang et al. 1989a) levels.
Calcium chelating agents, protein kinase C inhibitors and calcium
\/
channel blockers inhibit the effects of GnRH (Eckstein et al. 1986), and
phorbol esters mimic its effects (Shinohara et al. 1985a; Kawai & Clark,
1985; Kawai & Clark, 1986; Wang et al. L989b). The action of GnRH on
granulosa cells, like its action on pituitary cells (Roberts et al. 1988), is
therefore very probably mediated through the protein kinase C pathway.
The protein kinase A and C pathways are apparently not entirely
independent of one another, since GnRH also affects cAMP metabolism
by reducing gonadotrophin-stimulated adenylate cyclase activity and
stimulating phosphodiesterase activity (Knecht et al. 1983a; Knecht et al.
1983b), and also reducing FSH receptor numbers (Knecht et al. 1983b),
thereby reducing the effectiveness of FSH in stimulating generation of
cAMP. GnRH and phorbol esters are also capable of inhibiting the
granulosa cell response to cAMP (Shinohara et al. 1985a; Eckstein et al.
1986), further reducing granulosa cell FSH sensitivity.
The function of GnRH in the local control of follicle development is
still unknown, but interesting insights into the relative importance of
second messenger systems operating in granulosa cells have been gained
from its study. The protein kinase A and C signalling systems appear to be
absolutely antagonistic in immature cells, differentiation being
stimulated through the protein kinase A system and inhibited through
the protein kinase C system (Shinohara et al. 1985a; Shinohara et al.
1985b; Petraglia et al. 1987). However, in more mature cells, activation of
the protein kinase C system stimulates plasminogen activator secretion
(Ny et al. 1987) and production of progesterone (Wang & Leung, 1987b;
Shinohara et al. 1986) and prostaglandins (Kawai & Clark, 1985; Wang &
Leung, 1989), which suggests a stimulatory role for protein kinase C in
ovulation and luteinisation. This concept is not consistent with reports
that phorbol esters can stimulate plasminogen activator expression in
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immature cells (Ohlsson et al. 1988), and inhibit progesterone production
by mature cells (Leung et al. 1988), nor with a study which found no
difference between the responses of immature and mature cells to
manipulation of this signalling pathway (Carnegie & Tsang, 1984), and so
the physiological importance of the protein kinase C signalling pathway
in granulosa cell function remains unknown.
6.2.7 FGFs
Fibroblast growth factors (FGFs) are single chain polypeptides which
are mitogenic for many cell types. The name FGF was first given to a
pituitary-derived mitogen, based on its ability to stimulate fibroblast
growth. FGF was subsequently found to consist of two separate but closely
related factors (Baird et al. 1986). The pituitary factor was designated basic
FGF (bFGF), and its counterpart acidic FGF (aFGF). Since then, growth
factors isolated from many different tissues have been found to be either
bFGF, aFGF or closely related to them. All these factors share the property
of binding to the sulphated glycosaminoglycan heparin, and for this
reason these factors are also known as heparin-binding growth factors
(Burgess & Maciag, 1989). FGFs, like the members of the TGFP family, are
involved in embryonic development at least in frogs and birds (Cooke &
Wong, 1991). Like TGFp and activin, FGFs cause differentiation of
embryonic cells destined to be epidermis cells into mesoderm-type cells
(Smith et al. 1990b); TGF(3-like factors induce dorsal structures and FGFs
y
induce ventral ones (Slack, 1990). However, the property for which FGFs
have attracted the most interest from the ovarian point of view is their
potent angiogenic activity (i.e. their ability to stimulate the proliferation
of capillary endothelial cells to form new blood vessels). In fact, bioassays
for FGF have been used, based on the stimulation of vascularisation of
transplanted chick chorioallantoic membranes, rabbit cornea and hamster
cheek pouch (Gospodarowicz & Ferrara, 1989). As discussed above, blood
vessels invade the collapsed follicle after ovulation, and this is associated
with local production of an angiogenic factor, which was subsequently
identified as bFGF (Baird et al. 1986). bFGF mRNA has been detected in
cow corpora lutea, and its production in cultured cow luteal cells is
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stimulated by LH (Stirling et al. 1991). In this study, bFGF mRNA was not
detected in follicles, but bFGF has been detected by immunocytochemistry
in granulosa cells of cow follicles of all stages of development (Grothe &
y
Unsicker, 1989). Moreover, bFGF mRNA has been detected in cultured
bovine granulosa cells which also secreted bFGF protein into the medium
(Neufeld et al. 1987). Expression of mRNA encoding both bFGF and aFGF
has been detected in rat ovaries, using reverse transcriptase-PCR (Koos &
Olson, 1989; Koos & Seidel, 1989). It was found that all of the bFGF and
most of the aFGF expression occurs in cells other than the granulosa cells.
The authors favoured ovarian endothelial cells as the major site of FGF
expression. This difference between the rat and cow is reflected in the fact
that FGF stimulates proliferation of cow granulosa cells (Neufeld et al.
1987), but is not mitogenic for rat granulosa or theca cells (Gospodarowicz
& Bialecki, 1979; Dorrington et al. 1988; Adashi et al. 1988a; Hurwitz et al.
1990). Rat granulosa cells do respond to FGF, however, but the effects are
exerted on differentiation rather than growth. bFGF suppresses FSH-
stimulated production of oestradiol (Baird & Hsueh, 1986; Adashi et al.
1988a) and inhibin (LaPolt et al. 1990b), and induction of LH receptors
(Oury & Darbon, 1988; Baird & Hsueh, 1986) in rat granulosa cells, and
inhibits LH-stimulated androgen production in rat theca cells (Hurwitz et
al. 1990). Not all its effects are inhibitory, since bFGF has been shown to
increase cAMP accumulation in response to FSH or forskolin (Adashi et
al. 1988a; LaPolt et al. 1990c), and to stimulate plasminogen activator
expression, progesterone production (Baird & Hsueh, 1986), oocyte
.
maturation and prostaglandin production (LaPolt et al. 1990c). Decreased
androgen, oestrogen and inhibin production and increased progesterone,
prostaglandin and plasminogen activator production, associated with
oocyte maturation, are all events which take place during ovulation and
luteinisation. Together with the established angiogenic effects of FGFs,
and their lack of effect on granulosa cell proliferation in the rat, these
results strongly implicate FGFs in ovulation and establishment of the
corpus luteum in this species. However, the fact that granulosa cells of
several species including humans, pigs, rabbits and guinea pigs grow in
response to FGF (Gospodarowicz & Bialecki, 1979; Tapanainen et al. 1987)
suggests that the rat is not a representative model for the study of the
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regulation of granulosa cell proliferation. Furthermore, FGF has no effect
on the differentiation of pig, cow and human granulosa cells
(Tapanainen et al. 1987; Mondschein & Hammond, 1988; Urban et al.
1990; Schams et al. 1988), except at high doses in the pig (May et al. 1987;
Biswas et al. 1988). FGFs, mainly bFGF, are probably most important for
stimulating the vascularisation of the theca layer and the corpus luteum,
and their direct effects on granulosa cells depend on the species.
6.2.8 Other Factors
Because of the accessibility of the in vitro granulosa cell model, an
extremely wide variety of different factors have been tested for potential
regulatory effects. Such factors include platelet-derived growth factor
(PDGF) (Hammond & English, 1987; May et al. 1990), nerve growth factor
(Lara et al. 1990), cytokines such as tumour necrosis factor (Adashi et al.
V. /
1990; Andreani et al. 1991; Veldhuis et al. 1991) and interleukins (Adashi,
1989; Adashi, 1990; Kasson & Gorospe, 1989), components of the renin-
angiotensin system (Itskovitz & Sealey, 1987; Do et al. 1988; Kim et al.
1987), substance P (Dees et al. 1985), vasoactive intestinal peptide
(Davoren & Hsueh, 1985; Liu et al. 1987b), relaxin (Too et al. 1984) and
arginine vasopressin (Khan Dawood & Dawood, 1989; Verges et al. 1986).
Many of these factors, and possibly several so far unknown factors as well,
will inevitably affect ovarian function in vivo, but there is not enough
information to speculate on the nature and extent of their involvement
in the control of ovarian function.
7 Summary
At the beginning of the ovarian cycle, a large number of primary
follicles begin to grow under the control of the gonadotrophins, FSH and
LH. Of these follicles, only a small number (which depends upon the
species) will ovulate at midcycle. Growth of small follicles is initiated by a
rise in circulating levels of FSH which acts on the granulosa cells of the
follicle, causing them to proliferate, and also to differentiate into active
steroidogenic cells whose major product is oestradiol. A number of other
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functional changes take place during granulosa cell differentiation,
including the induction of receptors for LH, and the production of
inhibin. As granulosa cells differentiate in response to FSH, their output
of oestradiol, and also inhibin, increases. Oestrogen feeds back to the
pituitary, where it suppresses FSH secretion, leading to a drop in
circulating levels of FSH. Inhibin may also participate in this negative
feedback loop. The majority of the growing follicles are unable to
withstand this fall in trophic support, and degenerate. A number of these
follicles, however, continue to grow in spite of the fall in FSH levels, and
will ultimately ovulate. Since all follicles are exposed to the same
concentrations of gonadotrophins at any one time, it is likely that there
are mechanisms operating at the local level which determine whether a
follicle is selected or becomes atretic. It is thought that the fate of a follicle
depends upon the sensitivity of its granulosa cells to FSH and also LH,
and that this is a function of the degree of differentiation of these
granulosa cells. A variety of factors have been implicated in this local
control of granulosa cell differentiation, in particular locally produced sex
steroids, which have been shown to augment strongly the actions of FSH
on some aspects of granulosa cell differentiation. This interaction
between FSH and locally produced androgen and oestrogen in the control
of granulosa cell differentiation was the subject of the studies described in
this thesis.
8 Scope of the Thesis
Much is known about the effects of steroids on certain aspects of
granulosa cell differentiation, in particular steroidogenesis and LH
responsiveness, but few systematic studies have addressed their effects on
gene expression and protein synthesis in these cells. In the course of this
project, two main fields of study have been identified. Firstly, the role of
steroids in the control of morphological differentiation at the level of
cytoskeletal protein synthesis and gene expression was investigated.
Secondly, the importance of ovarian protein hormones, in particular the
inhibins and activins, as local as well as endocrine regulators of ovarian
function is becoming increasingly recognised. Consequently, studies were
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carried out to investigate the effects of steroids on the expression of the
inhibin genes. In Chapter 2 the adaptation and validation of a rat
granulosa cell culture system for the study of the effects of steroids on
protein synthesis and gene expression is presented. Studies on steroidal
regulation of cytoskeletal protein synthesis and gene expression are
described in Chapter 3. The control of inhibin gene expression by steroids
is presented in Chapter 4, and the gonadotrophic regulation of inhibin
gene expression is correlated with changes in steroidogenic enzyme and
LH receptor gene expression both in vitro and in vivo. Because little
consensus has been reached on the regulation or even existence of steroid
receptors in granulosa cells, studies on the expression of the androgen
and oestrogen receptors were carried out, and the results of these studies
are also presented in Chapter 2. Because of the limited material available
from cultured cells, and the lack of quantitative information on RNA
levels that can be gained from membrane hybridisation, the development
of a sensitive and quantitative solution hybridisation assay for inhibin-a
mRNA was undertaken, and is presented in Chapter 5.
Chapter 2 Progesterone Production and
Protein Synthesis In Vitro
1 Introduction
Studies on the specific effects of hormones on a particular cell type
require a convenient model system with clearly defined conditions. The
model used throughout this thesis was a serum-free culture system using
granulosa cells isolated from immature rats pretreated in vivo with
diethylstilboestrol. This model has been in widespread use for a number
of years, and much of what is known about the differentiation of
granulosa cells has been gleaned using this model (Hsueh et al. 1984),
which is based on the ability of oestrogen to stimulate proliferation of rat
granulosa cells when administered in vivo (Simpson et al. 1941), to yield
large numbers of granulosa cells from preantral and small antral follicles,
and therefore in an undifferentiated state.
The purpose of this part of the project was to identify some of the
changes in protein synthesis and gene expression which accompany
granulosa cell differentiation in response to FSH and steroids. The
steroids of particular interest were not only oestrogen, but also their
precursors (androgens), and metabolites (catecholoestrogens). Since
granulosa cell progesterone production has been widely used as a marker
of differentiated function in vitro (Armstrong & Dorrington, 1976; Welsh
et al. 1983; Hudson et al. 1987) and is easily measured by
radioimmunoassay, this was the criterion by which the effects of FSH and
steroids on granulosa cell differentiation, and their dose-response
characteristics, were initially evaluated before studies on protein
synthesis were undertaken.
Progesterone production was also used as a marker for hormonal
responsiveness during the optimisation of an existing rat granulosa cell
culture system, which is also described in this chapter. This system, in
which cells are cultured for 48h at a plating density of 2.5x104 cells per
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well, was developed for the study of the hormonal regulation of
granulosa cell steroidogenesis and cAMP formation (Hillier & deZwart,
1982; Hudson et at. 1987). However, since other end-points were to be
studied in this project, experiments were carried out to determine the
optimum incubation time for the study of hormone-dependent changes
in protein synthesis. The possibility of increasing the cell density was also
explored, to improve yields of protein samples for analysis by
electrophoresis and immunoprecipitation. Plating density has been
shown to influence granulosa cell hormonal responsiveness in vitro
(Davoren & Hsuehj 1986), so patterns of protein synthesis and
progesterone production were observed over a range of cell densities.
The major aim of the project was to investigate the modulatory
effects of oestrogen on FSH-induced granulosa cell differentiation. The
use of oestrogen to stimulate proliferation of cells in vivo may affect their
subsequent responses to oestrogen and other steroids in vitro, so
experiments were also carried out to establish the effects, if any, of DES
treatment in vivo on the effects of steroids in vitro. In addition, most
culture media include phenol red as a pH indicator. This compound has
been shown to exhibit weak oestrogenic activity in cultures of MCF-7 cells
(Berthois et at. 1986; Welshons et at. 1988), and therefore has the potential
to compromise the defined conditions of the culture system. Therefore,
the effects of phenol red on granulosa cell steroidogenesis were
investigated.
As discussed in chapter 1, section 6.1, there is still some doubt
concerning the existence of steroid receptors in granulosa cells, and
therefore the specificity of the effects of steroids. One way in which
specificity can be demonstrated is by the use of competitive antagonists. A
number of studies have shown clear reversal of the augmentation by
androgens of FSH-stimulated differentiation using the antiandrogen
hydroxyflutamide (Hillier & deZwart, 1981; Hillier & deZwart, 1982;
Duleba et at. 1985), suggesting that these effects of androgens are mediated
through the androgen receptor. However, the nonsteroidal
antioestrogens tamoxifen and keoxifene have been shown to inhibit FSH-
or cAMP-induced differentiation of cultured rat granulosa cells in the
absence of oestrogen (Knecht et at. 1985; Kessel & Hsueh, 1987), suggesting
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either that the antioestrogens were inhibiting the action of endogenous
oestrogen produced in response to FSH or cAMP, or that the effects of the
antioestrogens were nonspecific. Furthermore, these compounds are
partial oestrogen agonists in this and other systems (Kessel & Hsueh,
1987; Wakeling et al. 1989), and have other effects as well as their
antioestrogenic properties (Faye et al. 1987; Vonderhaar & Banerjee, 1991),
making interpretation of results difficult. A "pure" antioestrogen (i.e.
without agonistic activity), ICI 164,384, which is a 7a- tertiary amide
derivative of 17(3-oestradiol, has been used successfully in assays such as
the inhibition of MCF-7 cell proliferation and oestrogen-stimulated rat
uterine weight and progesterone receptor synthesis (Wakeling & Bowler,
1988; Wakeling et al. 1989). This compound was used to study the
specificity of the effects of 17p-oestradiol on granulosa cell progesterone
production, and the results of these experiments are described in this
chapter.
An alternative approach to the investigation of steroid receptors in
granulosa cells is to use nucleic acid probes to detect mRNA encoding
these proteins. Despite demonstration of high affinity oestrogen binding
sites in the nuclei of granulosa cells, studies using nucleic acid probes
failed to detect oestrogen receptor mRNA in mouse ovaries, although a
related RNA species was detected (reviewed in chapter 1, section 6.1.1).
Similarly, expression of androgen receptor mRNA in granulosa cells has
not been reported (reviewed in chapter 1, section 6.1.2). Therefore, a
further aim of the studies described in this chapter was to investigate the
expression of mRNA encoding the androgen and oestrogen receptors in
rat granulosa cells, and to study the effects of gonadotrophins on the
expression of these genes.
2 Materials and Methods
2.1 Hormones and Antagonists
Where FSF1 was administered to animals in vivo, 20pg of ovine
FSH (NIADDK-o-FSH-16; FSH bioactivity = 20U/mg, LH bioactivity = 0.04
x NIH-LH-S1; donated by the National Institute of Arthritis, Metabolism
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and Digestive Diseases, Bethesda, U.S.A.), in lOOpl DPBS containing 0.1%
BSA, was injected subcutaneously every 12 hours for the 48 hours prior to
removal of the ovaries. Where hCG was administered in vivo, to mimic
a surge of LH, 20IU hCG (purchased from Sigma Chemical Co., Poole,
Dorset) were injected subcutaneously in lOOgl DPBS containing 0.1%
BSA, 12h before animals were killed.
Human (h) FSH, which was the generous gift of Prof. L.E. Reichert,
Jr. (LER 8/116; FSH bioactivity = 900U/mg, LH bioactivity = ~0.5IU/mg)
was stored at -20C in 0.1% BSA in DPBS, and was used for all in vitro
experiments at final concentrations of 3-200ng/ml. hCG was also stored at
-20C in DPBS containing 0.1% BSA, and was added to cultures at a final
concentration of 200mIU/ml. Stock solutions (10"6M to 10"3M) of
Testosterone (T; 17(3-hydroxyandrost-4-en-3-one), 17(3-oestradiol (E2;
l,3,5,[10]-oestratrien-3,17(3-diol), 5a-dihydrotestosterone (DHT; 17(3-
hydroxy-5a-androstan-3-one) and 2-hydroxyoestradiol (2-OH-E2; 1,3,5[10]-
oestratriene-2,3,17(3-triol), all purchased from Sigma, were stored at -20C
in ethanol. Steroids were added to culture wells in a volume of 5jil, to
give final concentrations of 10~9M to 10~5M. The antioestrogen
ICI 164,384 (N-n- butyl - 11 - [l,3,5(10)-oestratriene-3,17(3-diol -7a- yl] -N-
methylundecanamide) and the inactive 7|3-isomer of the secondary
amide, ICI 164,275 were donated Dr. A. Wakeling, ICI Pharmaceuticals,
Macclesfield, Cheshire (see Fig.2.1 for structures). Stock solutions of these
compounds were stored in ethanol at -20C. Phenol red was purchased
from Sigma.
2.2 Animals
Immature female Wistar and Sprague-Dawley rats were used for the
experiments presented throughout this thesis. These animals were either
bred in-house or purchased from Bantin and Kingman Ltd., Hull. The
animals were 21 days old at the beginning of the experiments. Animals
were treated with DES (Sigma) using 1cm silastic tubing capsules
containing solid DES, which were implanted subcutaneously under
general anaesthesia in the neck region of the animals. These capsules
were left in place for 4 days. Adult mice (hybrids of CBA and C57BL






Fig.2.1 A. Structure of the antioestrogen ICI 164,384 (N-rc-butyl-11 -
(l,3,5[10]-oestratriene-3,17P-diol-7a-yl)-N-methylundecanamide). B. Structure of
the 7(3-isomer of the secondary amide derivative, ICI 164,275 (N-n-butyl-11-
(l,3,5[10]-oestratriene-3,17p-diol-7P-yl) undecanamide).
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strains, 40 days old) were also used for studies of oestrogen receptor
mRNA expression.
2.3 Cell Culture Method
Animals were killed with carbon dioxide or by cervical dislocation.
Ovaries were removed and dissected free from fat and other surrounding
tissue. Granulosa cells from preantral and early antral follicles were
harvested in culture medium by gentle puncture with a hypodermic
needle. Cells were then centrifuged at 1500rpm for lOmin and
resuspended in lml of medium. To disperse the cells and to eliminate
clumps, the suspension was drawn through a pipette tip several times,
made up to 10ml with medium, and allowed to settle for lmin. The cells
remaining in suspension were then centrifuged, resuspended and
triturated again as before. An aliquot of the cell suspension was removed
and mixed with an equal volume of trypan blue solution, and cells in this
mixture were counted using a haemocytometer. Viability was assessed
based on the exclusion of the dye, and was typically >40%. Yields of
granulosa cells were 2.03 (±0.11) xlO6 cells per DES-treated animal (29
experiments), or 0.95 (±0.07) xlO6 cells per control animal (13
experiments). Cells were cultured in Medium 199 containing 25 mM
HEPES buffer, extra (2 mM) L-glutamine, penicillin (50 IU/ml) and
streptomycin (50 mg/ml) (all from Gibco Ltd, Paisley, UK) with 0.1%
(w/v) BSA (ICN Biomedicals, High Wycombe, Bucks, UK). Multiwell
plastic dishes (Linbro Space Savers, Flow Laboratories, Rickmansworth,
Herts, UK) were precoated with donor calf serum (Gibco) and washed
twice with 1 ml Dulbecco's phosphate buffered saline (DPBS; Oxoid)
before use. The culture wells were inoculated with replicate 250 pi
portions of cell suspension containing the required number of viable
granulosa cells. The cultures were incubated at 37C in a humidified
incubator gassed with 95% air/5% CO2. Cultures were incubated for 48h
for most experiments. To study the time-course of hormonal responses,
however, incubations of 6, 24, 48 and 72h duration were also carried out.
Metabolic labelling incubations (see below) lasted for 24h in all cases.
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To investigate the effect of cell plating density on hormonal
responsiveness and protein synthesis, granulosa cells were cultured at
densities of 50, 100, 150, 200, 300 and 400x103 cells per well. After 48h in
culture, medium was removed and the monolayers were washed once
with 1ml of Minimum Essential Medium (MEM; Gibco), and cells were
recovered from some of the culture wells by incubation at room
temperature for lOmin in 250gl trypsin/EDTA solution (0.5mg/ml
trypsin and 0.5mM EDTA in Modified Puck's Saline A; Gibco). 250 pi of
MEM containing 5% donor calf serum was added to each well, to prevent
over-digestion with trypsin, and cells were transferred to microcentrifuge
tubes. Wells were washed out with 500gl MEM, which was pooled with
the cells. Cells were pelleted at 1500 x g for lOmin, and gently resuspended
in 250gl DPBS. Cells were then counted in a haemocytometer.
2.4 Progesterone Radioimmunoassay
After the culture period, media were removed and stored at -20C
until required. Progesterone (4-pregnene-3,20-dione) was measured in
culture media by specific radioimmunoassay. The assay buffer was
phosphate buffered saline/gelatine (0.05M sodium phosphate, 0.15M
NaCl, 0.1% gelatine). The antibody, raised in the rabbit against
progesterone-lla-hemisuccinate-BSA (R31/12), was provided by MRC,
Mill Hill. Antibody was used at a working dilution of 1:4,500. Cross-
reaction of the antibody with oestradiol-17(3, ICI 164,384, ICI 164,275 or
SCH 16423 was <0.01%. Cross-reaction with testosterone,
5a-dihydrotestosterone and 2-hydroxyoestradiol was 0.04%, 0.05% and
0.02%, respectively. Tracer, [l,2,6,7-3H]-Progesterone (80-110Ci/mmol,
Amersham), was stored at -20C in ethanol, at a concentration of
10gCi/ml. Before use this stock was diluted 1:400 in assay buffer to give
~10,000cpm/500gl. A standard curve covering the range of 12.5 to
1600pg/tube 4-pregnene-3,20-dione (Sigma), made up in culture medium,
was used. Samples (5-100gl) or standards (in 200pl) were placed in tubes,
and the volume of samples was adjusted to 200pl. Quality controls (83
and 850pg/tube) were also included at the beginning and end of each
assay. Antibody (300|il) and tracer (500gl) were added, and tubes were
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incubated overnight at 4C. Tubes were placed on ice for 15min before
addition of 200pl dextran charcoal (1.25% dextran, 1.25% charcoal in assay-
buffer) to separate bound and free progesterone. Tubes were mixed and
incubated for lOmin on ice, then centrifuged at 3000rpm for lOmin at 4C.
Supernatants were decanted, 3ml scintillation cocktail (RIALUMA,
Lumac LSC b.v., Olen, Belgium) was added, and bound tracer was
measured by liquid scintillation counting (RackBeta, LKB Wallac, Turku,
Finland). Standard curves were calculated using a commercial computer
program (AssayZap, Biosoft, Cambridge, UK). Samples which were
outwith the detection limits were re-assayed at the appropriate volume.
Specific binding (B/B0) was 38-43%, and nonspecific binding was 2-4%.
The detection limit of the assay was in the range 15-20pg/tube. Inter- and
intra-assay coefficients of variation were 15% and 6%, respectively.
Statistical analysis was carried out using commercial software (CLR
ANOVA, Clear Lake Research Inc., Houston, TX, USA). Analysis of
variance was carried out on results after log transformation to reduce
heterogeneity of variation, and statistical differences at the p<0.05 level
were revealed using Duncan's Multiple Range Test.
2.5 Analysis of Protein Synthesis
2.5.2 Metabolic Labelling
In order to study the effects of in vitro treatments on patterns of
protein synthesis, cultures were incubated as above in the presence of test
agents, and monolayers were washed once with 1ml MEM before being
incubated for an additional 24h in 250gl methionine-free MEM
containing extra (2 mM) L-glutamine, penicillin (50 IU/ml) and
streptomycin (50 mg/ml), but without BSA. 10-20 gCi 35S-methionine
(Tran35S-Label, ICN) was then added to each culture well. The test agents
treatments were also included in the medium during this labelling
period. In an experiment to study the effects of FSH administration in
vivo on the patterns of granulosa cell protein synthesis, cells were
isolated as described above, but were resuspended in methionine-free
MEM containing 35S-methionine, and cultured for 24h.
Chapter 2 Protein Synthesis 78
The media from metabolically labelled cultures were removed after
the labelling period, replicates being pooled, and aprotinin (Sigma) was
added to a final concentration of 15 KlU/ml. The cell monolayers from
those cultures were lysed with a solution containing 20mM Tris-HCl
(pH6.8), 0.5% (v/v) NP-40, 40 KlU/ml aprotinin, 2 mM phenyl-methyl-
sulphonylfluoride (PMSF) and 0.02% (w/v) sodium azide (all from
Sigma). Cells were scraped off the bottom of the wells with a pipette tip
and replicates were pooled. Media and cell extracts were centrifuged at
13,000g for 5min to remove cell debris, and supernatants were transferred
to fresh tubes, and stored at -20°C until required.
2.5.2 TCA Precipitation
The amount of radioactive label incorporated into protein in the
samples was determined by precipitation of the proteins with
trichloroacetic acid (TCA) according to the method of Kessler (1981).
Triplicate aliquots of each sample were mixed with 30jj.1 of a solution of
lOmM sodium phosphate pH6.5 and 130mM sodium chloride containing
lOmg/ml BSA as a carrier protein. 1ml of 10% (w/v) TCA containing
lOmM L-methionine was added to each tube and tubes were placed on ice
for 30min. Samples were centrifuged at 13000g for 5 min and the
supernatants were aspirated. Pellets were taken up in 200pl 0.1M
potassium hydroxide, and a further lml of TCA was added. Tubes were
placed on ice, centrifuged and supernatants aspirated again as before.
Final pellets were taken up in 100^1 0.5M KOH, and 100pl of each sample
was counted by liquid scintillation counting.
2.5.3 One Dimensional SDS-PAGE
Radiolabeled proteins were routinely separated according to their
molecular weight by electrophoresis in polyacrylamide gels containing
sodium dodecyl sulphate (SDS), according to the method of Laemmli et
at. (1970). A BioRad Mini Protean II minigel system was used for this
purpose.
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Either 12.5% single percentage or 7.5%-15% polyacrylamide gradient
slab gels were used, containing 375mM Tris (pH8.8) and 0.1% SDS (w/v).
The ratio of acrylamide:bisacrylamide used was 37.5:1, and gels were
prepared from a stock solution of 30% acrylamide (w/v) and 0.8%
bisacrylamide (w/v). Gel mixtures were polymerised with 0.05% (v/v)
N,N,N',N'-tetramethylethylenediamine (TEMED, Sigma) and 0.05%
(w/v) ammonium persulphate (APS, BDH). Gradient gels were prepared
using a gradient former, and the mixture was pumped into a BioRad
Mini Protean II multi-casting chamber, forming up to 11 gels at one time
which could be stored until needed. Gels were overlaid with water-
saturated butanol until polymerisation was complete. In all cases
discontinuous gels with a stacking gel were used. The composition of the
stacking gel was 4% acrylamide, 125mM Tris-HCl (pH6.8) and 0.1% (w/v)
SDS.
Samples were prepared by adding an equal volume of denaturing
sample buffer (40mM Tris-HCl [pH6.8], 2% [w/v] SDS, 10% [v/v] glycerol
and 5% [v/v] (3-mercaptoethanol [[3ME]) to an aliquot of each sample and
boiling for 5min. Samples were then centrifuged at 13,000xg for 5min, and
supernatants transferred to fresh tubes.
Equal counts of radioactive protein samples as determined by TCA
precipitation (10-20xl03 cpm) were loaded onto polyacrylamide gels in a
volume of 0.5-50pl. Molecular weight standards (Sigma) were also loaded,
and electrophoresis was carried out in an electrode buffer containing
25mM Tris (pH8.3), 200mM glycine and 0.1% (w/v) SDS at 180V until the
dye-front had reached the end of the gel (approximately 45min). Proteins
were then stained by soaking gels for lh in 1.5% (w/v) Coomassie
brilliant blue (Sigma) in 20% (v/v) ethanol and 8% (v/v) acetic acid and
gels were destained overnight in acid ethanol alone to visualise
molecular weight markers. Radiolabeled proteins were visualised by
autoradiography or fluorography of dried gels. Gels containing 20xl03
cpm or more of radioactive proteins were exposed to Amersham [3-Max
film at room temperature (direct autoradiography), whereas gels
containing less radioactivity were soaked in Amplify (Amersham) for
5min before drying, and then exposed to Kodak XAR-5 film at -70C
(fluorography).
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2.5.4 Two Dimensional Electrophoresis
To reveal the effect of FSH on patterns of proteins secreted by
granulosa cells in vivo, proteins secreted by cells freshly isolated from
control and FSH treated animals were analysed by two dimensional
polyacrylamide electrophoresis, according to the method of Hochstrasser
et al. (1988), using a Bio-Rad Mini-Protean II 2-D cell. First dimension
(isoelectric focussing) tube gels were prepared, containing 4% acrylamide,
9M urea, 2% (v/v) NP-40 and 2% (v/v) ampholines (from a 7:1 mixture
of Biolytes pH 7-9 and 3-10, Bio-Rad). The mixture was thoroughly
degassed before being polymerised with 0.02% APS and 0.1% TEMED and
overlaid with distilled water. After polymerisation had been allowed to
take place, the overlay was replaced with degassed 20mM NaOH. After a
further 30min, this was replaced with fresh 20mM NaOH. Gels were
prefocussed at 200V for lOmin, 300V for 15min, and 400V for 15min. The
upper chamber buffer was 20mM NaOH, and the lower chamber buffer
was 6mM H3PO4. Samples were mixed with an equal volume of
solubilising/reducing buffer (9M urea, 2% NP-40, 2% ampholines and 1%
[w/v] dithiothreitol [DTT]), and additional urea was added to a final
concentration of 9M. Samples were incubated at room temperature for
15min and centrifuged at 13,000 x g for 3min. Supernatants were
transferred to fresh tubes, and lxl05cpm of total radiolabeled proteins
were loaded onto the first dimension gels immediately. Blank gels,
loaded with diluted sample buffer only, and gels loaded with isoelectric
point standards (IEF Mix 3.6-9.3, Sigma) were also run, to calibrate the pH
(
separation range. Isoelectric focussing was carried out at 500V for 2.5h,
750V for Ih, and 990V for 30min. Samples were separated in the second
dimension according to molecular weight as described in the previous
section, after equilibration of first dimension gels for lOmin in
denaturing sample buffer. Proteins were detected by fltiorography as
described above.
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2.6 Analysis ofmRNA
2.6.1 Extraction, Purification and Quantitation of Total Cellular
RNA
Total RNA was extracted from granulosa cells according to the
method of Chomczynsky and Sacchi (Chomczynski & Sacchi, 1987).
Medium was removed from granulosa cell cultures, and the cells were
lysed on ice with cold "solution D" (4M guanidinium thiocyanate [Fluka,
Glossop, Derbyshire], 25mM sodium citrate, 0.5% [w/v] sarcosyl, lOOmM
P-mercaptoethanol; 200|il/well). The cell lysate was transferred to
polypropylene tubes (Falcon 2059, Becton Dickinson, Cowley, Oxford), and
an additional lOOgl of solution D was added to each well, and pooled with
the initial lysate. One tenth of a volume of 2M sodium acetate (pF14), one
volume of water-saturated phenol and one fifth of a volume of
chloroform:isoamyl alcohol (49:1) were added, tubes being capped and
shaken between additions. Tubes were shaken vigorously for lOsec after
the last addition, and placed on ice for 15min. Tubes were then
centrifuged at 10,000g for 20min at 4C to separate the phases. The aqueous
(top) phases were transferred to fresh tubes, taking great care to leave
behind the protein present at the interface, and an equal volume of cold
isopropanol was added. Tubes were left at -20C for at least lh to allow the
RNA to precipitate. Precipitated RNA was recovered by centrifugation at
10,000g for 20min at 4C. The supernatants were poured off, pellets were
dissolved in 300gl of solution D, and transferred to microcentrifuge tubes.
RNA was reprecipitated with an equal volume of isopropanol at -20C for
at least lh, and then recovered by centrifugation at 13,000g for lOmin at
4C. RNA pellets were washed with 70% (v/v) ethanol and allowed to dry
by leaving tubes open at room temperature, before being dissolved in 30pl
of 0.5% (w/v) SDS.
Concentration and purity of RNA preparations were determined by
spectrophotometry. A small aliquot of each preparation was diluted with
water, and transferred to a spectrophotometer cuvette. The purity of an
RNA sample was calculated from the ratio of the absorbance of the
solution at 260nm (A260) to its absorbance at 280nm (A28o)- A ratio of 2.0
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was considered optimal purity. Any samples with an A260;A.280 ratio of
less than 1.5 were re-extracted with an equal volume of
phenohchloroform and reprecipitated with 0.1 volume of 3M sodium
acetate and 2.5 volumes of ethanol at -20C for at least lh, then recovered
by centrifugation, taken up in 0.5% SDS as before, and scanned in the
spectrophotometer once again. Concentration of RNA samples was
calculated from the A260- A solution containing 40mg of RNA/ml has an
A-260 1.0. A26O values of samples were therefore multiplied by
40mg/ml, and corrected for the dilution factor to give the concentration
of RNA in the original sample. One tenth of a volume of 3M sodium
acetate and 2.5 volumes of ethanol were added to the samples, and they
were stored at -70C until required.
2.6.2 Electrophoresis and Northern Blotting
Equal amounts of total RNA from each sample were centrifuged at
13,000g for lOmin, washed with 1ml 75% (v/v) ethanol, and pellets were
allowed to dry at room temperature. RNA was redissolved in 4.4(il 0.5%
(w/v) SDS by heating to 65C for lOmin. Buffer (15.6|il) was added to a final
concentration of 20mM 3-(N-morpholino) propanesulphonic acid
(MOPS), 5mM sodium acetate, ImM EDTA, 50% formamide, 18%
formaldehyde, and 50(ig/ml ethidium bromide, and samples were heated
to 60C for a further 5min, to denature RNA, and placed immediately on
ice. Two microlitres of dye (25% [w/v] Ficoll 400 [Pharmacia], 0.25%
bromophenol blue, ImM EDTA) was added, samples were vortexed
briefly, and centrifuged for 5s, to bring the samples to the bottom of the
tubes. Samples were immediately loaded onto gels containing 1.5% (w/v)
agarose, 6.6% (v/v) formaldehyde in running buffer containing 20mM
MOPS, 5mM sodium acetate, ImM EDTA (pPI7.0), and subjected to
electrophoresis using a commercial horizontal gel electrophoresis tank
(Bio Rad), in running buffer. After electrophoresis, gels were
photographed under ultraviolet transillumination to check integrity and
even loading of RNA, and to measure migration of RNA molecular
weight standards and ribosomal RNA. RNA was partially hydrolysed by
soaking gels in 0.05M NaOH for 20min, to improve RNA transfer. Gels
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were then soaked for 45min in 20xSSC (3M NaCl, 300mM sodium citrate
[pH7.0]), before RNA was transferred overnight to uncharged nylon
membranes (Hybond-N, Amersham) by capillary blotting. RNA was fixed
to Northern blots by exposure to ultraviolet radiation (260nm) for 5min.
2.6.3 Preparation of Plasmids
Plasmid containing cDNA encoding the mouse oestrogen receptor
(White et at. 1987) was obtained from Dr. M.G.Parker, ICRF, Lincoln's Inn
Fields, London. The 1.9kb insert was cloned into the EcoRI site of the
plasmid pSP64. The orientation of the insert was such that SP6 RNA
polymerase could be used to transcribe antisense RNA probes.
The rat androgen receptor cDNA (Chang et al. 1988) was obtained
from Dr.S.Liao, Chicago, Illinois, USA. The 2830bp insert was cloned
between the EcoRI and PstI sites of the plasmid pGEM3Z.
Plasmids were amplified by transfection of JM109 strain E. coli
(Promega), which were rendered competent for transfection by the
following procedure. Cells were streaked on M-9 plates containing
thiamine-HCl (42mM Na2HP04, 22mM KH2P04, 20mM NH4C1, 9mM
NaCl, 2mM MgS04, ImM thiamine-HCl, lOOgM CaCl2, 1.5% [w/v]
agarose, 0.2% [w/v] glucose) and incubated overnight at 37C. A single
colony was picked, and used to inoculate 25ml of Luria-Bertani medium
(LB; 1% [w/v] bactotryptone, 0.5% [w/v] bacto-yeast extract [both from
Difco,], 0.5% [w/v] NaCl) which was then shaken at 225rpm overnight at
30C. Five hundred millilitres of LB medium were inoculated with 5ml of
this culture and shaken at 150rpm until the absorbance of the culture at
600nm reached 0.5. The culture was placed on ice water for 2h, and the
cells collected by centrifugation at 2500g for 15min at 4C. The cells were
gently resuspended in 20ml of ice-cold trituration buffer (lOOmM CaCl2,
70mM MgCl2, 40mM sodium acetate [pH5.5]) and the volume was made
up to 500ml with the same solution. The cells were then incubated on ice
for 45min before being centrifuged at 1800g for lOmin and gently
resuspended in 50ml of ice-cold trituration buffer. 80% (v/v) glycerol was
added to the suspension, dropwise with gentle swirling, to a final
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concentration of 15%. The cells were divided into 1ml aliquots, snap-
frozen in an ethanol-dry ice bath and stored at -70C.
Purified plasmids were introduced into the cells by a heat-shock
transfection method. Aliquots of competent cells were thawed on ice and
lOOpl of cell suspension were pipetted on ice into pre-chilled Falcon 2059
15ml polypropylene tubes. Purified plasmids (lOng) were added to the
cells on ice, moving the pipette tip through the cell suspension to mix,
and tubes left on ice for 30min. Tubeswere heated to 42C for 45sec, and
then placed on ice again for 2min. 900|i.l of room temperature SOC
medium (2% [w/v] bactotryptone, 0.5% [w/v] bacto-yeast extract, lOmM
NaCl, lOmM MgSC>4, lOmM MgCl2, 2.5mM KC1, 20mM glucose) was
added, and tubes placed at 37C and shaken at 225rpm for lh. 100(il of
transformed cells were spread on LB agar (as LB medium, containing
1.5% [w/v] agar [Difco]) plates, containing 100gg/ml ampicillin, 40)ig/ml
X-Gal and 500gM IPTG. Plates were incubated overnight at 37C. White
recombinant colonies were picked using a flamed inoculating loop and
used to inoculate 5ml aliquots of LB medium containing 50pg/ml
ampicillin in sterile Falcon 2059 tubes. The tubes were incubated for at
least 6h at 37C with shaking at 225rpm. Cells were recovered from 1.5ml
of these cultures by centrifugation at 13,000g for 30sec, and the
supernatants discarded. Plasmids were recovered from the bacteria by
resuspension in llOgl STETL (50mMTris [pH8.0], 50mM EDTA, 8% [w/v]
sucrose, 5% [v/v] Triton X-100, 0.5 mg/ml lysozyme), and incubation at
room temperature for lOmin. The suspensions were boiled for 2min, and
then centrifuged at 13,000g for 15min. The gelatinous pellets were then
removed with sterile pipette tips, and llOgl isopropanol was added to the
supernatants at room temperature, and the samples were immediately
centrifuged at 13,000g for 15min. The pellets of DNA were then washed
with 70% ethanol, and allowed to dry. After dissolving the pellets in 30pl
TE buffer (lOmMTris [pH7.5], ImM EDTA), the plasmids were stored at -
20C. In order to confirm that clones contained the required plasmid,
plasmid preparations were incubated with the appropriate restriction
enzymes to liberate inserts, and plasmids and restriction digests were
subjected to electrophoresis in 0.8% [w/v] agarose gels containing lgg/ml
ethidium bromide, using TAE (40mMTris-acetate, ImM EDTA) as the
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electrode buffer, and visualised under ultraviolet light. Positive clones
were then grown in large-scale culture. Cells transformed with plasmids
of interest were used to inoculate 25ml cultures of LB medium
containing 50gg/ml ampicillin, which were incubated overnight at 37C
with shaking at 200rpm. Overnight cultures were used to inoculate 400ml
cultures of LB medium containing 50gg/ml ampicillin, which were
incubated at 37C with shaking at 150rpm until the absorbance at 600nm
reached 0.8. Cloramphenicol was added to a final concentration of
170gg/ml, and cultures were incubated overnight at 37C with shaking at
150rpm. Bacteria were pelleted at 3000g for lOmin, and plasmids were
purified by an alkaline lysis method, using a commercial kit (Qiagen Maxi
Prep kit, Hybaid). Bacterial pellets were resuspended in 10ml of a buffer
containing 50mM Tris, lOmM EDTA, 100gg/ml RNase A. Ten ml of
200mM NaOH containing 1% [w/v] SDS were added, an^ the suspensions
incubated at room temperature for 5min. Ten ml of 2.55M potassium
acetate (pH4.8) were added, suspensions were immediately gently mixed
and centrifuged at 20,000g for 30min at 4C. Supernatants were removed
promptly, and centrifuged again at 20,000g for lOmin at 4C, to obtain a
clear lysate. Plasmids were purified from lysates by ion exchange
chromatography. Columns (Qiagen tip 500) were equilibrated with 10ml
of a buffer containing 50mM MOPS (pH7.0), 750mM NaCl, 0.15% (v/v)
Triton X-100, 15% (v/v) ethanol, and the lysates applied by gravity.
Columns were washed with 3x10ml of a buffer containing 50mM MOPS
(pH7.0), 1M NaCl and 15% (v/v) ethanol, to remove RNA, protein and
other impurities. Plasmids were eluted from the resin in 15ml of a buffer
containing 50mM MOPS (pH8.2), 1.25M NaCl and 15% (v/v) ethanol, and
recovered by precipitation with 0.7 volumes of isopropanol and
centrifugation at 10,000g for 30min at room temperature. Pellets of
plasmid DNA were washed with 10ml 70% (v/v) ethanol, allowed to dry,
and redissolved in TE buffer. Concentration of plasmids was assessed by
spectrophotometry as described for RNA above, except that for the
calculation of concentration, an A26O of 1.0 was assumed to indicate a
concentration of 50|ig/ml double-stranded DNA. Plasmids were stored at
-20C in TE buffer, at a concentration of 5mg/ml.
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2.6.4 Preparation of 32P-labeJled cDNA Probes
cDNA inserts were liberated from purified plasmids by incubation
with restriction enzymes. The rat androgen receptor cDNA contains an
internal EcoRI site, so that restriction of the plasmid with EcoRI and Pstl
liberated the full cDNA in two fragments of approximately 2.4kb and
0.4kb. The reaction mixture was subjected to electrophoresis in a 0.8%
agarose TAE gel as described above, and the two insert fragments were
excised from the gel. A commercial kit (Geneclean II, Bio 101, Stratech
Scientific, Luton, Beds) was used to purify DNA from gel slices. Gel was
melted by incubation in three volumes of a solution containing 6M
sodium iodide at 50C for 5min. 1 OjLil of a suspension of silica matrix
(Glassmilk) to which DNA binds in high salt concentrations was added,
and tubes were incubated at room temperature for 5min with mixing.
The silica-DNA complex was then centrifuged for 5sec in a
microcentrifuge, and washed three times with 400pl of a buffer (NEW
Wash, stored at -20C), containing NaCl,Tris, EDTA and 50% (v/v)
ethanol. DNA was recovered by elution into TE buffer at 50C for 3min.
The eluate was extracted once with phenokchloroform (1:1), and
precipitated with 0.1 volume of 3M sodium acetate (pH7.0) and 2.5
volumes of ethanol at -20C for at least lh. Concentration of recovered
cDNA was assessed by electrophoresis of aliquots of eluates in 0.8%
agarose gels containing ethidium bromide as described above, and
comparison of staining with that of standards of known concentration
(lkb DNA ladder, BRL). Purified inserts were stored at -20C in TE buffer at
a concentration of 5-10gg/ml.
cDNA probes were labelled by random priming using a commercial
kit (Multiprime Kit, Amersham), based on the method of Feinberg and
Vogelstein (1983). Approximately 25-50ng of purified cDNA was
denatured by boiling for 2min, and placed on ice. Water was added to give
a final reaction volume of 50|il, and IOjllI of labelling buffer (unlabelled
dGTP, dATP and dTTP in a buffer containing Tris [pH7.8], MgCl2 and
P-mercaptoethanol), 5|il random sequence hexamer primers (in
a buffer containing BSA) and 50gCi of labelled dCTP (deoxy-
cytidine 5'-[a-32P] triphosphate; specific activity -3000 Ci/mmol,
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Amersham) were added on ice in order. Klenow DNA polymerase (2U)
was added, the components were mixed by gentle passage through a
pipette tip, and centrifuged briefly to the bottom of the tube, and the
reaction mixture was incubated at 37C for 30min. Incorporation of
labelled nucleotide and specific activity of probe were measured by
adsorption of DNA to charged paper filters (DE81, Whatman). Duplicate
lpl aliquots of the reaction mixture were spotted onto DE81 filters and
allowed to dry. One filter was washed five times for 5min in ~200ml 0.5M
Na2HP04 (pH7.0), then rinsed in 70% ethanol and allowed to dry. Both
filters were placed in scintillation vials with 4ml of scintillation fluid,
and radioactivity bound to the filters was measured by liquid scintillation
counting. Counts bound to the washed filter represented dCTP
incorporated into DNA, and those on the unwashed filter represented the
total input of dCTP. Incorporation and specific activity were calculated to
be >80% and ~109cpm/gg respectively (assuming approximately equal
proportions of all four nucleotides in the template sequence). Labelled
cDNA was separated from unincorporated nucleotides by
chromatography on Sephadex G-50 columns (Nick Columns, Pharmacia)
in TE buffer, and yield of probe was measured by scintillation counting.
Denatured, fragmented herring sperm DNA (lmg; Promega) was added to
the labelled probe fraction, and lOOgl 5M NaOH was added, to denature
DNA. Denatured probe was neutralised by the addition of 600gl 1M Tris
(pH7.4) and 475gl IN HC1 (dropwise). Elybridisation buffer was added to
give ~106cpm/ml antisense DNA probe.
2.6.5 Preparation of 32P-labelled cRNA Probes
Oestrogen receptor mRNA was analysed by Northern hybridisation
with a complementary RNA probe, transcribed in vitro from the mouse
oestrogen receptor cDNA. Template was prepared by digestion of plasmid
with Bglll. In order to ensure that plasmid was fully linearised, restriction
digestion was carried out overnight at 37C. An aliquot of digested DNA
was subjected to agarose gel electrophoresis and visualised under UV
light. A single band of DNA was observed, indicating that plasmid was
fully linearised, and its concentration was estimated by comparison with
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standards of known concentration. Template DNA was precipitated with
0.1 volume of 3M sodium acetate (pH7.0) and 2 volumes of ethanol at
-20C for at least lh, and centrifuged at 13,000g for lOmin. The DNA pellet
was redissolved in TE buffer to give a concentration of ~lmg/ml.
Transcription of RNA from this template using SP6 RNA polymerase
results in synthesis of RNA probes complementary to the portion of
mRNA encoding the steroid-binding domain of the oestrogen receptor
(Hillier et al. 1989a). In vitro transcription was carried out using a
commercial kit (Riboprobe Gemini System II, Promega). One microgram
of template DNA was added to a tube containing 40mM tris (pH7.5),
lOmM NaCl, 6mM MgCl2, 2mM spermidine, lOmM DTT, 20U
ribonuclease inhibitor (RNasin, Promega), unlabelled ATP, UTP and CTP
at 500|J.M each, and 12|iM unlabelled GTP. Fifty microcuries of 32P-labelled
GTP (specific activity ~400Ci/mmol; final concentration, 6(iM,
Amersham), and 20U SP6 RNA polymerase were added, the components
were mixed gently by passage through a pipette tip and brought to the
bottom of the tube by brief centrifugation, and the reaction was allowed to
take place for lh at 37C. Incorporation and specific activity were calculated
as described in section 2.6.4, and were >85% and ~2xl08cpm/|ig,
respectively. Template DNA was removed by incubation with 2U RNase-
free DNase (RQ1 DNase, Promega) for 15min at 37C. RNA probes were
separated from unincorporated NTPs and degraded template by size
exclusion chromatography through Sephadex G-50 columns (Nick
Column, Pharmacia) in TE buffer containing 0.1% (w/v) SDS. Probe
(106cpm/ml) was added to hybridisation buffer containing lOOgg/ml
denatured, fragmented herring sperm DNA.
2.6.6 Northern Hybridisation with 32P-JabeUed Probes
Northern blots were prehybridised by incubation for at least lh in
hybridisation buffer (7% [w/v] SDS, 1% [w/v] BSA, 200mM sodium
phosphate [pH7.2], ImM EDTA), containing 15% [v/v] formamide, for
hybridisation with cDNA probes, or 50% [v/v] formamide, for
hybridisation with cRNA probes, using a commercial hybridisation oven
(Hybaid). Prehybridisation buffer was replaced with probe solution.
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Prehybridisation and hybridisation were carried out at 55C in buffer
containing 15% formamide, and at 42C in buffer containing 50%
formamide. Blots were washed twice for 30min at 65C in a large volume
of washing buffer (40mM sodium phosphate [pH7.2], ImM EDTA, 1%
[w/v] SDS), then wrapped in cling film (Saran Wrap, GRI, Dunmow,
Essex), and exposed to X-ray film (Kodak X-Omat AR-5, Sigma), using two
intensifying screens (GRI).
3 Results
3.1 Responses to FSH and Steroids
3.1.1 Progesterone Production
Figure 2.2A shows progesterone secretion of cells from immature
animals pretreated in vivo only with DES, and cultured in the presence
or absence of lOOng/ml FSH or 0.2 IU/ml hCG. Basal progesterone
secretion by these cells was low, and was moderately (approximately
4-fold) stimulated by treatment in vitro with FSH. Although all cells were
isolated from small follicles, hCG also caused a small but significant
increase in progesterone production.
Figure 2.2B shows the results of a similar experiment, using cells
from animals pretreated in vivo with DES and FSH. Basal progesterone
production by these cells was much greater than basal or stimulated
progesterone production by control cells (see Fig.2.2A; note different
scale). Treatment of these cells in vitro with FSH caused a slight
stimulation of progesterone production, but treatment with hCG caused a
very much greater stimulation, demonstrating the effect of FSH
treatment in vivo in inducing LH/CG responsiveness.
The effect of FSH treatment of granulosa cells in vitro in stimulating
progesterone secretion was further investigated by incubating cells in the
presence of increasing doses of FSH. Fig 2.3 shows progesterone
production by granulosa cells from immature animals pretreated with
DES only, in response to 3-200ng/ml FSH. Note that at low to moderate
concentrations (3-30ng/ml), FSH had little effect on progesterone

































Fig.2.2 Progesterone production by rat granulosa cells cultured in the absence (C) or
presence of lOOng/ml hFSH (FSH) or 200mIU/ml hCG (hCG). A. Animals were
treated in vivo only with DES for 4 days before isolation of granulosa cells. B.
Animals were injected with 20jig oFSH every 12 hours for 2 days, in addition to DES
treatment before isolation of cells. Values represent the mean (±SE) from triplicate
wells. In each graph, histograms with different superscripts are significantly different
from one another (p<0.05).
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Fig. 2.3 Progesterone production by rat granulosa cells cultured in the presence or
absence of increasing concentrations of hFSH. Values represent the mean (±SE) from
triplicate wells. Points with different superscripts are significantly different from one
another (p<0.05).
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secretion by these cells, and at high concentrations of FSH (>30ng/ml),
progesterone production was stimulated, but did not reach a plateau.
The effects of different sex steroids on basal and FSH-responsive
progesterone production were investigated using cells from DES-treated
animals. Figure 2.4 shows that, in the absence of FSH, oestradiol,
2-hydroxyoestradiol, testosterone and 5a-dihydrotestosterone had little or
no effect on basal progesterone production by immature granulosa cells
in vitro, across a wide dose-range. However, Figure 2.5 shows that, in the
presence of a high dose (lOOng/ml) of FSH, all four steroids (at a dose of
10"6M) markedly augmented the stimulation of granulosa cell
progesterone secretion by FSH, with an order of potency x)f
E2<2-OH-E2<DHT<T.
Figure 2.6 shows a dose-response curve to FSH in the presence of
10"6M testosterone, using the same range of FSH concentrations as in Fig.
2.3 (note that the scale is much larger than that of Fig. 2.3). In the presence
of testosterone, the FSH dose-response curve was shifted to the left, with
a minimally effective dose of FSFI of <10ng/ml; maximal stimulation of
progesterone synthesis being achieved at a dose of <100ng/ml, and a half
maximal response at about 30ng/ml.
In the presence of FSH, all four steroids tested stimulated
progesterone production throughout the range of concentrations used
(Figs. 2.7 and 2.8). Indeed, at a plating density of 2x105 cells per well,
maximal augmentation of FSH-stimulated progesterone production may
not have been reached even at steroid concentrations of 10~5M.
Concentrations of steroids greater than 10~5M could not be used due to
the low solubility of steroids in aqueous solution.
From these studies, it was concluded that a maximal dose of FSH
was lOOng/ml, and that a dose of 10~6M steroid was capable of significant
augmentation of the stimulatory effect of FSH on granulosa cell
progesterone production. This combination was used as the stimulus for
studies of protein synthesis and for the optimisation of the culture
conditions.
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Fig. 2.4 Progesterone production by rat granulosa cells cultured in the presence or
absence of increasing concentrations of oestradiol-17(3, 2-hydroxyoestradiol,
5oc-dihydrotestosterone or testosterone, in the absence of gonadotropins. Values
represent the mean (±SE) from triplicate wells. No significant differences were found
between points.



















Fig.2.5 Progesterone production by rat granulosa cells cultured in the presence of
lOOng/ml hFSH, and in the absence (C) or presence of 10"6M oestradiol-17|3 (E2),
2-hydroxyoestradiol (2-OH-E2), 5a-dihydrotestosterone (DHT) or testosterone (T).
Values represent the mean (±SE) from three separate experiments. Histograms with
different superscripts are significantly different from one another (p<0.05).
















3 10 30 100 200
FSH Concentration (ng/ml)
Fig. 2.6 Progesterone production by rat granulosa cells in the presence of 10"6M
testosterone and in the presence or absence of increasing concentrations of hFSH.
Values represent the mean (±SE) from triplicate wells. Points with different
superscripts are significantly different from one another (p<0.05).
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Fig. 2.7 Progesterone production by rat granulosa cells cultured in the presence of
lOOng/ml hFSH and in the presence or absence of increasing concentrations of
oestradiol (A), or 2-hydroxyoestradiol (B). Values represent the mean (±SE) from six
wells, from two separate experiments (A), or triplicate wells (B). In each graph,
points with different superscripts are significantly different from one another
(p<0.05).
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Fig. 2.8 Progesterone production by rat granulosa cells cultured in the presence of
lOOng/ml hFSH and in the presence or absence of increasing concentrations of
testosterone (A), or 5a-dihydrotestosterone (B). Values represent the mean (±SE)
from six wells, from two separate experiments (A), or triplicate wells (B). In each
graph, points with different superscripts are significantly different from one another
(p<0.05).
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3.1.2 Protein Synthesis
The dramatic changes in patterns of secreted proteins induced by
treatment of animals in vivo with FSH are shown by two dimensional
electrophoresis in Fig. 2.9. Most strikingly, FSH treatment in vivo led to
increased synthesis of a major neutral protein of approximately 24kDa
molecular weight. Synthesis of several other abundant proteins was
increased by FSH treatment in vivo, including three neutral proteins
with molecular weights between 30 and 351<Da, and two others migrating
at approximately 70 and 80kDa. An acidic ~27kDa minor protein was also
induced by FSH. Also, synthesis of at least four proteins was reduced by
FSH treatment, the most abundant being a ~40kDa neutral protein and a
~55kDa acidic protein.
This treatment also induced changes in cellular proteins, shown in
Fig. 2.10 by one dimensional SDS-PAGE. The most prominent changes in
cellular protein synthesis were the reduced synthesis of proteins with
approximate molecular weights of 45kDa and 35kDa, and the increased
synthesis of a 24kDa protein.
The in vitro effects of FSH and steroids on patterns of cellular
protein synthesis by granulosa cells are shown in Fig. 2.11A. FSH alone
caused a slight increase in the synthesis of two moderately abundant
proteins of approximately 65 and 241<Da, and a slight decrease in the
synthesis of two other proteins about 100 and 32kDa in size. The effect of
FSH on these proteins was enhanced by simultaneous treatment with
10"6M T, E2 or 2-OH-E2, especially with regard to the increase in synthesis
of the 24kDa protein. Steroids had no discernible effect on patterns of
protein synthesis in the absence of FSH. The effect of FSH and steroids on
the metabolism of the 32kDa protein may have been an increase in its
molecular weight rather than a decrease in its synthesis, since a band
migrating at a slightly higher molecular weight appeared to become more
diffuse as the 32kDa band was lost. Treatment with these steroids in the
presence of FSH also revealed changes in the synthesis of two other
proteins; synthesis of a 28kDa protein was slightly increased, and that of
an 85kDa protein was slightly reduced. T appeared to be the most potent
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Fig. 2.9 Two dimensional polyacrylamide electrophoresis of rat granulosa cell
secreted proteins. Animals were treated only with DES for 4 days before isolation of
granulosa cells (A) or injected with 20|lg oFSH every 12 hours for 2 days in addition
to DES treatment (B) before granulosa cell isolation. After isolation, cells were
cultured for 24h in methionine-free MEM containing ^5S-labelled methionine to label
granulosa cell proteins. Equal amounts (lxlO5 cprn) of TCA precipitable radiolabelled
proteins secreted into the culture medium were subjected to isoelectric focussing and
SDS-PAGE. Gels (12.5% polyacrylamide) were soaked in Amplify, dried and
exposed to X-ray film for 2 days at -70C. Migration of molecular weight standards are
marked on the left, and migration of standards of known isoelectric points are marked
along the bottom of each gel. Proteins whose abundance decreased with FSH
treatment are circled in A, and those whose abundance increased with FSH treatment
are circled in B.
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Fig. 2.10 One dimensional SDS-PAGE of granulosa cell cellular proteins. Animals
were treated and cells cultured as described in the legend to Fig. 2.9. Radiolabeled
cellular proteins were obtained by lysis of cell monolayers with detergent, and equal
amounts of TCA precipitable radiolabeled protein (4xl04 cpm) were separated by
SDS-PAGE in 7.5-15% polyacrylamide gradient gels. Gels were dried and exposed to
X-ray film for 3 days at room temperature.
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Fig. 2.11 One dimensional SDS-PAGE of cultured granulosa cell cellular and
secreted proteins. Cells were incubated for 48h in the presence or absence of hFSH
and/or steroids. Equal amounts (2x1c)4 cpm) of radiolabeled protein from each sample
were subjected to electrophoresis in 7.5-12.5% polyacrylamide gels. Gels were dried
and exposed to x-ray film for 7 days at room temperature. Panel A. Cellular proteins:
Lane 1. Control. Lane 2. 10_6M oestradiol alone. Lane 3. 10"6M 2-hydroxyoestradiol
alone. Lane 4. lO'^M testosterone alone. Lane 5. lOOng/ml hFSH alone. Lane 6.
lOOng/ml hFSH and 1()~6M oestradiol. Lane 7. lOOng/ml hFSH and 10'^M
2-hydroxyoestradiol. Lane 8. lOOng/ml hFSH and 10~6M testosterone. Panel B.
Secreted proteins: Lane 1. Control. Lane 2. 1()"6M oestradiol alone. Lane 3. 10~6M
testosterone alone. Lane 4. lOOng/ml hFSH alone. Lane 5. lOOng/ml hFSH and
lO'^M oestradiol. Lane 6. lOOng/ml hFSH and 1()~6M testosterone.
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of the three steroids, but because of small differences in the loading of
radiolabeled proteins on the lanes of the gels, it was not possible to
determine the order of potency.
Patterns of protein secretion were also influenced by FSH and
steroids. Fig. 2.11B shows one dimensional SDS-PAGE of radiolabeled
proteins secreted into the culture medium by granulosa cells after 48h
incubation with FSH and steroids. The most striking effects were a
decrease in the synthesis and secretion of a large major protein with a
molecular weight of approximately 2401<Da, and an increase in the
synthesis of a protein migrating at the same molecular weight as the
24kDa cellular protein, the synthesis of which was also stimulated by
FSH. The suppression by FSFI of the synthesis of the 240kDa protein was
markedly augmented by steroids. The synthesis of at least two other
proteins appeared to be stimulated by FSH, one very large with a
molecular weight of about 4001<Da, and one about 65kDa molecular
weight.
3.2 Time-Course of Responses
3.2.1 Progesterone Production
Fig. 2.12 shows progesterone accumulation in the culture medium at
6, 24, 48 and 72h after plating of cells in medium containing lOOng/ml
FSII and 10~6M T. It can be seen that the accumulation of progesterone
increased with time in culture throughout the duration of the
experiment, most of the progesterone being produced during the second
day in culture.
3.2.2 Protein Synthesis
Fig. 2.13 shows one dimensional SDS-PAGE gels of cellular proteins
synthesised during the labelling period by cells preincubated for different
times in the presence or absence of lOOng/ml FSH and 10~6M T. A protein
migrating at approximately 24kDa was present in abundance in the
monolayers of freshly isolated cells and those cells which had been






































Fig. 2.12 Progesterone accumulation in the medium from rat granulosa cells cultured
for 6, 24, 48 or 72h, in the presence of lOOng/ml hFSH and 10~6M testosterone.
Values represent the mean (±SE) from triplicate wells. Histograms with different
superscripts are significantly different from one another (p<0.05).
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Fig.2.13 One dimensional SDS-PAGE of metabolically labelled cellular proteins
synthesised by rat granulosa cells cultured in the presence or absence of lOOng/ml
hFSH and 10~6M testosterone for different times before the labelling period. Equal
amounts (2xl04 cpm) of radiolabeled protein from each sample were subjected to
electrophoresis in 7.5-12.5% polyacrylamide gels. Gels were dried and exposed to
X-ray film for 4 days at room temperature. Top panel (A); Lane 1, no preincubation.
Lanes 2-5, control. Lanes 6-9, FSH and testosterone. Lanes 2 and 6, 6h
preincubation. Lanes 3 and 7, 24h preincubation. Lanes 4 and 8, 48h preincubation.
Lanes 5 and 9, 72h preincubation. The same samples are also shown in the lower
panel (B) in the following order; Lane 1, no preincubation. Lanes 2, 4, 6 and 8,
control. Lanes 3, 5, 7 and 9, FSH plus testosterone. Lanes 2 and 3, 6h preincubation.
Lanes 4 and 5, 24h preincubation. Lanes 6 and 7, 48h preincubation. Lanes 8 and 9,
72h preincubation.
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preincubated for 61a, and was synthesised to a lesser degree by cells
incubated for longer periods. Consequently, after 6h preincubation, the
previously observed stimulation by FSH of the synthesis of this protein
(see Fig. 2.11A) was not seen. After 24h, the pattern of protein synthesis
was markedly different from the patterns observed at other time-points, a
major protein of approximately lOOkDa molecular weight being induced,
synthesis of a ~120kDa protein being enhanced, and a less abundant
~70kDa protein being lost. Moreover, no effect of FSH and T on the
synthesis of the ~24kDa protein by these cells was observed. At this time
point, synthesis of a ~60kDa protein was slightly increased, and that of a
~45kDa protein was reduced by FSH and T treatment. After 48h
preincubation, a strong induction of the ~24kDa protein by FSH and T
was seen. The stimulation of synthesis of the ~60kDa protein, and
inhibition of synthesis of the ~451<Da protein by FSH and T were more
marked after 48h preincubation. The pattern of cellular protein synthesis
and the response to FSH and T after 72h preincubation were similar to
those at 48h, although less pronounced.
The patterns of secreted protein synthesis under the same conditions
are shown in Fig. 2.14. The prominent ~240kDa FSH-responsive protein
secreted by untreated cells (see Fig. 2.1 IB) did not appear until cells had
been preincubated for at least 24h. Conversely, the ~24kDa protein
observed in the medium from FSH-treated cells (see Fig. 2.11B) was
secreted by freshly isolated cells and untreated cells which had been
preincubated for 6 or 24h, and was lost after more prolonged incubation
of untreated cells. Because of the lack of secretion of the ~240kDa protein
after 6h preincubation and the elevated secretion of the ~24kDa protein
after 6 or 24h preincubation by untreated cells, no effect of FSH and T on
the secretion of these two proteins was observed unless cells had been
preincubated for at least 48h. The effect of FSH and T after 72h of
pretreatment was less marked than after 48h.
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Fig.2.14. One dimensional SDS-PAGE of metabolically labelled secreted proteins
synthesised by rat granulosa cells cultured in the presence or absence of lOOng/ml
hFSH and 10'^M testosterone for different times before the labelling period. Equal
amounts (2xl04 cpm) of radiolabelled protein from each sample was subjected to
electrophoresis in 7.5-12.5% polyacrylamide gels. Gels were dried and exposed to
X-ray film for 6 days at room temperature. Top panel (A); Lane 1, no preincubation.
Lanes 2-5, control. Lanes 6-9, FSH and testosterone. Lanes 2 and 6, 6h
preincubation. Lanes 3 and 7, 24h preincubation. Lanes 4 and 8, 48h preincubation.
Lanes 5 and 9, 72h preincubation. The same samples are also shown in the lower
panel (B), in the following order; Lane 1, no preincubation. Lanes 2, 4, 6 and 8,
control. Lanes 3, 5, 7 and 9, FSH plus testosterone. Lanes 2 and 3, 6h preincubation.
Lanes 4 and 5, 24h preincubation. Lanes 6 and 7, 48h preincubation. Lanes 8 and 9,
72h preincubation.
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3.3 Effect of Plating Density
3.3.1 Progesterone Production
Fig. 2.15 shows accumulation of progesterone in the culture
medium 48h after treatment of cells plated at different densities with
lOOng/ml FSH and 10~6M T. Progesterone accumulation increased with
cell numbers up to a density of 3x105 cells per well, and then reached a
plateau, suggesting that some hormonal responsiveness was lost at high
cell density. After 48h of incubation, cell monolayers were counted in a
haemocytometer as described above to ascertain the actual numbers of
cells attached to the culture wells in each nominal cell density group. Fig.
2.16A shows that the number of cells observed after 48h of culture in the
absence of hormonal treatment correlated well with the nominal plating
density, indicating that little cell proliferation or death had occurred over
that time. However, in groups where cells had been treated with FSH and
T, the number of cells was consistently lower than in the corresponding
control group. A further experiment was carried out, in which cell
monolayers were not washed before being detached and cells counted.
Under these conditions (Fig. 2.16B), the numbers of cells counted after
48h were the same in both groups.
3.3.2 Protein Synthesis
Fig. 2.17A shows the yield of TCA precipitable counts from cell
monolayers cultured at different cell densities in the presence or absence
of lOOng/ml FSH and 10~6M T. As expected, the yield of radiolabeled
protein increased with cell density throughout the range of densities
studied. However, yield of radiolabeled protein (Fig. 2.17B) secreted into
the medium decreased with increasing cell density. Moreover, yields
were much lower from media than from cell monolayers (compare scales
on y-axes of Figs. 2.17A and 2.17B).
Metabolically labelled proteins were then subjected to one
dimensional SDS-PAGE to investigate possible effects of cell density on
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Fig.2.15. Progesterone production by rat granulosa cells cultured at different plating
densities. Cells were stimulated with lOOng/ml hFSH plus 10"6M testosterone (A),
oestradiol-17(3 (B) or 2-hydroxyoestradiol (C). Values represent the mean (±SE) from
triplicate wells.
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Fig.2.16. Numbers of cells attached to culture plates after 48h incubation at different
cell densities in the presence or absence of lOOng/ml hFSH plus 10~6M testosterone.
A. Cell monolayers were washed once with lml MEM before counting. B. Cells were
not washed before counting. Cells were recovered from the wells and counted as
described in section 2.3. Values represent the mean (±SE) from counts from triplicate
wells, counting 4 fields of a haemocytonreter for each well. Asterisks in A denote
statistically significant differences between control and treated at individual cell
densities (p<0.05). In B, no significant differences in cell numbers were found
between control and treated at any cell density.
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Fig.2.17. Trichloroacetic acid precipitable counts from radiolabeled protein samples
from rat granulosa cells cultured at different plating densities, in the presence (open
bars) or absence (shaded bars) of lOOng/ml hFSH plus 10"6M testosterone; A) cellular
proteins, and B) secreted proteins. Values represent the mean (±SE) from six wells,
from two separate experiments.
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the patterns of protein synthesis and the changes in patterns induced by
FSH and testosterone. Fig. 2.18A shows cellular proteins extracted from
cell monolayers seeded at different densities and cultured for 48h in the
presence or absence of lOOng/ml FSH and 10~6M T. The only effect of cell
density on the patterns of protein synthesis observed was a reduced
synthesis of a prominent ~45kDa protein by FSH-treated cells at high cell
density (4xl05 cells/well). The most prominent effects of FSH and T were
the suppression of the synthesis of the -85 and ~321<Da proteins, and the
enhancement of synthesis of the -24 and ~65kDa proteins. Synthesis of
several other proteins with molecular weights between 25 and 35kDa was
also enhanced by FSH treatment. At high cell density (4xl05 cells/well),
treatment with FSH and T caused a reduction in the synthesis of the
~45kDa protein (see above).
The SDS-PAGE gels on which the corresponding culture medium
proteins were separated are shown in Fig. 2.18B. No effect of cell density
on the pattern of protein secretion by FSFI-treated cells was observed.
However, the pattern of protein secretion by control cells was affected by
cell density. Secretion of two proteins with approximate molecular
weights of 240 and 140kDa increased with cell density. One of these
proteins migrated at the same molecular weight as the ~240kDa protein
the secretion of which was shown to be inhibited by FSH treatment. As
above, the most striking effect of FSH and T was the inhibition of the
synthesis and secretion of the 2401<Da protein. Due to the effect of cell
density on the basal secretion of this protein, this effect of FSH was most
easily seen at high cell densities (1.5xl05 or more cells/well). It should be
noted that the overall pattern of protein secretion in this experiment was
slightly different from that observed in some experiments such as that
presented in Fig. 2.11B. In particular, the reproducible stimulation of
secretion of the ~24kDa protein was not observed in this experiment.
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Fig.2.18. Effect of plating density on patterns of protein synthesis and response to
FSH and testosterone. 2xl()4 cpm of radiolabelled protein from each sample was
subjected to electrophoresis in 7.5-12.5% polyacrylamide gels. Gels were dried and
exposed to X-ray film for 7 days at room temperature. Panel A: Cellular proteins.
Lanes 1-4, control. Lanes 5-8, lOOng/ml hFSH plus 10"6M testosterone. Lanes 1 and
5, lxlO5 cells/well. Lanes 2 and 6, 2xl()5 cells/well. Lanes 3 and 7, 3xl05 cells/well.
Lanes 4 and 8,4xl05 cells/well. Panel B: Secreted proteins. Lanes 1-6, control. Lanes
7-12, lOOng/ml hFSH plus 10"6M testosterone. Lanes 1 and 7, 5X104 cells/well.
Lanes 2 and 8, lxlO5 cells/well. Lanes 3 and 9, 1.5xl05 cells/well. Lanes 4 and 10,
2xl05 cells/well. Lanes 5 and 11, 3x105 cells/well. Lanes 6 and 12, 4xl05 cells/well.
Proteins of interest, and their approximate molecular weights, are marked on the right.
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3.4 Effects of Antioestrogens
3.4.1 Progesterone Production
Fig. 2.19 shows cell numbers after treatment of cells with 10~5M
ICI 164,384 and ICI 164,275. No difference in numbers of cells attached was
observed between control and treated groups. Fig. 2.20 shows the effect of
increasing concentrations of ICI 164,384 on progesterone production
stimulated by lOOng/ml FSH alone (Fig.2.20A), lOOng/ml FSH plus 10"7M
E2 (Fig. 2.20B) and lOOng/ml FSH plus 10"7M DHT (Fig. 2.20C). Although
ICI 164,384 effectively, dose-dependently and reversibly inhibited the
stimulatory effect of E2 on FSH-stimulated progesterone production (Fig.
2.20B), the level to which it inhibited progesterone production was well
below the level produced in response to lOOng/ml FSH alone.
Furthermore, ICI 164,384 also inhibited the effects of FSH alone (Fig.
2.20A) and FSH plus DHT (Fig. 2.20C). The supposedly inactive
compound ICI 164,275 was found to have the same, although less
marked, effects as ICI 164,384 (Fig. 2.21).
Fig. 2.22 shows that phenol red had no effect on progesterone
production by granulosa cells over the dose range of lO-lOOjig/ml, either
alone or in the presence of lOOng/ml FSH. Note that medium 199
contains 20pg/ml phenol red, and MEM contains lOjig/ml.
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Fig.2.19. Effect of ICI 164,384 and ICI 164,275 (10"5M) on numbers of rat
granulosa cells attached to culture dishes after 48h of culture. Medium was removed,
monolayers were washed once with lml MEM before being detached and counted.
Values represent the mean (±SE) from counts from triplicate wells, counting 4 fields
of a haemocytometer for each well. No statistically significant differences in cell
numbers were observed between treatments.
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Fig.2.20. Effect of increasing concentrations of ICI 164,384 on progesterone
production by cultured rat granulosa cells, stimulated by lOOng/ml FSH alone (A),
lOOng/ml FSH plus 10~7M oestradiol-17(3 (B) or lOOng/ml FSH plus 10"7M
5a-dihydrotestosterone (C). Shaded bars on the right (X) show progesterone
production by cells cultured in the presence of equimolar (1()~6M) concentrations of
ICI 164,384 and oestradiol-17(3 (B) or 5a-dihydrotestosterone (C), to demonstrate
reversibility of effect of ICI 164,384. Values represent the mean (±SE) from twelve
wells, from four separate experiments. In each graph, points sharing the same
superscript are not significantly different from one another (p<().()5).
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Fig.2.21. Effect of increasing concentrations of ICI 164,275 on progesterone
production by cultured rat granulosa cells, stimulated by lOOng/ml FSH alone (A),
lOOng/ml FSH plus 10"7M oestradiol-17(3 (B) or lOOng/ml FSH plus 10"7M
5a-dihydrotestosterone (C). Shaded bars on the right (X) show progesterone
production by cells cultured in the presence of equimolar (1()~6M) concentrations of
ICI 164,275 and oestradiol-17(3 (B).pr 5oc-dihydrotestosterone (C), to demonstrate
reversibility of effect of ICI 164,275. Values represent the mean (±SE) from triplicate
wells. In each graph, points sharing the same superscript are not significantly different
from one another (p<().()5).
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Fig.2.22. Effect of increasing concentrations of phenol red on progesterone
production by cultured rat granulosa cells, stimulated by lOOng/ml FSH alone (A) or
lOOng/ml FSH plus 10~7M 5a-dihydrotestosterone (B). Values represent the mean
(±SE) from triplicate wells. No significant effect of phenol red was observed.
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3.5 Influence of DES Pretreatment
3.5.1 Progesterone Production
Fig. 2.23 shows in vitro progesterone production in response to FSH
and steroids by granulosa cells isolated from control animals and animals
which had been implanted in vivo with DES. Responsiveness of both
groups of cells to FSH plus T was readily observed, although the
magnitude of the response of the DES-pretreated cells was greater than
that of the control cells.
3.5.2 Protein Synthesis
Fig. 2.24 shows an autoradiograph of an SDS-PAGE of cellular and
secreted granulosa cell protein samples from control animals or animals
pretreated for 4 days with DES. No difference in the pattern of protein
secretion or the responses to FSH and FSH plus T were seen.
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Fig.2.23. Effect of treatment of animals in vivo with DES on subsequent in vitro
steroidogenic responsiveness of granulosa cells to FSH and steroids. Treated animals
were treated with DES for 4 days before animals were killed and granulosa cells
isolated. Cells from control (filled bars) and treated animals (open bars) were then
cultured for 48h in the absence (Control) or presence of lOOng/ml hFSH alone (FSH),
or in combination with 1()-6M oestradiol-17|3 (FSH + E2) or testosterone (FSH + T).
Values represent the mean (±SE) from nine wells from three separate experiments.
Asterisks denote statistically significant differences in progesterone production
between cells from control and DES-treated animals (p<0.05).
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Fig.2.24. Effect of treatment of animals in vivo with DES on subsequent patterns of
cellular (A) and secreted (B) protein synthesis in vitro. Cells from control animals
(lanes 1-3) or DES-treated animals (lanes 4-6) were cultured for 48h in the absence
(lanes 1 and 4) or presence of lOOng/ml hFSH (lanes 2 and 5) or lOOng/ml hFSH plus
10"6M testosterone (lanes 3 and 6) before the labelling period. 2xl04 (A) or 104 cpm
(B) were subjected to SDS-PAGE in 12.5% polyacrylamide gels. Cellular proteins
were visualised by direct autoradiography for 5 days at room temperature. Secreted
proteins were visualised by fluorography for 5 days at -70C.
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3.6 Expression of mRNA Encoding Steroid Receptors
Fig.2.25 shows a Northern blot which was probed using a cDNA
probe to the rat androgen receptor. No hybridisation of this probe to
spleen or uterus RNA was observed. One band of RNA with an
approximate molecular weight of lOkb, in agreement with previously
published reports (Tan et al. 1988; Lubahn et at. 1988; Namiki et al. 1991),
was detected with the androgen receptor probe in prostate, adrenal and
granulosa cell RNA. Levels of androgen receptor mRNA were highest in
RNA extracted from granulosa cells. The expression of androgen receptor
mRNA did not appear to be influenced by gonadotrophin treatment
either in vivo or in vitro. Differences in intensity of hybridisation to
granulosa cell RNA on this blot can be explained in terms of differences
in amounts of RNA loaded in each lane.
Fig.2.26 shows a Northern blot probed with an RNA probe
complementary to mRNA coding for the steroid-binding domain of the
mouse oestrogen receptor. Full length oestrogen receptor mRNA (~6.5kb)
was detected in mouse and rat uterus and ovary, although the signal was
much less intense in ovary than uterus. However, a smaller RNA species
(~1.5kb) present only in ovary RNA hybridised strongly to the probe. The
full length oestrogen receptor mRNA was detected in rat ovary, and was
somewhat enriched in residual ovary RNA samples, and was absent from
granulosa cell RNA samples. The smaller transcript, however, was not
detected in residual ovary RNA, and was greatly enriched in granulosa
cell RNA. The abundance of this oestrogen receptor-related transcript was
also found to be influenced by treatment of animals in vivo with
gonadotropins. Treatment of animals with hCG caused a slight increase
in the abundance of this transcript, although this was not certain, since
loading of total granulosa cell RNA from hCG-treated animals was
slightly greater than that of the other samples. Treatment with FSH
caused a greater increase in the level of this transcript. Treatment with
hCG following treatment of animals with FSH led to a fall in levels of
this molecule to or below control levels. Another even smaller RNA
species present only in spleen RNA also hybridised to the probe, although
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Fig.2.25. Expression of androgen receptor mRNA in rat tissues, and its regulation
in vivo in granulosa cells. RNA was extracted from tissues as described in section
2.6.1, and 2()pg of each sample were subjected to electrophoresis in a 1.5%
agarose/formaldehyde gel, and transferred to a nylon filter. The blot was probed with
a 32P-labelled rat androgen receptor cDNA probe, washed at 65C, and exposed to x-
ray film for 7 days. Lane 1, spleen; lane 2, uterus; lane 3, prostate; lane 4, adrenal;
lane 5, granulosa cells from control animals; lane 6, granulosa cells from animals
treated in vivo with 20IU hCG 12h before isolation of cells; lane 7, granulosa cells
from animals treated in vivo with four injections of 20pg oFSH at intervals of 12h, the
last injection being given 12h before isolation of cells; lane 8, granulosa cells from
animals treated in vivo with four injections of 20pg oFSH and one of 20IU hCG 12h
before isolation of cells. All animals, except those from which prostate tissue was
obtained, were treated in vivo with DES for 4 days. Migration of RNA molecular
weight markers is indicated on the left. The 18s ribosomal RNAbandsstained with
ethidium bromide, from the gel used to generate the Northern blot are shown at the
bottom, to show loading of RNA.
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Fig.2.26. Expression of oestrogen receptor mRNA in rat and mouse tissues, and its
regulation in vivo in rat granulosa cells. RNA was extracted from tissues as described
in section 2.6.1, and 20p.g were subjected to electrophoresis in a 1.5%
agarose/formaldehyde gel, and transferred to a nylon filter. The blot was probed with
a 32P-labelled mouse oestrogen receptor cRNA probe, washed at 70C, and exposed to
x-ray film for 5 days. Lane 1, molecular weight markers; lane 2, mouse spleen; lane 3,
mouse uterus; lane 4, mouse ovary; lane 5, rat spleen; lane 6, rat uterus; lane 7, rat
whole ovary; lane 8, rat ovary after isolation of granulosa cells; lane 9, granulosa cells
from control rats; lane 10, granulosa cells from animals treated in vivo with 20IU hCG
12h before isolation of cells; lane 11, granulosa cells from animals treated in vivo with
four injections of 20p.g oFSH, the last injection being given 12h before isolation of
cells; lane 12, granulosa cells from animals treated in vivo with four injections of 20|ig
oFSH and one of 20IU hCG 12h before isolation of cells. All rats were treated in vivo
with DES for 4 days. Sizes of RNA molecular weight markers are indicated on the
left. The 18s ribosomal RNA bands stained with ethidium bromide, from the gel used
to generate the Northern blot are shown at the bottom, to show loading of RNA.
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hybridisation was not observed after washing of blots at 70C, whereas
hybridisation to the ~1.5kb species was reduced but not lost at this
temperature (not shown).
4 Discussion
These studies demonstrate that effects of FSH on granulosa cell
function can be observed using cultured granulosa cells from rats
pretreated in vivo with oestrogen. FSH administered in vivo led to
increased production of progesterone, induced LH/CG responsiveness,
and caused major changes in protein synthesis. However, exposure of
granulosa cells in vitro to FSH alone stimulates progesterone production
to only a modest degree and caused slight changes in patterns of protein
synthesis, suggesting that the effects of FSH are facilitated, or even
mediated, by other factors in vivo. Effects of FSH on both of these
parameters of granulosa cell differentiation are markedly and dose-
dependently augmented by simultaneous treatment of cells with sex
steroids. In agreement with the literature (Hudson et al. 1987; Hillier &
deZwart, 1981), the rank order of potency of the four steroids studied in
stimulating progesterone production was E2<2-OH-E2<DHT<T. These
results underline the extreme potency of sex steroids in augmenting the
effect of FSH on these markers of in vitro differentiation of granulosa
cells, in particular production of progesterone. Because the technique of
SDS-PAGE is not quantitative, no conclusions about the relative
potencies of these steroids in stimulating changes in patterns of protein
synthesis could be reached.
The strongly stimulatory effect of the combination of FSH and
testosterone was not due in any way to a stimulation of proliferation,
since this combination did not cause any change in cell numbers. If cell
monolayers are washed before recovery and counting of cells, it appears
that stimulated cultures contain fewer cells than controls, implying that
treatment of cells with FSH and testosterone leads to reduced cell
proliferation, or increased cell death. Reduced proliferation is unlikely,
since numbers observed in control cultures after 48h in culture are close
to the numbers initially added. If cell monolayers are not washed before
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recovery and counting of cells, however, cell numbers in control and
stimulated groups are the same, indicating that many of the cells in the
stimulated groups were not attached to the culture dishes. It could be
argued that those unattached cells are dead, but there is good evidence
that FSH treatment leads to aggregation and rounding of granulosa cells
.
in culture (Amsterdam & Rotmensch, 1987), causing cells to detach from
the substrate (see Chapter 3). Trypan blue exclusion could not be used to
assess viability of cells in these experiments because almost all cells in
both control and stimulated groups took up the dye after trypsinisation,
possibly due to the enzymatic disruption of gap junctions between cells.
Timecourse experiments revealed that although effects of FSH and
steroids on granulosa cell progesterone production (but not protein
synthesis) could be detected after only 6h in culture, the greatest
accumulation of progesterone occurred during the second day. Thereafter,
the rate of progesterone production was seen to fall. This may be due to
loss of responsiveness after prolonged exposure to hormones, or it may
be that 72h is an excessive length of time to culture these cells without
changing the medium.
Patterns of protein synthesis are also dependent on the length of
exposure of cells to hormones prior to labelling. As on progesterone
production, the effects of FSH and steroids were most apparent after 48h
of treatment. The changes in patterns of protein secretion by control cells
changed gradually with time in culture, the ~200kDa and the ~24kDa
proteins being lost, and the ~240kDa protein being induced, by 48h
preincubation. However, the pattern of cellular protein synthesis
followed a different pattern. The patterns of cellular protein synthesis by
freshly isolated cells and control cells incubated for 6, 48 and 72h prior to
labelling were very similar, with the exception of the ~24kDa protein,
which was synthesised less with longer incubation. The pattern of
cellular protein synthesis after 24h of preincubation was strikingly
different from these patterns, two proteins of ~'120kDa and ~100kDa
molecular weight being induced, and a less abundant ~70kDa protein
being lost. These observations were reproducible, and are difficult to
explain. Possibly they reflect an episode of mitotic activity, or a change in
morphology in response to being placed in culture. Mitotic activity is
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unlikely, since these cells do not appear to proliferate in this culture
system, and since these cells continue to secrete progesterone in response
to FSH and steroids at that time. The lack of effect of FSH on cellular
protein synthesis at this time-point does suggest that the cells undergo
some process at this time which overrides the normal response to FSH.
Intriguingly, a clear effect of FSH and testosterone on secreted protein
synthesis, and indeed on progesterone production, was apparent after 24h
preincubation. This suggests that the process overriding the response to
FSH and testosterone which affects cellular proteins does not prevent the
effects of FSH on steroidogenesis or secretory protein patterns. On the
basis of these results, it was decided that future experiments would be
conducted for 48h.
Patterns of protein synthesis and production of progesterone in vitro
were also found to be dependent upon the plating density of the cells in
culture. The accumulation of progesterone in the medium in response to
FSH plus testosterone increased with cell density, reaching a plateau of
~500ng/ml at 3x105 cells/well. Since no exogenous cholesterol substrate
such as LDL was added to the medium, this apparent loss of
responsiveness could have been due to a shortage of substrate for
steroidogenesis at high cell density. Progesterone accumulation in
response to FSH plus oestradiol and FSH plus 2-OH-E2 bore the same
relationship to cell density, increasing with cell density up to a plateau at
150x105 cells/well. However, the maximum level reached was only
~90ng/ml in response to FSH plus E2, and ~300ng/ml in response to FSH
plus 2-OH-E2, showing that the reduced apparent responsiveness at high
cell density was not due to exhaustion of substrate. The reason for this
phenomenon is not clear. Although progesterone production on a per-
cell basis decreases with cell density at high densities, the amount of
progesterone produced by stimulated cells at all cell densities was vastly
greater than that produced by untreated cells (<lng/ml in all cases).
Patterns of protein synthesis were found to be only slightly affected
by plating density, the synthesis of the FSH-responsive ~240kDa secreted
protein, which increases with cell density in particular. Therefore, the
effect of FSH on the secretion of this protein was most easily seen at high
cell density. Effects of FSH on the synthesis of the ~241<Da, ~32kDa and
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~100kDa cellular proteins could be observed at all cell densities, although
the inhibition of the synthesis of the ~45kDa cellular protein was only
clear at high cell density. These results would suggest that high cell
densities (>4xl05 cells/well) are best for the study of FSH-induced changes
in protein synthesis. However, at such high cell density, the yield of
radiolabeled secreted protein was low, for reasons that are not clear. As
discussed above, culture of cells at high plating density also results in
some quantitative reduction in their steroidogenic response to FSH and
steroids. High cell density also imposes practical limitations on
experiments, in that more cells are required for each treatment, reducing
the number of treatments which can be used in an experiment. As a
trade-off between FSH-responsiveness, radiolabelled protein yield and
numbers of experimental treatments, the cell density which was chosen
for use in subsequent experiments was 2xl05 cells/well.
The magnitude of the steroidogenic response of granulosa cells to
FSH and steroids in vitro may be somewhat increased by treatment of
animals in vivo with DES. However, the strong augmentation by sex
steroids of the effects of FSH on progesterone production was observed in
all granulosa cell cultures, whether or not the animals had been treated
with DES. In vitro patterns of protein synthesis and changes in patterns
in response to FSH and steroid were also unaffected by treatment of
animals with DES, so it was concluded that the use of DES treatment to
increase yields of granulosa cells is justified for studies of the steroidal
control of FSH-induced in vitro differentiation.
Although patterns of protein synthesis were not absolutely
consistent between experiments, several consistently FSH-responsive
proteins were observed. The most prominent of these proteins was the
major ~24kDa protein present in both cell monolayers and in culture
media, the synthesis of which was stimulated by FSH. The effect of FSH
on the synthesis of this protein was augmented by all four sex steroids
studied. The fact that this protein was present in samples of cellular
proteins and was also secreted into the culture medium suggests that it is
a secretory protein which is stored in relatively large amounts. A protein
which migrates at the same molecular weight was synthesised and
secreted by freshly isolated cells, and its synthesis and secretion was
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strongly stimulated by treatment in vivo with FSH. The abundance of
this protein, and its marked FSH-responsiveness both in vitro and in
vivo suggest that it has an important role in granulosa cell function.
The other highly reproducible effect of FSH on synthesis of secreted
proteins in vitro was the inhibition of synthesis of the very abundant
~240kDa protein. However, this protein was not synthesised by freshly
isolated cells, and did not appear in cultured granulosa cell samples until
they have been incubated for at least 24h. Furthermore, the synthesis of
this protein was also dependent on the plating density of the cells, being a
major secreted protein only at cell densities of >1x105 cells/well. These
data suggest that this protein is produced in response to the conditions of
cell culture. However, its FSH-responsiveness does suggest that it is of
some functional significance.
The most clear and consistent FSH-induced changes in in vitro
synthesis of cellular proteins, other than the induction of the ~24kDa
protein, were the inhibition of synthesis of the ~1001<Da protein and the
induction of the ~651<Da protein. It is not clear whether FSH administered
in vivo induces the same changes, but both these proteins were observed
in samples of cellular protein synthesised by freshly isolated cells. The
synthesis of an extremely abundant ~451<Da cellular protein was also
frequently observed to be inhibited by treatment with FSH, both in vitro
and in vivo, suggesting that this may also be an important protein.
It was hoped that the effects of oestrogen could be shown to be
specific using antioestrogens. This would allow the presence or absence of
oestrogen receptors in granulosa cells to be inferred, since it is still not
clear whether the effects of oestrogen on granulosa cell steroidogenesis
are receptor mediated.
The results of studies using antioestrogens were inconclusive.
ICI 164,384 and ICI 164,275 were shown to have no partial agonistic
(oestrogenic) activity in the granulosa cell culture model. ICI 164,384
appeared to act as an effective antioestrogen, dose-dependently and
reversibly suppressing the augmentation of FSH-stimulated progesterone
production by oestradiol. The level to which FSFI and oestradiol-
stimulated progesterone production was inhibited by 10~5M ICI 164,384
was far below that stimulated by FSFI alone, suggesting that this
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compound inhibits more than just the stimulation by the exogenous
oestrogen. This was confirmed by the fact that ICI 164,384 inhibits
progesterone production stimulated by FSH alone and by FSH plus the
nonaromatisable androgen, DF1T. This inhibition was not due to toxicity
of the antioestrogen because cell numbers attached after 48h of treatment
were unaffected by the presence of any of the compounds tested at up to
10~6M. This does not rule out the possibility that ICI 164,384 and
ICI 164,275 may be toxic at the highest dose used (10~5M). Nor was the
antioestrogen inhibiting an oestrogenic effect of phenol red present in the
culture medium, since this was shown to have no oestrogenic activity in
this system. ICI 164,275, which is reported in other systems to be inactive
as an antioestrogen, also dose-dependently and reversibly inhibited
progesterone stimulated by FSH alone, FSH plus oestradiol or FSH plus
DHT.
These results using the "pure" antioestrogens could be interpreted as
evidence that the effects of oestrogen are not specific. However, it could
also be argued that these results show that these compounds have
nonspecific inhibitory effects on granulosa cell function, and are therefore
not suitable for studies of this kind. If these effects are nonspecific, it is
curious that these compounds display the same inhibitory properties as
other, completely unrelated, antioestrogens in the absence of oestrogen
(Kessel & Hsueh, 1987; Knecht et at. 1985). The fact that addition of excess
oestrogen can reverse the effect of the ICI compounds suggests a specific
and competitive inhibition of oestrogen action. The inhibition by the ICI
compounds of progesterone production stimulated by FSH plus DHT was
less profound, and the reversal with excess DHT more dramatic, than the
inhibition of the response to FSH plus oestradiol, and its reversal with
oestradiol. These results argue in favour of the explanation that the
antioestrogen was acting to block the effect of endogenous oestradiol,
produced in response to FSFI and steroids, which is the conclusion
reached by Knecht et at. (1985) to explain the inhibitory effects of
tamoxifen and keoxifene in the absence of oestradiol. However, in the
absence of aromatisable androgen substrate, synthesis of oestradiol by
cultured granulosa cells is negligible (ITillier & deZwart, 1982; Hillier &
deZwart, 1981). The androgen used in these cultures was
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5oc-dihydrotestosterone, which is unable to act as a substrate for oestrogen
synthesis, and even acts as a competitive aromatase inhibitor (Wickings
et at. 1987). Steroidogenic enzymes can be inhibited directly by high
concentrations of steroids (Gower & Cooke, 1983), so it is possible that
these compounds, which are steroids, may be acting as nonspecific
inhibitors of progesterone synthesis, perhaps with a direct effect on the
P-450scc enzyme. ICI 164,384 does not appear to be a useful tool for the
study of the specificity of oestrogen regulation of granulosa cell function,
and its use was abandoned.
The results of the studies on androgen receptor mRNA expression
were less ambiguous. It was clearly shown that granulosa cells express
significant levels of androgen receptor mRNA, which do not appear to be
strongly influenced by treatment of animals with gonadotrophins in
vivo. The levels of androgen receptor mRNA detected in granulosa cells
were low, but were substantially higher than those detected in prostate
RNA. Assuming that levels of this mRNA are reflected in the production
of the androgen receptor, this relatively high level of gene expression
may explain, at least in part, the extreme potency of androgens in
modulating the action of FSH. The apparent lack of effect of
gonadotrophins on levels of androgen receptor mRNA is consistent with
the finding that the androgen receptor gene contains an SP1 binding site
in its promoter region, characteristic of a "housekeeping" promoter
(Tilley et at. 1990).
Although very low levels of oestrogen receptor mRNA of the
expected molecular weight (~6.5kb) were detected in rat and mouse
ovarian RNA, the present study failed to detect this message in rat
granulosa cell RNA. However, a smaller transcript (~1.5kb), which was
not present in uterus RNA samples, was detected in mouse ovary and rat
granulosa cell RNA using a probe complementary to the region of the
oestrogen receptor mRNA encoding the oestrogen-binding domain of the
receptor. The full length oestrogen receptor mRNA was detected in RNA
extracted from residual ovarian tissue, but the shorter transcript was not.
The same results were found in the mouse in a previous study (Hillier et
at. 1989a). In that study, this smaller transcript was shown not to be
detected using a probe complementary to the part of the oestrogen
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receptor mRNA encoding the amino terminus and DNA binding
domain of the receptor. The authors also showed that this species is not a
truncated form of the oestrogen receptor mRNA, based on the lower
thermal stability of hybridisation of the probe to this message than to the
authentic oestrogen receptor mRNA. The identity of this oestrogen
receptor-related transcript is still unknown. Since it was only detected
using a probe complementary to the region of the oestrogen receptor
mRNA encoding the oestrogen-binding domain of the receptor, it is
possible that this message encodes a protein capable of binding oestrogen.
Oestrogen-binding species distinct from the oestrogen receptor have been
reported previously in rat granulosa cells (Kudolo et al. 1984b; Kudolo et
al. 1984a). Also, Hillier et al. (1989a) point out that regions of the
androgen-binding protein (ABP) and sex hormone-binding globulin
(SHBG) rnRNAs share significant nucleotide sequence homology with
regions of the oestrogen-binding domain of the mouse oestrogen
receptor, and that the rat ABP mRNA is ~1.61<b in length. Therefore, it is
possible that the ~1.5kb oestrogen receptor-related transcript is also related
to ABP and SHBG. In contrast to the expression of androgen receptor
mRNA, expression of oestrogen receptor-related RNA was found to be
under the control of gonadotrophins. Administration of FSH or hCG in
vivo led to an increase in the abundance of this RNA, and
administration of hCG after prior FSH treatment caused a decrease in its
abundance. This pattern of expression suggests that expression of the
oestrogen receptor-related RNA increases with the maturity of the
granulosa cells, and would predict that its expression would be greatest in
the granulosa cells of preovulatory follicles, and would decrease after the
LH surge. Since preovulatory follicles contain the highest levels of
oestrogen, these findings are consistent with the speculative explanation
for the existence of a cytoplasmic oestrogen-binding protein offered by
./
Kudolo et al. (Kudolo et al. 1984a), who suggested that such a molecule
may act to regulate intracellular oestrogen levels. However, the
physiological significance of this oestrogen receptor-related transcript
awaits its further characterisation.
In conclusion, the results of these experiments indicate that the DES-
primed immature rat granulosa cell culture model is highly suitable for
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studies on the role of paracrine factors such as sex steroids in the
regulation of granulosa cell differentiation. Granulosa cells can be
cultured at high cell density without greatly compromising their
hormonal responsiveness, to yield sufficient material for studies of
protein synthesis. Several differentiation-related changes in protein
synthesis were observed, in particular increased synthesis of a ~24kDa
protein which was secreted and stored in high abundance, increased
synthesis of a ~651<Da cellular protein, reduced synthesis of a high
molecular weight secreted protein and reduced synthesis of ~100kDa,
~45kDa and ~321<Da cellular proteins. The significance of these changes
requires the identification of these proteins. The abundance of some of
these proteins suggests that they may be structural proteins, and their
FSH-responsiveness may reflect morphological changes occuring during
the growth of the follicle. Based on a growing literature on the
morphological aspects of granulosa cell differentiation, these
observations were extended to studies on the regulation by FSH and
steroids of synthesis of cytoskeletal and extracellular matrix proteins,
which are described in the following chapter.
Chapter 3 Morphological Correlates of
Differentiation In Vitro
1 Introduction
The experiments described in the previous chapter showed, using
progesterone production as a marker of differentiated function, that
granulosa cells maintained in culture can be induced to differentiate in
response to FSH, and that steroids are potent enhancers of FSH action. It
was also shown that this differentiation of granulosa cells in vitro is
accompanied by changes in their gross patterns of protein synthesis. The
synthesis of a number of abundant proteins was observed to be
particularly strongly influenced by FSH treatment, and so the object of
further study was to identify some of these proteins. Since cultured
granulosa cells undergo dramatic changes in morphology during
gonadotrophin stimulation, it was likely that some of these proteins were
involved in this morphological differentiation.
1.1 Cytoskeleton, Extracellular Matrix and Cell Shape
Cell shape is determined by the cytoskeleton, which in turn is
influenced by the extracellular matrix. The cytoskeleton is composed of
three types of protein structure, microfilaments, microtubules and
intermediate filaments. Microtubules are composed of tubulins (a and p)
and microtubule-associated proteins (MAPs), and are primarily
responsible for intracellular transport (e.g. of chromosomes during cell
division, and of organelles) (Darnell et al. 1986). Intermediate filaments,
whose constituents (such as vimentin, desmoplakin and various
cytokeratins) vary between cell types, are probably involved in the control
of cell shape, although disruption of intermediate filaments has been
shown not to affect cell shape, motility or division (Birchmeier, 1984).
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Microfilaments are certainly important in the determination of cell
shape. Most cells grown in culture on plastic dishes will adopt a flattened
shape (Freshney, 1987; Gospodarowicz et al. 1978), as a consequence of the
formation of focal adhesion plaques between the cells and extracellular
J
matrix (Watt, 1986; Hay, 1981). These plaques are formed by the binding of
extracellular matrix proteins by cell surface receptors, which are coupled
to microfilaments via the membrane-associated actin-binding protein
vinculin (Otto, 1990; Darnell et al. 1986). The microfilaments are
composed of polymerised actin filaments, with other proteins such as
myosin, a-actinin and tropomyosins bound at intervals to the fibres,
which act to stabilise and cross-link actin filaments into bundles known
y
as stress fibres (Craig & Pollard, 1982). These stress fibres run between the
adhesion plaques throughout the cytoplasm, and are responsible for the
flattening of the cell. Cells can be induced to become rounded in culture
by the use of agents such as cytochalasin B, which depolymerises actin
microfilaments (Amsterdam & Rotmensch, 1987), microinjection of
antibodies to actin (Birchmeier, 1984), or by transfection with the avian
/
retrovirus, Rous Sarcoma Virus (RSV) (Kellie, 1988). The transformation
by RSV is brought about by a protein kinase pp60u~src, which
phosphorylates several cytoskeletal proteins on tyrosine, especially
vinculin, disrupting the connection of stress fibres to the membrane at
the adhesion plaque (Kellie et al. 1986). In fact, vinculin has been shown
to be a substrate for phosphorylation by protein kinases A and C,
suggesting that modification of vinculin may be a common feature of
hormonal stimulation of cells (Werth & Pastan, 1984; Schliwa et al. 1984;
Turner et al. 1989).
In addition to its functions in the control of cell shape and motility,
the cytoskeleton is involved in a variety of other functions. Many
membrane proteins are associated with microfilaments, and so receptor
mobility and turnover are affected by microfilaments. Mobility of
membrane receptors in the membrane is necessary for their interaction
with signal transducing proteins such as G-proteins and adenylate cyclase,
so the cytoskeleton is very important in the control of hormone
responsiveness and desensitisation (for review, see Zor, 1983 ). The
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cytoskeleton is also involved in the regulation of water and ion balance
within the cell and within cellular compartments (Cameron et al. 1988).
The cytoskeleton itself is influenced by the substrate to which the
cell is attached. Cells form contacts with the proteins of the extracellular
matrix by way of cell surface receptors, which recognise specific
components of the extracellular matrix (Kellie, 1988; Watt, 1986). The
exact composition of the extracellular matrix varies according to the cell
type in question, but the major constituents are collagens, proteoglycans
and fibronectin (Watt, 1986; Hay, 1981). The latter has been studied in
some detail, and is used as an attachment factor in many cell culture
systems (Freshney, 1987). Fibronectin is a glycoprotein which is present in
serum, where it is involved in wound healing, and is also secreted by
many cell types into the extracellular matrix (Yamada & Olden, 1978). It
exists as a dimer or oligomer of similar subunits (Vartio & Vaheri, 1983).
There are three types of subunit, all of which are derived from the same
gene by alternative splicing, with molecular weights between 220 and
250kDa (Ruoslahti et al. 1982). In vitro, fibronectin promotes cell
spreading and proliferation, and cells often take on a flattened
morphology when cultured on fibronectin-coated plates (Yamada &
Olden, 1978; Watt, 1986).
Cell shape has a profound influence on cell function and
proliferation (Gospodarowicz et al. 1978). For example, macrophages,
which are normally rounded, respond to prostaglandins with an increase
in intracellular cAMP levels. However, when placed in culture, these
cells will become flattened. Such cells no longer respond to
prostaglandins, although there is no change in prostaglandin binding
(Zor, 1983).
1.2 Morphological Differentiation of Granulosa Cells
It is well known that granulosa cells cultured on plastic adopt a
flattened morphology in the absence of hormones, but become rounded
and form multilayered aggregates upon treatment with FSH (Tsang et al.
1988; Ben Ze'ev et al. 1987; Morley et al. 1987; Amsterdam et al. 1981). In
addition, microvilli form on the surface of the cells (Ben Ze'ev &
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Amsterdam, 1986; Ben Ze'ev et al. 1987), gap junctions form between cells
(Lindner et al. 1977; Amsterdam & Rotmensch, 1987), and cytoplasmic
projections connect neighbouring aggregates of cells (Amsterdam &
Rotmensch, 1987; Amsterdam et al. 1989). At the same time, FSH induces
the expression of LH receptors, which are associated with these microvilli
(Zor, 1983), and are most abundant on cells which have been induced to
aggregate (Amsterdam et al. 1981). Lipid droplets accumulate in the
cytoplasm, and smooth endoplasmic reticulum and large numbers of
mitochondria develop around the nuclear region (Ben Ze'ev et al. 1987;
Amsterdam et al. 1981; Soto et al. 1986). Steroid secretion increases as this
y
cellular reorganization proceeds (Ben Ze'ev & Amsterdam, 1986). Studies
using agents which disrupt cytoskeletal structures have further
emphasised the involvement of the cytoskeleton in granulosa cell
function. Steroid secretion by cultured granulosa cells is increased
following disruption of microfilaments with antibodies to actin or using
cytochalasin B (Tsang et al. 1988; Carnegie & Tsang, 1988), or disruption of
microtubules with colchicine (Carnegie & Tsang, 1987; Carnegie et al.
1988). Steroid secretion by adrenal cells is also increased by colchicine
(Temple & Wolff, 1973). However, the response of granulosa cells to
gonadotrophins is reduced by disruption of microfilaments with
cytochalasin B (Zor, 1983; Zor et al. 1978) or microtubules with colchicine
(Carnegie et al. 1987; Zor, 1983; Zor et al. 1978). Interestingly, taxol, which
stabilises microtubules (in contrast to the depolymerising effect of
colchicine) has the same inhibitory effect as colchicene on gonadotrophin
responsiveness in granulosa cells (Carnegie et al. 1987). Possibly these
divergent effects of drugs which interfere with the cytoskeleton on steroid
secretion and hormonal responsiveness are due on one hand to the role
of the cytoskeleton in steroid transport and secretion, and on the other
hand, to its role in receptor mobility and recycling (Zor et al. 1979; Zor,
1983). Because of the importance of the cytoskeleton in cell function, and
the marked changes in morphology of granulosa cells which accompany
their differentiation in vitro, a number of studies have concentrated on
the regulation of several cytoskeletal and extracellular matrix proteins in
granulosa cells.
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It has been shown that fibronectin secretion by cultured granulosa
cells is low at the start of culture, but increases with time in culture, such
that after 72h, fibronectin becomes a major protein product of these cells
(Skinner & Dorrington, 1984; Dorrington & Skinner, 1986). FSH
treatment of cultured cells dramatically reduces fibronectin synthesis
✓
(Skinner et al. 1985; Carnegie, 1990) by a cAMP-dependent mechanism
(Lobb & Dorrington, 1987; Dorrington & Skinner, 1986). A cAMP-
responsive element (CRE) is situated in the 5' regulatory region of the
bovine fibronectin gene, although cAMP analogues inhibit fibronectin
mRNA expression and synthesis (Bernath et al. 1990). This effect requires
other regulatory sequences, and also requires synthesis of an unidentified
presumptive regulatory protein (Bernath et al. 1990). The influence of
steroids on the effect of FSH on fibronectin synthesis has not been well
studied, although one report showed that testosterone and oestradiol-17[3
had no effect alone, and it was stated (although the data were not shown)
that neither steroid modified this effect of FSH (Skinner et al. 1985).
The changes in the synthesis of several microfilament proteins
during granulosa cell differentiation have also been studied.
Immunofluorescence studies have demonstrated that untreated cultured
granulosa cells contain a well developed network of actin stress fibres
throughout the cytoplasm, attached to vinculin-containing adhesion
✓
plaques (Ben Ze'ev & Amsterdam, 1986; Ben Ze'ev & Amsterdam, 1989).
Following stimulation of these cells with FSH or cAMP analogues, the
pattern of actin distribution became diffuse, and vinculin was no longer
detected. With the loss of these stress fibres, the cells became rounded.
The synthesis of actin, a-actinin, vinculin and tropomyosins fell, and was
associated with a fall in the levels of translatable mRNA encoding all
these proteins (Ben Ze'ev et al. 1987; Ben Ze'ev & Amsterdam, 1987; Ben
Ze'ev et al. 1989). In addition, it has been shown by timecourse
experiments that the drop in synthesis of these proteins correlates with
.
acquisition of steroidogenic responsiveness (Ben Ze'ev & Amsterdam,
1986; Amsterdam et al. 1989; Skinner et al. 1985).
The effects of steroids in modulating the effect of FSH on
cytoskeletal protein expression have not been studied, although one
study has shown that androgens prevent flattening of granulosa cells in
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culture (Anderson et al. 1988). Therefore, the aim of the work described in
this chapter was to identify some of the cytoskeletal and extracellular
matrix proteins involved in the morphological changes accompanying
granulosa cell differentiation, and to examine the effects of sex steroids on
the control by FSH of these proteins.
2 Materials and Methods
Animals, hormones, cell culture method, extraction and analysis of
RNA, and electrophoresis of protein samples were as described in chapter
2. Except for the timecourse experiment described below, all culture
experiments were conducted for 48h, with a 24h metabolic labelling
incubation in immunoprecipitation experiments. The following
additional methods were employed in the experiments described in this
chapter.
2.1 Immunoprecipitation
Vinculin was immunoprecipitated from cultured granulosa cell
lysates, and fibronectin was immunoprecipitated from culture media, by a
method based on those of Anderson & Blobel (1983), Kessler (1981) and
McSween & Eastwood (1981). A monoclonal mouse IgGl antibody to
smooth muscle vinculin from chicken gizzard (clone no. VIN-11-5,
Sigma), and a polyclonal goat antiserum raised against rat fibronectin
(Calbiochem, La Jolla, CA) were used at dilutions of 1:50 and 1:20,
respectively. Equal amounts of radioactivity (10-1 OOpil) from each sample
were mixed with SDS to give a final concentration of 0.5% (w/v) and
boiled for lmin. Two volumes of buffer containing 1.25% (v/v) Triton
X-100, 0.19M NaCl, 5mM EDTA, 25mM Tris/HCl pH 7.4 and lOKIU/ml
aprotinin was added. Non-specific protein A binding in the samples was
preabsorbed for 60min with 15|il of protein A (10% crude Staphylococcus
cell suspension [Sigma] in buffer as above) and 10gl of normal mouse
(cell lysates) or goat (media) serum. Samples were centrifuged and
supernatants transferred to fresh tubes. Antibody was added to each
sample to the desired dilution, and lubes were incubated overnight at 4C.
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To act as a non-immune control, one tube in each series received a
volume of normal mouse or goat serum (Scottish Antibody Production
Unit [SAPU]) equal to the volume of antiserum added to the other tubes.
Protein A was "prearmed" with rabbit antiserum to goat IgG (Sigma) or
sheep antiserum to mouse IgG (SAPU) by mixing two volumes of protein
A suspension with one volume of antiserum, and incubating for 2h at
4C. This mixture was centrifuged and the supernatant dicarded. The
pellet was then resuspended to the original volume of protein A
suspension in "wash" buffer (0.1% [v/v] Triton X-100, 0.02% [w/v] SDS,
0.19M NaCl, 25mM Tris/HCl pH 7.4, 5mM EDTA, lOKIU/ml aprotinin).
50|il of this pre-armed protein A suspension was then added to each
sample, and incubated at room temperature for 4h, with occasional
shaking. Samples were then centrifuged at 5,000g for 2min and
supernatants discarded.The pellets were then resuspended in 1ml "wash"
buffer. This procedure was repeated at least four times with "wash" buffer
as above, and then once in detergent-free "wash" buffer, in order to
remove nonspecific protein A binding. Final pellets were resuspended in
70pl of dissociating sample buffer (see chapter 2) and boiled for 5min to
dissociate the protein of interest from the protein A. Tubes were
centrifuged at 13,000g for 2min and supernatants (containing
immunoprecipitated antigen) were transferred to fresh tubes. 30fil of each
sample was subjected to SDS-PAGE as described in chapter 2, section 2.5.3,
and immunoprecipitated protein was detected by autoradiography of
dried gels, as described in chapter 2, section 2.5.3.
2.2 Northern Analysis of Actin mRNA
Mouse |3-actin cDNA, cloned in pSP64 plasmid, was donated by Dr.
M.G. Parker, ICRF, Lincoln's Inn Fields, London. The ~2kb cDNA insert
was liberated with Pstl, gel purified and labelled for use as a probe by
random priming as described in chapter 2, sections 2.6.3 and 2.6.4.
Prehybridisation and hybridisation were carried out at 55C and washing
was carried out at 65C (see chapter 2, section 2.6.6).
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3 Results
The effect of FSH on the morphology of cultured granulosa cells is
shown in Fig.3.1. Control (Fig.3.1A) and testosterone treated (Fig.3.IB)
cells formed a monolayer of flattened cells. FSH (lOOng/ml) caused some
rounding and aggregation (Fig.3.1C), an effect which was enhanced by
simultaneous treatment with 10~6M testosterone (Fig.3.ID). Cells treated
with both FSH and testosterone formed large aggregates of rounded cells
several cells thick, with cytoplasmic projections extending between cells
of neighbouring aggregates.
Immunoprecipitation of vinculin (Fig.3.2) yielded one faint band
migrating at an approximate molecular weight of 130kDa, which was not
precipitated in the absence of vinculin antiserum. A prominent ~45kDa
protein was present in all precipitates, including the non-immune
precipitate. Treatment of cells with 10~6M testosterone alone had no effect
on the abundance of this protein. Treatment with lOOng/ml FSH caused a
decrease in the synthesis of vinculin, and simultaneous treatment with
10~6M testosterone augmented the action of FSH. The amount of
nonspecific precipitation of the ~45kDa protein also followed the same
pattern.
The abundant ~2401<Da secreted protein was identified by
immunoprecipitation as fibronectin (Fig.3.3). The immunoprecipitation
of fibronectin was carried out by Dr. P.T.K. Saunders, whom I thank for its
use in Fig.3.3. This protein was not precipitated in the absence of specific
fibronectin antiserum. Treatment of cells with 10~6M testosterone alone
had no effect on the abundance of this protein. Treatment with lOOng/ml
FSH caused a decrease in the synthesis of fibronectin, and simultaneous
treatment with 10~6M testosterone augmented the action of FSH.
Attempts to identify actin by this method were unsuccessful.
Therefore, the expression of this protein was studied by measurement of
the steady-state levels of its mRNA. Fig.3.4 shows a Northern blot bearing
total cellular RNA from cultured granulosa cells, probed with a
32P-labelled mouse (3-actin cDNA probe. Two RNA species were detected
with this probe; one highly abundant band approximately 2.2kb in length,
assumed to be (3-actin mRNA, and one much weaker ~1.65kb band,
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Fig.3.1. Phase contrast photomicrographs of granulosa cells, isolated from
immature DES-treated rats, after 48h in culture. Treatments were as follows: A)
control, B) 10"6M testosterone alone, C) lOOng/ml FSH and D) lOOng/ml FSH plus
10"6M testosterone. Magnification: x!50.
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Fig.3.2. Immunoprecipitation of vinculin from samples of metabolically labelled rat
granulosa cell proteins. Cells were cultured for 48h in the presence or absence of
hormones, and then for a further 24h in the presence of ^5S-labelled methionine, in
addition to hormonal treatments. Cells were lysed, and vinculin was
immunoprecipitated from the lysates using a specific antiserum. Precipitated protein
was then subjected to electrophoresis and autoradiography. Lane 1) total cellular
protein from untreated cells; lane 2), non-immune precipitate, in which normal serum
was substituted for specific antiserum; lanes 3-6), protein immunoprecipitated from
cell lysates using vinculin antiserum. Treatments were as follows: lane 3) control, lane
4) 10~6M testosterone, lane 5) lOOng/ml FSH, and lane 6) lOOng/ml FSH plus 10~6M
testosterone. Position of origin (O), and migration of molecular weight (in kDa)
standards are marked on the left.
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Fig.3.3. Immunoprecipitation of fibronectin from samples of metabolically labelled
rat granulosa cell proteins. Cells were cultured for 48h in the presence or absence of
hormones, and then for a further 24h in the presence of 35s-labelled methionine, in
addition to hormonal treatments. Medium was removed, and fibronectin was
immunoprecipitated from the medium using a specific antiserum. Precipitated protein
was then subjected to electrophoresis and autoradiography. Lane 1) total secreted
protein from untreated cells; lane 2), non-immune precipitate, in which normal serum
was substituted for specific antiserum; lanes 3-6), protein immunoprecipitated from
culture medium using fibronectin antiserum. Treatments were as follows: lane 3)
control, lane 4) 10"6M testosterone, lane 5) lOOng/ml FSH, and lane 6) lOOng/ml
FSH plus 10"6M testosterone. Position of origin (O), and migration of molecular
weight (in kDa) standards are marked on the left.
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Fig.3.4. Effects of FSH and steroids on granulosa cell actin mRNA levels in vitro.
Granulosa cells were cultured for 48h in the presence or absence of hormones. Culture
medium was removed, cells were lysed with solution D, and RNA was isolated from
lysates by phenolxhloroform extraction. Four micrograms of total cellular RNA were
subjected to electrophoresis in a 1.5% agarose gel containing 6.6% formaldehyde.
RNA was transferred to a nylon membrane, and hybridised to a 32P-labelled mouse
P-actin cDNA probe at 55C overnight. The blot was washed at 65C twice for 30min,
and exposed to x-ray film for 24h with one intensifying screen. Cells were treated as
follows: panel a) no FSF1, and panel b) lOOng/ml FSH, lane 1) no steroid, lane 2)
10"6M testosterone, lane 3) 10~6M 5a-dihydrotestosterone, and lane 4) 10"6M
oestradiol-17p. Migration of RNA molecular weight (in kb) standards is marked on
the left.
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assumed to be y-actin mRNA, since a-actins are present only in muscle
cells. Treatment of cells in vitro with oestradiol-17p, testosterone or
5a-dihydrotestosterone alone (10~6M) had no effect on the level of actin
mRNA. Treatment with lOOng/ml FSH alone caused a moderate decrease
in p-actin mRNA. All three steroids tested strongly enhanced the
inhibition of actin mRNA expression caused by FSH. Fig.3.5 shows that
FSH had little effect on levels of P-actin mRNA at a concentration of
30ng/mh and that the augmentative effect of androgen was dose-
dependent, being apparent only at a steroid concentration of 10~6M. Fig.3.6
shows that the in vitro effects of FSH and steroids on actin mRNA levels
were unaffected by prior treatment of animals with DES. The timecourse
of this effect of FSH was investigated by allowing cells to become flattened
in culture in the absence of hormones, treating cells with lOOng/ml FSH,
and extracting RNA from cells 1, 2, 4, 8, 24, and 48h after treatment. It was
found that the effect of FSH, although modest in this experiment was
apparent within 2h of treatment (Fig.3.7). Thereafter, levels of actin
mRNA did not change.
The relationship of these findings with the pattern of actin mRNA
levels in vivo was investigated. Fig.3.8 shows a Northern blot bearing
total RNA extracted from cells freshly isolated from animals which had
been treated in vivo with FSH and/or hCG. It was found that neither
gonadotrophs administered in vivo had any effect on levels of actin
mRNA.
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Fig.3.5. Dose-dependent augmentation by DHT of the effect of FSH on granulosa
cell actin mRNA levels in vitro. Granulosa cells were cultured for 48h in the presence
or absence of hormones. Culture medium was removed, cells were lysed with solution
D, and RNA was isolated from lysates by phenolxhloroform extraction. Ten
micrograms of total cellular RNA were subjected to electrophoresis in a 1.5% agarose
gel containing 6.6% formaldehyde. RNA was transferred to a nylon membrane, and
hybridised to a 32P-labelled mouse (3-actin cDNA probe at 55C overnight. The blot
was washed at 65C twice for 30min, and exposed to x-ray film for 24h with one
intensifying screen. Cells were treated as follows: panel a) no FSH, and panel b)
30ng/ml FSH, lane 1) no steroid, lane 2) 10_8M 5a-dihydrotestosterone, lane 3)
10"6M 5a-dihydrotestosterone. Migration of RNA molecular weight (in kb) standards
is marked on the left.
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Fig.3.6. Effect of pretreatment of animals with DES on the regulation of granulosa
cell actin mRNA levels by FSH and steroids in vitro. Granulosa cells from control
animals and DES-treated rats were cultured for 48h in the presence or absence of
hormones. Culture medium was removed, cells were lysed with solution D, and RNA
was isolated from lysates by phenokchloroform extraction. Five micrograms of total
cellular RNA were subjected to electrophoresis in a 1.5% agarose gel containing 6.6%
formaldehyde. RNA was transferred to a nylon membrane, and hybridised to a
32P-labelled mouse (3-actin cDNA probe at 55C overnight. The blot was washed at
65C twice for 3()min, and exposed to x-ray film for 24h with one intensifying screen.
Animals were either not treated (panel a), or treated (panel b) for 4 days with DES in
vivo. Cells were treated as follows: lane 1) control, lane 2) 10~6M testosterone, lane 3)
10"6M oestradiol-17(3, lane 4) 30ng/ml FSH, lane 5) 30ng/ml FSH plus 10"6M
testosterone, lane 6) 30ng/ml FSH plus 10'6M oestradiol-17|3. Migration of RNA
molecular weight (in kb) standards is marked on the left.
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Fig.3.7. Time-course of the suppression of granulosa cell actin mRNA levels by
FSH in vitro. Cells were allowed to attach overnight in the absence of hormones, and
medium was replaced with medium containing 30ng/ml FSH. Culture medium was
removed before stimulation (lane 1), or lh (lane 2), 2h (lane 3), 4h (lane 4), 8h (lane
5), 24h (lane 6) or 48h (lane 7) after stimulation, cells were lysed with solution D, and
RNA was isolated from lysates by phenohchloroform extraction. Five micrograms of
total cellular RNA were subjected to electrophoresis in a 1.5% agarose gel containing
6.6% formaldehyde. RNA was transferred to a nylon membrane, and hybridised to a
32P-labelled mouse (3-actin cDNA probe at 55C overnight. The blot was washed at
65C twice for 30min, and exposed to x-ray film for 24h with one intensifying screen.
Migration of RNA molecular weight (in kb) standards is marked on the left.
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Fig.3.8. Effects of gonadotrophins on granulosa cell actin mRNA levels in vivo.
Immature female rats were treated with DES for four days and gonadotrophins as
follows: lane 1) control, lane 2) one injection of 20IU hCG 12h before isolation of
cells, lane 3) 20|ig oFSH every 12h for the 48h prior to cell isolation, and lane 4)
20|J.g oFSH every 12h for 48h, plus one injection of 20IU hCG 12h before isolation
of cells. Freshly isolated granulosa cells were lysed with solution D, and RNA was
isolated from lysates by phenokchloroform extraction. Five micrograms of total
cellular RNA were subjected to electrophoresis in a 1.5% agarose gel containing 6.6%
formaldehyde. RNA was transferred to a nylon membrane, and hybridised to a
32P-labelled mouse (3-actin cDNA probe at 55C overnight. The blot was washed at
65C twice for 30min, and exposed to x-ray film for 48h with two intensifying
screens. Migration of RNA molecular weight (in kb) standards is marked on the left.
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4 Discussion
The results presented in this chapter have confirmed that FSH
causes marked changes in morphology of cultured granulosa cells, and
that these changes are associated with a decrease in fibronectin and
vinculin synthesis and actin gene expression, as published studies have
shown previously. Furthermore, they have also shown that androgens
and oestrogens are capable of enhancing the effects of FSH on these
markers of morphological differentiation. However, in contrast to the
findings of Anderson et al. (1988), testosterone alone (10~6M) had no effect
on the morphology of cultured granulosa cells. The effects of FSH and
steroids on actin mRNA levels were most closely studied, and it was
found that FSH dose-dependently reduces the levels of actin mRNA in
cultured granulosa cells, and that the modulatory effect of androgen, at
least, is also dose-dependent. Pretreatment of animals in vivo with DES
did not affect the subsequent response of granulosa cells to steroids in
vitro with regard to actin mRNA levels. The effect of FSH on actin gene
expression is rapid, occuring within 2h, although not profound.
Immunofluorescence and electrophoretic studies of actin protein
expression in granulosa cells have suggested that the changes in cell
shape which occur in response to FSH are not accompanied by a complete
loss of actin, but rather a redistribution (Ben Ze'ev & Amsterdam, 1986;
Ben Ze'ev & Amsterdam, 1989). The effect of FSH and steroids on
synthesis of fibronectin and vinculin appears to be more profound,
synthesis of these proteins being barely detectable after treatment of cells
with FSH and testosterone. This may be because vinculin and fibronectin
are both required only for cell attachment, whereas the function of actin
is less specialised, being the major component of microfilaments, which
are required for functions other than cell attachment.
During immunoprecipitation of vinculin, a protein of
approximately 45kDa was non-specifically precipitated. This protein was
the most abundant protein in granulosa cell lysates. Being non-specific,
one would expect the amount of this protein precipitated to remain
unchanged between samples. However, the amount precipitated followed
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the same pattern as vinculin. This may suggest that the efficiency of
immunoprecipitation varied between samples, invalidating the
conclusions drawn from the experiment. However, by comparison with
published work on the electrophoresis of granulosa cell proteins, which
demonstrated that actin, which is a 45kDa protein in its monomeric form,
is the most abundant of granulosa cell proteins, it is likely that this non-
specifically precipitated protein is actin. This was not confirmed, since
attempts to immunoprecipitate actin failed, due to a failure to remove
the ~45kDa protein from non-immune precipitates. Actin is a protein
which interacts with a very large number of other proteins (Craig &
Pollard, 1982), so it is likely that this is the non-specifically precipitated
protein. If this is so, then the variation in the amount of this protein
precipitated would be expected to follow the same pattern as that of
vinculin, as was observed.
The regulation of actin gene expression in granulosa cells in vivo is
quite different from that in vitro. In fact, no effect of gonadotrophins,
alone or in combination, on actin mRNA levels was observed.
Localisation of actin in sections of follicles has shown that there is very
little actin in the granulosa or theca interna layers of the follicle, although
the theca externa, which is a far more fibrous layer, is rich in actin
(Lindner et al. 1977). In contrast to the in vitro data discussed in this
chapter which suggests that actin synthesis by granulosa cells falls with
increasing maturity, the only in situ granulosa cells in which actin has
been detected are those nearest to the basement membrane within large
follicles (Cran & Musk, 1985; Familiari et al. 1987), which might be
expected to be the most highly differentiated cells in the follicle. In vitro
studies suggest that fibronectin production by granulosa cells also falls
with increasing maturity, but this, too, is not the case in vivo. Granulosa
cell fibronectin production has been shown to be greatest in cells from
large follicles (Carnegie, 1990; Reinthaller et al. 1990). Fibronectin
synthesis has not been demonstrated in freshly isolated immature
granulosa cells (Skinner & Dorrington, 1984; Skinner et al. 1985) (see also
Fig.2.14), and is heavily dependent upon the plating density of granulosa
cells in vitro (see Fig.2.19). These discrepancies suggest that the changes in
expression of cytoskeletal and extracellular matrix proteins seen during in
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vitro differentiation of granulosa cells may be artefactual. Certainly, the
morphology of granulosa cells cultured in the absence of hormones does
not resemble that of granulosa cells present in ovarian follicles. However,
after stimulation of cultured granulosa cells with FSH, their morphology
becomes closer to their morphology in vivo; that is, they become rounded
and form aggregates several cell layers thick. It seems probable that
granulosa cells will flatten in culture in the absence of hormones since no
specialised functions are operating other than normal metabolic activity,
but they must take on their in vivo morphology in order to manifest
their differentiated functions, such as steroidogenesis. The flattened
morphology of unstimulated granulosa cells in culture could therefore be
seen as an artefact of placing these cells in culture, which must be
overcome during stimulation by FSH in order that they may differentiate
functionally. This interpretation is supported by the relatively rapid drop
in actin mRNA, compared to the slower acquisition of maximal
steroidogenic activity (Ben Ze'ev & Amsterdam, 1986; Skinner et al. 1985)
(see also Fig.2.12).
The composition of the extracellular matrix is very variable between
tissues, and cells from a particular tissue can be made to retain their
normal in vivo morphology in vitro if they are cultured on an
,
extracellular matrix derived from the same tissue (Watt, 1986). Therefore,
this problem might be overcome by creating conditions in culture which
more closely resemble the environment of granulosa cells within the
follicle. Culture of granulosa cells on plates coated with fibronectin,
which promotes cell spreading, lessens the effect of FSH on both
morphology and steroidogenesis of these cells (Morley et al. 1987).
However, if cells are cultured in collagen gels (Ben Rafael et al. 1988;
Carnegie et al. 1988), or on extracellular matrix (ECM) derived from
corneal epithelium (Furman et al. 1986; Ben Ze'ev & Amsterdam, 1986;
Amsterdam et al. 1989), their round morphology is retained even in the
absence of FSH. Basal production of progesterone by these cells is higher
than that of cells cultured on plastic or fibronectin-coated plastic.
To date the detailed composition of the follicular basement
membrane has not been analysed, and may prove difficult to reproduce
routinely in culture dishes, and so the in vitro approach remains to some
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extent an approximation to the true environment of the follicle. Despite
the discrepancy between the production of cytoskeletal and extracellular
matrix proteins by granulosa cells in vivo and their production in vitro,
suggesting that granulosa cells may not behave in vitro as they do in
vivo, these cells retain their responsiveness to gonadotrophins in
culture. Therefore, although cultured granulosa cells may be different
morphologically from those within a follicle, there is no evidence that
the mechanisms controlling their function are qualitatively different. It
was concluded that the regulation of cytoskeletal protein expression
probably does not reflect physiological phenomena during follicular
development. Therefore, these studies were discontinued in favour of
studies of the regulation of the expression of functionally important
granulosa cells proteins, of which the most interesting and potentially
important were deemed to be the inhibins and activins.
A technical point which was evident from the studies described
above concerns the widespread use of actin mRNA as an internal control
in Northern blotting experiments. Although the technique of Northern
blotting is not a quantitative one, some proof that equal amounts of RNA
are present on each lane of a membrane is required. To demonstrate
equal loading of gels and even transfer of RNA to Northern blots, the
membranes are often probed for actin mRNA. Indeed, in some cases,
autoradiographic signals are measured by densitometry, and the level of
the mRNA of interest in each sample is expressed as a ratio of the
intensity of the actin signal in the same lane. However, at least in
cultured rat granulosa cells, actin mRNA is a quite inappropriate internal
control to use, since its levels change so dramatically during
differentiation.
Chapter 4 Inhibin Gene Expression
1 Introduction
In the previous chapter, FSH and steroids were shown to have
marked effects on the morphology of granulosa cells, which are associated
with profound changes in the expression of cytoskeletal and extracellular
matrix proteins. However, evidence was found that these changes may
not reflect physiological changes occurring in the follicle in vivo, but are
probably artefacts of the in vitro approach. Therefore, little further
understanding of ovarian physiology can be gained by pursuing such
studies. However, it was shown in chapter 2, and in numerous published
reports that many parameters of granulosa cell function, such as
production of steroids and acquisition of LH responsiveness brought
about by FSH, are retained by these cells when maintained in culture.
With the caveat that cultured granulosa cells may not behave exactly as
they do in vivo, it is clear that this model is useful for detailed study of
the regulation of granulosa cell function (rather than structure) by FSH
and steroids.
One of the most interesting aspects of granulosa cell function to
emerge in recent years is their ability to produce inhibin. Current
knowledge of the biology of inhibin is "reviewed in detail in Chapter 1,
Section 6.2.4. There are several reasons why inhibin biology is interesting.
Firstly, like oestradiol, inhibin is capable of acting as a classic endocrine
hormone, by suppressing secretion of FSH by the pituitary (Ying, 1988). As
such inhibin is the only non-steroidal endocrine hormone known to be
secreted by the ovary. According to current understanding, as discussed in
chapter 1, suppression of FSH secretion by products of the developing
follicle is central to the selection of dominant follicles (Baird, 1987), so
inhibin may act in concert with oestradiol in the endocrine control of
follicle selection. Secondly, like androgen and oestrogen, inhibin has also
been shown to have direct paracrine effects within the ovary; in
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particular, it has been shown to stimulate thecal androgen synthesis
(Hsueh et al. 1987; Hillier et al. 1991b). The third major reason why
inhibin is interesting is the fact that the (3-subunits of inhibin are capable
of forming (3-f3 dimers, known as activins, which have opposite effects to
inhibin in all systems studied to date (Ying, 1988). Furthermore, activins
are closely related to other factors which have been shown to have direct
effects on ovarian cells, and on a diverse range of differentiative processes
in a variety of tissues and species. Intuitively, one would expect such
ubiquitous molecules to be of importance in the regulation of the
function of tissues in which they are expressed. Unlike inhibin, and like
oestradiol, activins have stimulatory effects on granulosa cells. In
immature cells, activin augments the action of FSH on several markers
of differentiation (Hutchinson et al. 1987; Sugino et al. 1988a; LaPolt et al.
1989; Xiao et al. 1990; Xiao & Findlay, 1991). This effect suggests that
activin may play a part in increasing sensitivity of granulosa cells to FSH,
which is necessary for continued growth of the follicle when FSH levels
begin to fall (Baird, 1987; Baird, 1991). Activin may also act as an
endocrine hormone, since it is capable of stimulating FSH secretion
(Schwall et al. 1988; Rivier & Vale, 1991).
The study of the synthesis and secretion of inhibins and activins is
extremely complex, and it is not yet clear which active molecules are
secreted by granulosa cells, and under what circumstances. At the time of
the experiments described in this chapter, the cDNA encoding all three
inhibin/activin subunits became available (Esch et al. 1987), and it became
possible to study the regulation of production of these hormones at the
level of their mRNA. Data on the levels of mRNA encoding the three
subunits cannot be directly extrapolated to the level of protein secretion,
but this approach provides a simpler model for understanding the
regulation of expression of inhibins and activins.
When these experiments were carried out it was known that inhibin
secretion by cultured granulosa cells is stimulated by FSH (Bicsak et al.
1986; Suzuki et al. 1987; Zhang et al. 1987b; Bicsak et al. 1988). FSH had
also been shown to stimulate expression of inhibin a-subunit mRNA
(Woodruff et al. 1987), but nothing was known about the regulation of
expression of (3-subunit mRNA, other than the way in which their levels
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changed during the oestrous cycle (Meunier et al. 1988a; Woodruff et al.
1988). A considerable amount of work had also been published on the
effects of growth factors on immunoreactive inhibin synthesis and
secretion by cultured granulosa cells (Suzuki et al. 1987; Zhang et al.
1987b; Zhang et al. 1988a; Bicsak et al. 1986; Franchimont et al. 1986), but
little was known about the effects of steroids. One study showed a
stimulation of bovine granulosa cell secretion of inhibin bioactivity by
androgens in the absence of FSH (Henderson & Franchimont, 1983),
although these cells were highly differentiated, and this observation has
not been confirmed in other species. Therefore the main objectives of the
experiments described in this chapter were to characterise the way in
which all three genes are regulated by gonadotrophins both in vivo and
in vitro, and to study the effects of androgens and oestrogens on inhibin
subunit gene expression, alone and in the presence of FSH. In order to
understand the role of inhibins and activins in the paracrine control of
follicle development, it is important to know at what stage of
differentiation the expression of these genes is activated. Therefore, levels
of mRNA encoding two other markers of granulosa cell differentiation,
LH receptor and P450arom, and a marker of luteal function, P450scc, were
also measured, for comparison with the inhibin subunits.
2 Materials and Methods
All materials and methods used in the experiments described in this
chapter were as described in chapter 2, section 2, except for the following
additional materials and methods.
2.1 Inhibin Radioimmunoassay
Inhibin secreted into the culture medium was measured by specific
radioimmunoassay (Sharpe et al. 1988) using a rabbit antiserum against a
synthetic inhibin a-subunit N-terminal 26 amino acid peptide (pla1"26-
Gly27_Tyr28), synthesised and supplied by Dr.J.Rivier, The Salk Institute,
La Jolla, CA, U.S.A. This peptide was also used as the standard and was
radioiodinated by Ms W. Crow, by the chloramine T method, for use as
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the tracer. The tracer had a specific activity of 250-350mCi/mg. The
antibody (R150) was used in the assay at a final dilution of 1:100,000 in
assay buffer (PBS, containing 0.1% BSA), at which concentration it
specifically bound 26-39% of the added tracer. A standard curve of 1.9-
lOOOpg pIa1"26-Gly27-Tyr28 was used. The sensitivity of the assay was in
the range 5-9pg pIa1"26-Gly27-Tyr28. Samples and standards were
incubated overnight at 4C in the presence of antibody before tracer
(1.5xl04cpm) was added. Tubes were incubated overnight at 4C again
before addition of donkey anti-rabbit serum and normal rabbit serum (at
dilutions of 1:40 and 1:500, respectively, SAPU), to precipitate bound
hormone. Tubes were incubated overnight again, 1ml saline was added to
all tubes, and tubes were centrifuged at 3000rpm for 30min. Supernatants
were discarded and precipitated radioactivity was measured using a
gamma counter (MultiGamma, LKB Wallac). Standard curves were
calculated using commercial software (AssayZap, BioSoft, Cambridge,
UK). Culture media from individual wells (10gl) were assayed in
duplicate, and results were expressed as ng of pIa1_26-Gly27-Tyr28
equivalent per 106 viable cells in the original inoculum per 48h. Inter-
and intra-assay variation were 18% and 8%, respectively.
Statistical analysis was carried out using commercial software (CLR
ANOVA, Clear Lake Research Inc., Houston, TX, USA). Analysis of
variance was carried out on results after log transformation to reduce
heterogeneity of variation, and statistical differences at the p<0.05 level
were revealed using Duncan's Multiple Range Test.
2.2 cDNA Probes
cDNA clones encoding all three rat inhibin subunits were obtained
from Dr.S.Shimasaki, Department of Molecular Endocrinology, Whittier
Institute, La Jolla, California, USA. These cDNA clones (a7, (3a30 and
PbH (Esch et al. 1987)) all contained ~1.51<b inserts in the EcoRI site of the
plasmid pUC18.
The cDNA encoding the bovine P450scc enzyme was obtained from
Dr.E.R.Simpson, Department of Obstetrics and Gynaecology, University of
y
Texas Southwestern Medical Centre, Dallas, Texas, USA (John et al. 1984).
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The ~1.7kb insert was inserted in the Pvilli site of pBR322. In Northern
hybridisation, the cDNA was found to cross-hybridise with rat and
human P450scc mRNA.
The cDNA encoding the rat aromatase enzyme was obtained from
Dr.J.S.Richards, Department of Cell Biology, Baylor College of Medicine,
Houston, Texas, USA (Hickey et al. 1990). The clone used contained an
insert approximately 1.2kb in length, cloned into the EcoRI site of pGEM3.
A 0.6kb cDNA encoding the rat LH receptor, inserted in the EcoRI
site of pGEM3, was obtained from Dr.A.J.W.Hsueh, Division of
Reproductive Biology, Department of Obstetrics and Gynaecology,
Stanford University Medical Centre, Stanford, California, USA (LaPolt et
al. 1990a).
All cDNAs were excised from the parent plasmid using EcoRI in all
cases except the bovine P450scc cDNA which was liberated with Pvull.
Inserts were purified by gel electrophoresis, and labelled by random
priming as described in chapter 2.
2.3 Slot-Blot Analysis of RNA
Where only very small amounts (<5gg) of total RNA were available
for analysis, mRNA encoding inhibin a-subunit mRNA was measured
by slot-blot analysis, using a commercial slot-blot manifold (Bio-Dot SF
apparatus, Bio Rad) according to the manufacturers' instructions. Total
RNA was extracted from cultured granulosa cells, and its concentration
determined by the methods described in chapter 2. Equal amounts of total
RNA were dissolved in 500pl of an ice-cold solution of lOmM NaOH and
ImM EDTA immediately before being applied to individual slots of the
apparatus, and blotted to a Zeta-Probe (Bio Rad) charged nylon membrane
by vacuum, until all wells were dry. A further 500gl of lOmM NaOH and
ImM EDTA was added to each well, and vacuum was applied once more,
until all wells were dry. The manifold was dismantled and the blot was
rinsed in 2xSSC, 0.1% SDS, before immediate probing for inhibin
a-subunit mRNA. Prehybridisation, hybridisation and washing were as
described for DNA probes in chapter 2.
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2.4 Stripping and Reprobing Northern Blots
After probing a blot for an mRNA of interest, it was often necessary
to hybridise the same blot with other probes. Before hybridisation with
subsequent probes, probes were removed from membranes by pouring a
boiling solution of 0.1% SDS onto the RNA-bearing face of the
membranes, and allowing the solution to cool to room temperature. The
process was repeated at least twice. Blots were exposed to x-ray film for at
least 3 days to confirm removal of probes. Blots were then prehybridised
and hybridised as described in chapter 2.
3 Results
3.1 Effects of Gonadotropins on Inhibin Gene Expression
In Vivo
Four inhibin subunit mRNA transcripts were detected by Northern
analysis of granulosa cell total RNA (Fig.4.1). One band of approximately
1.7kb was detected using the inhibin-a cDNA, one band of ~6.5kb was
detected using the inhibin-|3A cDNA, and two bands of -4.4 and ~3.4kb, of
which the larger was the more abundant, hybridised to the inhibin-PB
cDNA probe, in agreement with previous reports (Esch et al. 1987; Feng et
al. 1989a). The effects of FSH and hCG on the expression of the three
inhibin subunit genes in vivo were examined, and the results from two
experiments are presented in Fig.4.2. Granulosa cells from control
animals contained high levels of inhibin a-subunit mRNA, and
moderate levels of inhibin pB-subunit mRNA, but very low or
undetectable levels of inhibin PA-subunit mRNA. Injection of FSH (20(ig
oFSH, every 12h for two days prior to removal of ovaries) caused a small
increase in levels of inhibin a-subunit mRNA, and a more pronounced
increase in the expression of mRNA encoding the two p-subunits. One
injection of 20IU hCG 12h before the animals were killed also caused a
marked increase in levels of Pa- and pB-subunit mRNA, and a small
increase in a-subunit mRNA. However, injection of 20IU hCG after
treatment of animals with FSH caused a reduction in the levels of
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Fig.4.1. Northern blot analysis of inhibin subunit mRNA in rat granulosa cells.
Cells were cultured for 48h in the presence of lOOng/ml FSH. Total RNA (5|ig) was
subjected to electrophoresis in an agarose-formaldehyde gel, and transferred to a nylon
membrane. The membrane was sequentially probed with 32P-labelled rat inhibin
subunit cDNA probes as marked. Hybridisation was carried out overnight at 65C, and
washing was carried out for 2x30min at 65C. Blots were exposed to x-ray film at
-70C for the following times: a-subunit, 24h; pA-subunit, 8 days; pe-subunit, 50h.
Positions of the migration of RNA molecular weight markers are indicated on the left.
Chapter 4 Inhibin Gene Expression 184
a Pa Pb
2.4
Chapter 4 Inhibin Gene Expression 185
Fig.4.2. Regulation of rat granulosa cell inhibin subunit mRNA expression by
gonadotrophins in vivo. Immature female rats were treated for four days with DES,
and 1) no further treatment (control), 2) one injection of 20IU hCG 12h before
isolation of granulosa cells, 3) four injections of 20|ig oFSH every 12h for 48h before
isolation of cells, and 4) four injections of 20p.g oFSH every 12h for 48h, plus one
injection of 20IU hCG 12h before isolation of cells. Panels A and B show the results
from two separate experiments. Granulosa cells were isolated, and total RNA was
extracted immediately. Twenty micrograms of total RNA from each treatment were
subjected to electrophoresis in agarose-formaldehyde gels, and transferred to nylon
membranes, which were sequentially probed with 32P-labelled rat inhibin subunit
cDNA probes as marked. Autoradiograms from experiment A were exposed for 5h
(a), 48h (Pa) and 16h (Pb), and those from experiment B were exposed for 9h (a),
20h (Pa) and 12h (Pb). The 18s ribosomal RNA bands, stained with ethidium
bromide, from the gel used to generate each blot are shown at the bottom to indicate
loading of RNA.
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mRNA encoding all three inhibin subunits, when compared to treatment
with FSH alone. The levels of mRNA encoding the P-subunits appeared
to be more strongly influenced by FSH and hCG than the a-subunit
mRNA levels.
The relationship between the regulation of the expression of the
inhibin subunit genes and other markers of granulosa cell differentiated
function was investigated by probing the same samples for mRNA
encoding P450scc, P450arom and the LH receptor.
At least three different transcripts present in total RNA from
ovarian cells hybridised to the LH receptor cDNA probe (Fig.4.3). The
most abundant transcript was approximately 6.5kb in length, with much
less intense bands at approximately 4.2, 2.7 and 1.4kb, in agreement with
previous reports (LaPolt et al. 1990a; Segaloff et al. 1990). mRNA encoding
the LH receptor was not detected in granulosa cells from control animals.
In one experiment, injection of hCG alone caused a small increase in
levels of LH receptor mRNA (Fig.4.3B), although in another no effect of
hCG alone was seen (Fig.4.3A). FSH caused a massive induction of
granulosa cell LH receptor mRNA, which was strongly inhibited by
subsequent treatment with hCG. For comparison, RNA extracted from
ovaries from which granulosa cells had been isolated (residual ovary),
and which therefore contained the thecal and interstital cells, was also
probed for LH receptor mRNA (Fig.4.3C). It was found that RNA extracted
from residual ovaries of control animals contained levels of LH receptor
mRNA lower than, but comparable to the levels found in the granulosa
cells of FSH-treated animals. Levels of LH receptor mRNA in residual
ovary samples were unaffected by treatment of animals with FSH, but
were reduced to undetectable levels within 12h of injection of 20IU hCG,
with or without concomitant FSH treatment.
The aromatase cDNA hybridized to three major bands in granulosa
cell RNA, the predominant one being approximately 2.7kb in size, with
two rather less intense bands migrating at approximately 2.1 and 1.5kb
(Fig.4.4). Other studies have suggested that the 2.7kb species is the
functional aromatase mRNA, and that the other transcripts lack the
region encoding the haem-binding domain of the enzyme (Lephart et al.
1990). P450arom mRNA was undetectable in control granulosa cell RNA
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Fig.4.3. Regulation of rat granulosa cell LH receptor mRNA expression by
gonadotrophins in vivo. Animals were treated as described in the legend to Fig.4.2.
Panels A and B show the results from the same experiments presented in Fig.4.2.
Panel C shows expression of LH receptor mRNA in residual ovarian tissue under the
same experimental treatments. Granulosa cells were isolated, and total RNA was
extracted immediately from granulosa cells and residual ovarian tissue. Twenty
micrograms of total RNA from each treatment were subjected to electrophoresis in
agarose-formaldehyde gels, and transferred to nylon membranes, which were probed
with a 32p-iabelled rat LH receptor cDNA probe. Autoradiograms were exposed for
18h. Migration of 18s and 28s ribosomal RNA is indicated. Markers on the left hand
side refer to panel A, and those on the right refer to panels B and C. The 18s
ribosomal RNA bands, stained with ethidium bromide, from the gel used to generate
each blot are shown at the bottom to indicate loading of RNA.
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Fig.4.4. Regulation of rat granulosa cell P450arom mRNA expression by
gonadotropins in vivo. Animals were treated as described in the legend to Fig.4.2.
Panels A and B show the results from the same experiments presented in Figs.4.2 and
4.3. Granulosa cells were isolated, and total RNA was extracted immediately. Twenty
micrograms of total RNA from each treatment were subjected to electrophoresis in
agarose-formaldehyde gels, and transferred to nylon membranes, which were probed
with a 32P-labelled rat P450arom cDNA probe. Autoradiograms were exposed for 4
days. Migration of RNA molecular weight markers (panel A) or of 18s and 28s
ribosomal RNA (panel B) are indicated. The 18s ribosomal RNA bands, stained with
ethidium bromide, from the gel used to generate blot B are shown at the bottom to
indicate loading of RNA.




Chapter 4 Inhibin Gene Expression 192
samples. hCG caused a slight increase in levels of P450arom mRNA only
in one experiment (4.4B), and it was this experiment in which hCG
caused an increase in LH receptor mRNA. FSH caused a dramatic increase
in levels of mRNA encoding P450arom, and injection of hCG following
FSH treatment resulted in a precipitous drop in P450arom mRNA levels.
Expression of P450scc, however, was regulated in a significantly
different fashion from the inhibin subunits, LH receptor and P450arom.
A single transcript was detected with the P450scc cDNA probe (Fig.4.5), as
a broad band approximately 2.1kb in size, in agreement with other studies
(Goldring et al. 1987; Trzeciak et al. 1987). No mRNA encoding P450scc
was detected in RNA samples from granulosa cells isolated from control
animals. Again, hCG treatment in the absence of FSH had variable effects
on levels of P450scc mRNA. Only in the experiment in which hCG
stimulated expression of mRNA encoding P450arom and LH receptor
were P450scc mRNA levels also increased by hCG treatment (Fig.4.5C).
The effect of hCG alone, where it was observed, was small in comparison
to the potent stimulation of P450scc levels by FSH. However, in contrast
to levels of mRNA encoding the inhibin subunits, LH receptor and
P450arom, the levels of P450scc mRNA were further increased by
injection of hCG following FSFI treatment. Levels of P450scc mRNA in
residual ovarian tissue from control animals were found to be much
higher than those found in control granulosa cells (Fig.4.5D). FSH
treatment did not affect levels of P450scc mRNA in residual ovary.
However, hCG, alone or in combination with FSH, caused an increase in
levels of P450scc mRNA.
3.2 Effects of Gonadotrophins on Inhibin Gene Expression
In Vitro
Initially, the in vitro effects of FSH and hCG on inhibin subunit
gene expression were studied in experiments analogous to those
described above. Granulosa cells were isolated from immature rats which
had been treated in vivo with DES for four days. These cells were
cultured for 48h in the presence or absence of lOOng/ml hFSH. Cells
which received no hormones during the first 48h of culture were
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Fig.4.5. Regulation of rat granulosa cell P450scc mRNA expression by
gonadotropins in vivo. Animals were treated as described in the legend to Fig.4.2.
Granulosa cells were isolated, and total RNA was extracted immediately. Twenty
micrograms of total RNA from each treatment were subjected to electrophoresis in
agarose-formaldehyde gels, and transferred to nylon membranes, which were probed
with a 32P-labelled bovine P450scc cDNA probe. Panels A and B show the results
from the same experiments presented in Figs.4.2, 4.3 and 4.4, and both were exposed
for 16h. Panel C shows a longer exposure (19 days) of the Northern blot shown in
panel B, and panel D shows expression of P450scc in residual ovarian tissue under
the same experimental conditions (exposure: 19 days). Migration of 18s and 28s
ribosomal RNA is indicated. Markers on the left hand side refer to panel A, and those
on the right refer to panels B-D. The high molecular weight band visible on the
autoradiographs is due to LH receptor probe which was incompletely stripped from
the membrane.
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cultured for a further 24h in the presence or absence of 200mIU/ml hCG.
Cells which received FSH during the first 48h of culture were cultured for
a further 24h in the presence of lOOng/ml FSH, in the presence or absence
of 200mIU/ml hCG.
The results of a representative experiment are shown in Fig.4.6. Low
levels of inhibin a- and pA-subunit mRNA were detected in RNA
samples from control granulosa cells. Inhibin Pg-subunit mRNA was
undetectable in control cells in the experiment shown. However, the
amount of total granulosa cell RNA loaded on the Northern blot which
was probed for inhibin Pg-subunit mRNA was much less than that
loaded on the blot probed for a- and PA-subunit mRNA. Treatment of
cells with FSH for 72h caused a marked increase in levels of mRNA
encoding all three inhibin subunits. In the absence of FSH, incubation
with hCG for 24h did not have any effect on levels of mRNA encoding
any of the inhibin subunits. However, after pretreatment of cells with
FSH for 48h, hCG suppressed levels of mRNA encoding all three inhibin
subunits almost to control levels, even though FSH was still present in
the culture medium.
The levels of mRNA encoding P450arom, P450scc and LH receptor
in these RNA samples were also investigated (Fig.4.7). As was the case in
vivo, it was found that the regulation of P450arom and LH receptor
mRNA levels followed the same pattern as the mRNA encoding the
three inhibin subunits. No mRNA encoding these proteins was detected
in RNA samples from untreated or hCG-treated cultures. FSH treatment
in vitro caused an increase in levels of P450arom and LH receptor
mRNA, which was inhibited by concomitant treatment with hCG. Again,
P450scc mRNA levels were differently regulated by gonadotrophins,
being stimulated moderately by FSH treatment, and more strongly by
hCG following FSH treatment.
The molecular weights of mRNA species encoding inhibin subunits,
P450scc, P450arom and LH receptor detected in RNA from cultured cells
were identical to those detected in RNA from freshly isolated cells.
The time-course of these effects of FSFI was studied. Cells were
cultured for 24h in the absence of hormones, to permit attachment. Cells
were then treated with FSH (lOOng/ml). RNA was extracted from the cells
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Fig.4.6. Regulation of inhibin subunit rnRNA expression in rat granulosa cells by
gonadotrophins in vitro. Granulosa cells were cultured for 48h in the presence (lanes 3
and 4) or absence (lanes 1 and 2) of lOOng/ml FSH. Medium was changed, and cells
were cultured for a further 24h in the absence of hormones (lane 1), or in the presence
of 200mIU/ml hCG (lane 2), lOOng/ml FSH (lane 3), or 200mIU/ml hCG plus
lOOng/ml FSH (lane 4). RNA was extracted from monolayers, and 20jig (left hand
panels) or 4p.g (right hand panels) of total RNA were subjected to electrophoresis in
agarose-formaldehyde gels. RNA was transferred to nylon membranes, which were
hybridised with ^^P-labelled rat inhibin subunit cDNA probes as marked. Exposure
times were: a, 9h; (3a, 17h; (3b, 12 days. The 18s ribosomal RNA bands, stained
with ethidium bromide, from the gels used to generate the blots are shown at the
bottom to indicate loading of RNA.
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Fig.4.7. Regulation of expression of mRNA encoding LH receptor, P450arom and
P450scc in rat granulosa cells by gonadotrophins in vitro. Cells were treated as
described in the legend to Fig.4.7. RNA was extracted from monolayers, and 6(ig
(left and centre panels) or 10|ag (right panel) of total RNA were subjected to
electrophoresis in agarose-formaldehyde gels. RNA was transferred to nylon
membranes, which were hybridised with 32P-labelled rat LH receptor (LH-R), rat
P450arom and bovine P450scc cDNA probes as marked. Exposure times were: left
and centre, 13 days; right, 20 days. Migration of 18s and 28s ribosomal RNA is
indicated. Markers on the left hand side refer to panels A and B, and those on the right
refer to panelC.











Chapter 4 Inhibin Gene Expression 200
at fixed time-points of 0, 1, 2, 4, 8, 24 and 48 hours after treatment. Due to
the high abundance of the inhibin a-subunit mRNA, a possible increase
in the level of this message could be seen as early as 2h after FSH
treatment (Fig.4.8). However, a clear stimulation of inhibin-a mRNA by
FSH was not detected until 24h after treatment. Less abundant mRNA
species, such as those encoding the inhibin (3-subunits (Fig.4.8), LH
receptor, P450arom and P450scc (Fig.4.9) were not observed to increase in
response to FSH until 24h after treatment. After 48h, the stimulation by
FSH of levels of all mRNA species studied was very clear, and so further
experiments were conducted for 48h.
3.3 Effects of FSH and Steroids on Inhibin Gene Expression
In Vitro
Possible modulatory effects of sex steroids on the regulation of
inhibin subunit gene expression by FSH were then studied. It was found
that, in the absence of steroids, FSH is capable of stimulating expression of
mRNA encoding all three inhibin subunits. However, the magnitude of
this effect was very variable (Figs.4.10-4.12). In experiments in which
lOOng/ml FSH caused a great increase in levels of inhibin subunit mRNA
(Figs.4.10 and 4.11), simultaneous treatment with oestradiol or DHT had
no further effect. However, in experiments in which FSH, at a dose of
lOOng/ml, caused only a slight increase in expression of inhibin subunit
mRNA (Fig.4.12), this effect was augmented by androgens and oestradiol
at a dose of 10"6M. In such experiments, oestradiol appeared to be more
potent than DHT in augmenting this effect of FSH.
In the absence of FSH, no effect of androgen on the levels of inhibin
subunit mRNA was observed. However, oestradiol-17p alone, at a
concentration of 10"6M, stimulated expression of inhibin a- and
Pe-subunit mRNA, without having any measurable effect on levels of
mRNA encoding the inhibin pA-subunit.
The influence of treatment of animals in vivo with DES on the
regulation of inhibin gene expression in vitro was also studied (Fig.4.12).
The stimulation of inhibin-a and -Pb mRNA levels by FSH was observed
where animals had not been treated with DES. However, no effect of FSH
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Fig.4.8. Timecourse of stimulation by FSH of inhibin subunit mRNA expression in
vitro. Granulosa cells were cultured in the absence of hormones for 24h. Medium was
changed and cells were incubated for different times in the presence of lOOng/ml FSH.
RNA was extracted from monolayers at the times indicated after FSH addition. Total
RNA from each sample (5p.g) was subjected to electrophoresis in an agarose-
formaldehyde gel, and transferred to a nylon membrane, which were hybridised with
32P-labelled rat inhibin subunit cDNA probes, as marked. Exposure times were: a,
60h; (3a, 19 days; Pb, 7 days. The 18s ribosomal RNA bands, stained with ethidium
bromide, from the gel used to generate the blot are shown at the bottom to demonstrate
even loading of RNA.
Chapter 4 Inhibin Gene Expression 202
Hours
0 1 2 4 8 24 48





Chapter 4 Inhibin Gene Expression 203
Fig.4.9. Timecourse of stimulation by FSH in vitro of expression of mRNA
encoding LH receptor (top), P450 aroni (centre) and P450scc (bottom). Granulosa
cells were treated as described in the legend to Fig.4.9. The Northern blot presented
here is the same one presented in Fig.4.8. The membrane was sequentially hybridised
with 32P-labelled rat LH receptor, rat P450arom and bovine P450scc cDNA probes,
as marked. Exposure times were: top, 14 days; centre, 8 days; bottom, 7 days.
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Fig.4.10. Effects of FSH and steroids on expression of inhibin subunit mRNA in
vitro. Granulosa cells were cultured under the following conditions: 1) control, 2)
10"6M DHT, 3) 10"6M oestradiol, 4) lOOng/ml FSH, 5) lOOng/ml FSH plus 10-6M
DHT, and 6) lOOng/ml FSH plus 1(T6M oestradiol. RNA was extracted from
monolayers and total RNA from each sample (4p.g) was subjected to electrophoresis in
agarose-formaldehyde gels, and transferred to nylon membranes, which were
hybridised with 32P-labelled rat inhibin subunit cDNA probes, as marked. Exposure
times were: a, 48h; [3a, 8 days; [3b, 10 days. The 18s ribosomal RNA bands, stained
with ethidium bromide, from the gel used to generate the blot are shown at the bottom
to demonstrate even loading of RNA.
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Fig.4.11. Effects of FSH and steroids on expression of inhibin subunit mRNA in
vitro. Granulosa cells were cultured under the following conditions: 1) control, 2)
10-6M oestradiol, 3) 10"6M DHT, 4) lOOng/ml FSH, 5) lOOng/ml FSH plus 10-6M
oestradiol, and 6) lOOng/ml FSH plus 1()~6M DHT. RNA was extracted from
monolayers and total RNA from each sample (4pig) was subjected to electrophoresis in
agarose-formaldehyde gels, and transferred to nylon membranes, which were
hybridised with 32P-labelled rat inhibin subunit cDNA probes, as marked. Exposure
times were: a, 24h; (3a, 8 days; (3b, 10 days. The ISsribosomal RNA bands, stained
with ethidium bromide, from the gel used to generate the blot are shown at the bottom
to demonstrate even loading of RNA.
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Fig.4.12. Effects of FSH and steroids on expression of inhibin subunit mRNA in
vitro. Granulosa cells from animals which were (panel A) and which were not (panel
B) treated in vivo with DES were cultured under the following conditions: 1) control,
2) 10"6M DHT, 3) 10-6M oestradiol, 4) lOOng/ml FSH, 5) lOOng/ml FSH plus 10-6M
DHT, and 6) lOOng/ml FSH plus 1()"6M oestradiol. RNA was extracted from
monolayers and total RNA from each sample (4jig) was subjected to electrophoresis in
agarose-formaldehyde gels, and transferred to nylon membranes, which were
hybridised with 32p-iabenecj rat inhibin subunit cDNA probes, as marked. Exposure
times were: a, 20h; (3a, 8 days; (3b, 10 days. The 18s ribosomal RNA bands, stained
with ethidium bromide, from the gel used to generate the blot are shown at the bottom
to demonstrate even loading of RNA.
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alone on the expression of PA-subunit mRNA was observed. The effect of
oestradiol in augmenting the effect of FSH on expression of both
(3-subunit genes was greater than the effect of testosterone regardless of
whether animals had been treated with DES. It should be noted, however,
that the effect of oestradiol in augmenting FSH-stimulated a-subunit
mRNA was no greater than the effect of testosterone in animals which
had not been treated with DES. However, this could be explained by a
slight difference in loading of RNA on the gel.
Since the effects of sex steroids on the stimulation of inhibin subunit
mRNA appeared to depend upon the degree of stimulation by FSH, the
effects of steroids on inhibin gene expression were studied in the presence
of a lower concentration of FSH (30ng/ml). Fig.4.13 shows that oestradiol
is capable of dose-dependently stimulating inhibin a-subunit mRNA
levels in the absence of FSH (panel A), and of dose-dependently
augmenting the stimulation brought about by FSFI at a concentration of
30ng/ml (panel B) or lOOng/ml (panel C). Inhibin (3-subunit mRNA
levels were not measured in these experiments.
In contrast to oestradiol, DHT was never observed to have any effect
on inhibin subunit mRNA levels in the absence of FSH (Fig.4.14). In the
presence of 30ng/ml FSH, however, DHT dose-dependently stimulated
inhibin a- and pA-subunit mRNA expression. Basal levels of inhibin-(3A
mRNA were unusually high in the experiment shown in Fig.4.14A
(compare to control levels in Figs.4.10-4.12), and appeared to be decreased
by FSH treatment. Inhibin pg-subunit mRNA levels were not measured
in these experiments.
The regulation of inhibin gene expression by cAMP was also studied.
Fig.4.15 shows that the cAMP analogue, dibutyryl cAMP, caused a modest
stimulation of inhibin-a mRNA levels at a concentration of 100|iM. This
stimulation was augmented by oestradiol, and to a lesser extent DHT, in a
dose-dependent fashion. The only experiment in which the effect of
cAMP on expression of inhibin-pA mRNA was studied (Fig.4.15B)
was part of the same experiment presented in Fig.4.14A. In this
experiment, basal levels of this message were high, and
treatment with dibutyryl cAMP appeared to cause a reduction
in inhibin-PA mRNA levels. However, DHT stimulated
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Fig.4.13. Slot-blot analysis of dose-dependent stimulation of inhibin a-subunit
mRNA expression by oestradiol in cultured rat granulosa cells. Panel A: duplicate
experiments to show the effect of oestradiol in the absence of FSH; 1) control, 2)
10"8M oestradiol, and 3) 1()~6M oestradiol. Panel B: triplicate experiments to show the
effect of oestradiol in the presence of 30ng/ml FSH; 1) control, 2) 30ng/ml FSH
alone, 3) 30ng/ml FSH plus 10~8M oestradiol, and 4) 3()ng/ml FSH plus 10"6M
oestradiol. Panel C: the effect of oestradiol in the presence of lOOng/ml FSH; 1)
control, 2) lOOng/ml FSH alone, 3) lOOng/ml FSH plus 10~8M oestradiol, and 3)
lOOng/ml FSH plus 1()~6M oestradiol. Cells were cultured for 48h with hormonal
treatments before RNA was extracted, and applied to Zeta-Probe membrane using a
slot-blot apparatus. Amounts of RNA applied to each slot were 2(ig (panel A,
experiment [a] and panel B, experiments [a] and [b]) or 8|ig (panel A, experiment [b],
panel B, experiment [c] and panel C). Slot-blots were probed with a 32P-labelled
inhibin a-subunit cDNA. Autoradiograms were exposed for 7 days in all cases except
panel B, experiment (c), which was exposed for 18h.
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Fig.4.14. Dose-dependent effect of DHT on expression of inhibin a- and
pA-subunit mRNA. Rat granulosa cells were cultured for 48h under the following
conditions: 1) control, 2) 10"8M DHT, 3) 10"6m DHT, 4) 30ng/ml FSH, 5) 30ng/ml
FSH plus 1()-8M DHT, and 6) 30ng/ml FSH plus 1()-6M DHT. Total RNA was
extracted from monolayers, and analysed for inhibin subunit mRNA. Panel A: total
RNA (l()|ig) was subjected to electrophoresis in an agarose-formaldehyde gel,
transferred to a nylon membrane, and inhibin a- and pa-subunit mRNA were detected
by Northern blot analysis by hybridisation with 32p-iabelled cDNA probes as marked.
Autoradiographs were exposed for 24h (a) and 14 days (Pa)- The 18s ribosomal
RNA bands, stained with ethidium bromide, from the gel used to generate the blot are
shown at the bottom to demonstrate even loading of RNA. Panel B: inhibin a-subunit
mRNA was measured in total RNA (2|ig/slot) from a separate experiment by slot-blot
analysis. Exposure was for 7 days.
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Fig.4.15. Effects of steroids on cAMP-stimulated inhibin subunit mRNA expression
in cultured rat granulosa cells. Panel A: duplicate experiments to show inhibin
a-subunit mRNA in granulosa cells cultured for 48h under the following conditions;
1) control, 2) lOOpM dibutyryl cAMP, 3) 100(iM dibutyryl cAMP plus 10~8M
oestradiol, and 4) lOOpM dibutyryl cAMP plus 10_6M oestradiol. Total RNA was
extracted from cells, and applied to Zeta-Probe membrane using a slot-blot apparatus
(lpg [experiment a] or 2pg [experiment b] RNA per slot), and the membrane was
hybridised with a rat inhibin a-subunit cDNA probe. Autoradiograms were exposed
for 7 days. Panel B: cells were cultured for 48h under the following conditions; 1)
control, 2) lOOpM dibutyryl cAMP, 3) 100|iM dibutyryl cAMP plus 108M DHT, and
4) 10()|J.M dibutyryl cAMP plus 10~6M DHT. RNA was extracted and subjected to
electrophoresis (lOpg/lane) in an agarose-formaldehyde gel, and transferred to a nylon
membrane, which was sequentially hybridised with -'2P-labelled rat inhibin a- and
pa-subunit cDNA probes, as marked. Autoradiograms were exposed for 24h (a) and
14 days (Pa)- The 18s ribosomal RNA bands, stained with ethidium bromide, from
the gel used to generate the blot are shown at the bottom to demonstrate even loading
of RNA.
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inhibin-(3A mRNA levels slightly in the presence of cAMP, when
compared to cAMP alone.
In order to determine how these effects of gonadotrophins and
steroids on inhibin gene expression are reflected in changes in secretion
of inhibin protein, the culture medium from some of the experiments
described above was assayed for inhibin, using a radioimmunoassay
specific for the inhibin a-subunit. The results are shown in Fig.4.16. FSH
(lOOng/ml) stimulated inhibin secretion. The effect of oestradiol alone on
inhibin a- and pB-subunit gene expression was reflected in an increase in
secretion of immunoreactive inhibin, whereas DHT had no effect. The
stimulation of immunoreactive inhibin secretion by FSH was augmented
by oestradiol and DHT. As with the effects of steroids on levels of inhibin
subunit mRNA, oestradiol was more potent than DHT in this regard.
4 Discussion
The results presented in this chapter provide strong evidence that
^the expression of mRNA encoding the inhibin subunits in rat
granulosa cells is under direct control by gonadotrophins in vivo.
Stimulation of inhibin a-subunit mRNA expression by FSH was
confirmed, and a much stronger effect of FSH on the expression of the
p-subunits was also demonstrated. It was shown that, after treatment of
animals for 48h with FSH, hCG caused a decrease in the levels of mRNA
encoding all three inhibin subunits in granulosa cells. This is consistent
with a recent report that showed that PMSG, which has both FSH and LH
activity, has a biphasic effect on inhibin a- and pA-subunit mRNA, being
stimulatory in the short term and at low concentration, and inhibitory in
the longer term and at high doses (Michel et al. 1991a). The effects of
gonadotrophins on levels of P-subunit mRNA were more pronounced
than their effects on a-subunit mRNA, suggesting that the regulation of
inhibin synthesis may be exerted mainly at the level of expression of the
P-subunits.
The regulation by gonadotrophins of the expression of mRNA
encoding P450arom and LH receptor in these cells was found to follow a
very similar pattern, being stimulated by FSH, and inhibited by hCG after











Fig.4.16. Effects of FSH and steroids on secretion of immunoreactive inhibin by rat
granulosa cells in vitro. Cells from DES-treated animals were cultured in the absence
of hormones (C), or in the presence of 10'6M 5a-dihydrotestosterone alone (DHT),
10"6M oestradiol-17[3 alone (E2), lOOng/ml hFSH alone (FSH), lOOng/ml hFSH plus
10"6M 5a-dihydrotestosterone (FSH+DHT) or lOOng/ml hFSH plus 10"6M
oestradiol-17(3 (FSH+E2). Histograms with different superscripts are significantly
different from one another (p<0.05).
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treatment with FSH, suggesting that these genes are regulated in a very-
similar fashion. It was also found that the mRNA encoding the inhibin
subunits, P450arom and the LH receptor could also be stimulated by hCG
in the granulosa cells of immature DES-primed rats which received no
other treatment. The effects of FSH and hCG are consistent with the
results of other studies of the hormonal regulation of levels of mRNA
encoding the LH receptor (Peng et al.1991; Segaloff et al. 1990) and
P450arom (Hickey et al. 1988; Fitzpatrick & Richards, 1991). The effect of
hCG on the inhibin subunits was consistent, whereas its effect on LH
receptor and P450arom mRNA was observed only in one of three
experiments. According to the principles of the rat granulosa cell model
used throughout this thesis, the granulosa cells of these animals are in an
undifferentiated state, and should not, therefore, express receptors for LH
and hCG. The effect of hCG observed here, however, casts some doubt on
the homogeneity of the state of maturity of granulosa cells obtained by
this method. It was demonstrated that expression of LH receptor mRNA
was high in the residual ovarian tissue of untreated animals, and was
found to be profoundly suppressed by injection of hCG, in agreement
with previously published reports (Peng et al. 1991). The source of this LH
receptor mRNA was probably thecal and interstitial tissue. Therefore, it is
possible that the effect of hCG on the granulosa cells of untreated
animals, where observed, was mediated via a product of the theca whose
production was stimulated by hCG treatment. However, since this effect
was variable, it is also possible that the granulosa cells in which hCG
increased levels of LH receptor and P450arom mRNA were more mature
than those on which hCG had no effect, and already had some degree of
LH responsiveness. No LH receptor mRNA was detected in untreated
granulosa cells, but this does not necessarily mean that they had no LH
receptors, since it has been shown that, although synthesis of LH
receptors is closely linked to expression of the mRNA (LaPolt et al. 1990a;
Segaloff et al. 1990), substantial changes in LH receptor synthesis can take
place without any change in levels of the mRNA (Wang et al. 1991).
The expression of P450scc mRNA followed a different pattern,
yj
consistent with previous reports (Goldring et al. 1987). As was the case for
the other markers of granulosa cell maturity studied, FSH stimulated
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levels of P450scc mRNA. However, unlike the levels of mRNA encoding
the inhibin subunits, P450arom and the LH receptor, which fell upon
hCG treatment in granulosa cells of animals which had received 48h of
FSH treatment, P450scc mRNA levels were further stimulated by hCG.
These data are consistent with the present concepts of follicular
development, which hold that stimulation of growth of follicles by FSH
is associated with increased capacity of the granulosa cells to produce
oestradiol and to respond to LH. Evidently, increased capacity to produce
inhibin and/or activin is also intimately associated with the growth of
the follicle. As discussed in Chapter 1, this secretion of oestradiol and
inhibin is thought to lead to suppression of FSH secretion by the
pituitary. The increased responsiveness of the granulosa cells of highly
developed follicles to LH allows such follicles to continue growing in the
face of falling FSH levels. In the rat, following the ovulatory LH surge,
secretion of inhibin and oestradiol fall (Butcher et al. 1^74; Hasegawa et al.
1989; Watanabe et al. 1990), allowing FSH levels to rise, leading to
recruitment of another cohort of primary follicles, while progesterone
secretion by the newly formed corpus luteum rises.
Because of the potent effects of steroids in modulating FSH action
(see Chapters 1 and 2), the possible effects of steroids in modulating the
effect of FSH on the expression of the inhibin subunits genes were
examined using the granulosa cell culture system. Initially, the changes
in expression of the inhibin subunit genes in response to gonadotrophins
in vitro were studied in the absence of steroids, and were found to be
similar to those observed in vivo. FSH caused an increase in levels of
mRNA encoding all three inhibin subunits, an effect which was strongly
reversed by subsequent treatment with hCG. Again, LH receptor and
P450arom mRNA followed the same pattern as the inhibin subunits,
whereas P450scc message levels were stimulated by FSH, and further
stimulated by hCG after FSH treatment.
The most obvious differences between the expression of the inhibin
subunits in vitro and in vivo were a much lower basal level of inhibin
a-subunit mRNA in cultured cells, and an absence of effect of hCG on
expression of inhibin subunit mRNA in cells which had not been treated
with FSH. It is possible that the cells used for the in vitro experiments
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were less mature than those used for the in vivo experiments. However,
the stimulation of inhibin subunit mRNA by hCG in vivo, and the
ineffectiveness of hCG in vitro were consistently observed, suggesting
that the effect of hCG was indeed mediated via (a) theca cell product(s). It
is possible that granulosa cells lose their responsiveness to hCG when
placed in culture, but they do remain responsive to FSH, and acquire LH
responsiveness in response to FSH in vitro. The lower levels of inhibin-cc
mRNA in untreated cultured granulosa cells, when compared to levels
in freshly isolated cells, also suggest that there is some factor present in
vivo, driving inhibin-a mRNA expression, which is absent in vitro.
The effect of FSH alone in vitro was rather variable, further pointing
to the variable degree of maturity of cells isolated from immature rats
treated with DES. The modulatory effect of steroids appeared to be heavily
dependent upon the degree of stimulation brought about by FSH alone.
In experiments in which FSH had a strong stimulatory effect on inhibin
subunit mRNA expression, steroids appeared to have no further effect.
However, where the effect of FSH was small, strong evidence for
augmentation of the effect of FSH by both androgen and oestrogen was
found. Steroids also were found to augment the effect of cAMP,
consistent with cAMP being the major second messenger mediating the
effects of FSH.
These results were corroborated by the secretion of inhibin into the
medium, as measured by RIA. It should be noted that the assay measures
free inhibin-a as well as mature inhibin (Sharpe et al. 1988). It has been
shown that granulosa cells of several species secrete free a-subunit
molecules (Bicsak et al. 1988; Knight et al. 1989; Schneyer et al. 1990),
which is consistent with the apparently higher levels of mRNA encoding
the a-subunit than the [3-subunit under control conditions (judging by
the exposure times required for detection by Northern blotting).
All these results are consistent with current knowledge of steroid
action in granulosa cells, and of the changes in hormone secretion during
the oestrous cycle. Interestingly, it was found that oestradiol was more
potent than DHT in augmenting the effect of FSH on inhibin subunit
gene expression, as well as on immunoreactive inhibin secretion. This is
surprising because other steroid-responsive end-points studied to date in
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granulosa cells are generally more sensitive to androgen than oestrogen
(Armstrong & Dorrington, 1976; Hillier et al. 1985; Hudson et al. 1987;
Wang & Leung, 1987 a). Even more
surprising was the finding that oestradiol stimulates expression of
mRNA encoding the inhibin a- and pB-subunits in the absence of FSH.
This is difficult to reconcile with the present understanding of the role of
steroids in the control of granulosa cell function, since it is thought that
androgens and oestrogens act by amplifying the elevation of intracellular
cAMP levels stimulated by FSH, but not by stimulating cAMP generation
independently of FSH. It could be that there is a very small basal level of
cAMP generation in these cells, which is enhanced by oestradiol. If
expression of the inhibin subunit genes were particularly sensitive to
stimulation by cAMP, this mechanism could be sufficient to explain the
effect of oestradiol in the absence of FSH. However, this does not explain
why DHT does not have the same effect alone, or why oestradiol appears
to be more potent than DHT in augmenting FSH-stimulated inhibin gene
expression.
It is difficult to envisage a situation where there is sufficient
P450arom present in granulosa cells to produce stimulatory
concentrations of oestradiol in the complete absence of FSH. However,
differential control of inhibin subunit expression by FSH and oestradiol
may influence the forms of inhibin or activin which are produced in
different hormonal environments. It has been shown that oestrogen may
y
inhibit thecal androgen production (Leung & Armstrong, 1979; Magoffin
& Erickson, 1982), while inhibin stimulates androgen synthesis (Hsueh et
al. 1987; Hillier et al. 1991b). Therefore, the stimulation of inhibin
production by oestrogen could constitute a positive feedback mechanism
whereby oestrogen maintains the supply of thecal androgen to act as a
substrate for oestrogen synthesis despite high local levels of oestrogen.
Although these results provide strong evidence for stimulation of
inhibin subunit gene expression by FSH and by oestradiol, and
augmentation of the action of FSH by sex steroids, several questions
remained unanswered. Firstly, a knowledge of the relative amounts of
inhibin a-, Pa- and PB-subunit mRNA species expressed under different
stimuli would be useful for the prediction of the forms of inhibin or
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activin which are produced by granulosa cells under those circumstances,
and for the understanding of the molecular biology of inhibin and activin
synthesis. Secondly, the three genes appeared to be regulated by FSH in a
similar fashion to one another, but differentially regulated by oestradiol
alone. However, due to the apparently lower abundance of inhibin-PA
mRNA, it is possible that there is a direct effect of oestradiol on the
expression of this message, which is not detectable by the method used
here. The third, and most important, remaining question about the
regulation of inhibin subunit gene expression concerns the stage or stages
of granulosa cell differentiation at which inhibin and activin are
produced. A number of potential ovarian paracrine and autocrine
feedback mechanisms have been proposed, by which the development of
the follicle is controlled (Adashi et al. 1985a; Hsueh, 1986; Ledwitz Rigby,
1987; Terranova, 1991; Hillier, 1991; Hsueh et al. 1984). Central to these
mechanisms is the action of FSH in inducing various genes in granulosa
cells, but since the sequence of induction of different genes is not yet clear,
it is not yet known which potential feedback mechanisms operate at what
stage of follicular development. One hypothesis to explain the regulation
by gonadotrophins of expression of different genes in the ovary at
different times during the cycle is based upon differential sensitivity of
genes to stimulation by cAMP (Richards et al. 1987; Yong et al. 1991a).
Therefore, the sensitivity of important granulosa cell genes to
stimulation by cAMP and steroids could give valuable insights into the
sequence of events taking place during the differentiation of granulosa
cells. Based on the data presented here, it could be hypothesised that the
inhibin subunit genes have a lower threshold for expression than
P450arom, suggesting that inhibin and/or activin may be important in
local control of the early stages of follicle development.
Extensive dose-response experiments would be necessary to test this
hypothesis. Unfortunately, the techniques used in the experiments
described in this chapter are not adequate for the analysis of complex
experiments. Northern blotting requires large numbers of cells to provide
sufficient quantities of RNA for analysis, and only a limited number of
samples can be analysed on the same membrane. Also, Northern analysis
provides only semi-quantitative data, such that direct comparison cannot
Chapter 4 Inhibin Gene Expression 225
be made between autoradiographic signals obtained from different
membranes. Indeed, considerable variation was found when making
comparisons of intensities of signals obtained from different exposures of
the same blot. Therefore, in order to study quantitatively the dose-
response characteristics of the regulation of the inhibin subunit genes,
and to determine the relative amounts of the different gene products, a
more sensitive and reproducible assay was required. The method of
choice was a solution hybridisation RNase protection assay.
Chapter 5 Development of an RNase
Protection Assay for Inhibin-a
1 Introduction
Data obtained by Northern blotting, and presented in the previous
chapter, clearly showed that FSH stimulates the expression of all three
inhibin genes in rat granulosa cells, and that steroids are able to modulate
this effect of FSH. However, as discussed in the conclusion of that
chapter, in order to fully understand the regulation of these genes, a
considerable amount of quantitative data are still required; firstly, to
measure the absolute levels of each mRNA species, which would aid the
understanding of the synthesis of forms of inhibin and activin; secondly,
to investigate the dose-response characteristics of stimulation of inhibin
gene expression by steroids, FSH and the presumptive second messenger,
cAMP, in order to understand the timing of production of inhibin and
activin during the development of the follicle.
The technique of Northern analysis, which is almost universally
used to measure levels of specific mRNA species, is based on
hybridisation of labelled probes with RNA immobilised on membranes,
followed by detection of hybridisation by autoradiography. Originally
these methods were developed by molecular biologists for the purpose of
detecting qualitative differences in gene expression between samples (for
example, in identifying a tissue or experimental situation in which a
particular gene is being expressed, when compared to one in which it is
not), and there are advantages to the use of this approach. Since RNA
detected by Northern analysis has been separated by electrophoresis, the
molecular weights of specific mRNA species can be calculated. This
method also reveals the number of transcripts which hybridize to the
probe. This allows differentiation between functional mRNA molecules,
related or incomplete transcripts, and background hybridization. The
hybridization of a probe to RNA on a membrane is determined by the
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stringency of the hybridization and washing, and the degree of sequence
homology (i.e. the number of matching nucleotides) between the probe
and the RNA. As a result, a signal detected by Northern analysis may not
share complete sequence identity with the probe. This allows use of a
cDNA from one species to detect expression of the corresponding mRNA
in a different species, or to screen a cDNA library for a related sequence.
Also, the process of generating a Northern blot is straightforward and,
once the RNA is fixed to the nylon, the same blot may easily be probed,
stripped and reprobed for several different mRNA species.
However, this technique is not suitable for quantitative studies of
gene expression. Efforts have often been made to derive quantitative
information from autoradiographs by measuring the optical densities of
signals using densitometry. However, in addition to the abundance of a
specific mRNA, there are several other variables influencing the strength
of an autoradiographic signal from a Northern blot; the efficiency and
evenness of transfer of RNA from the gel to the membrane, the degree of
fixation of RNA to the membrane, the concentration and specific activity
of the probe, the uniformity of hybridization and washing of the probe
across the membrane, the use of intensifying screens and the length of
exposure of the blot to the film all can influence signal strength. Also, the
relationship between optical density and radioactive exposure is non¬
linear at both low and high signal intensities (Swillens et al. 1989).
Therefore, if the intensities of two signals are to be compared, both must
fall within a range over which this relationship is linear. Since it is not
known before the development of the film whether the signals obtained
will all fall within this range, the optimum exposure time is difficult to
acheive. The best degree of quantitation that can be achieved in this way
is a comparison of arbitrary densitometric units between spots on the
same autoradiogram. Relative abundances of different transcripts in an
RNA sample immobilised on a membrane cannot be measured by
densitometry, since detection of different mRNA species may require
different exposure times.
Another disadvantage of Northern analysis is the amount of RNA
the method requires. Abundant mRNA species such as inhibin a-subunit
mRNA were detected by Northern analysis of less than 5gg of total
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granulosa cell RNA after exposure of blots for 1-2 days (see previous
chapter, Figs.4.10-4.12). However, in order to detect relatively rare
transcripts, such as aromatase message, more RNA had to be analysed
and exposure times extended. The typical yield of total RNA from
cultured cells has been approximately 4pg per million cells. For studies on
the expression of inhibin subunit genes, the number of cells needed for
each treatment was 3-4million cells, which would yield enough RNA for
two or three Northern blots. As two ovaries will typically yield
approximately 1-2 million cells, cells from at least two animals were
needed for each treatment in a culture. As a result, the design of the
experiments was limited by the logistics of setting up very large-scale
cultures, and the availability of animals.
Because of these limitations of Northern analysis, a more
quantitative and sensitive detection method was required to study the
regulation of inhibin subunit gene expression in detail. The most direct
technique for the quantitative measurement of specific mRNAs is by
solution hybridization RNase protection assay. This method is based
upon the the fact that perfectly matched RNA:RNA hybrids are highly
resistant to digestion with RNases A and T-j, whereas unhybridized
(single-stranded) RNA is extremely susceptible to degradation by those
enzymes. The method is summarized in Fig.5.1. A uniformly labelled
complementary RNA probe is incubated in solution with a sample of
total cellular RNA containing an unknown quantity of the target mRNA
and hybridization is allowed to take place. The sample is then incubated
with a mixture of RNases A and Ti, which degrades all RNA not present
as perfectly matched hybrids. If the probe is present in an excess over the
target sequence, the amount of probe protected from RNase digestion is
proportional to the amount of target mRNA present in the original
sample. The amount of probe protected can be measured by visualization
on a polyacrylamide gel, or by scintillation counting of protected probe
adsorbed to charged paper filters. Two controls are included, containing
the same amount of probe as the samples, but no RNA; a background
control, in which the probe is digested with RNase, and an input control,
in which it is not.
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Fig.5.1. Diagrammatic representation of the RNase protection assay technique. 1. A
uniformly labelled cRNA probe (represented by the upper strand, black squares
denoting radioactive nucleotides) is allowed to hybridize to the mRNA of interest
(lower strand). 2. RNase is added, digesting all RNA not forming perfectly matched
hybrids. 3. RNase-resistant fragments are visualized by electrophoresis and
autoradiography.
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Because of its ability to detect sequence mismatches with extreme
accuracy, the major applications of this technique have been in the
mapping of intron/exon junctions in primary gene transcripts
(Hernandez et al. 1989; White et al. 1987) and in the detection of point
mutations and deletions (Garcia et al. 1988). However, it is also a useful
method for the measurement of the abundance of specific mRNAs
(Werner et al. 1989; Leung et al. 1987; Segaloff et al. 1990). The advantages
of this method of mRNA analysis over Northern blotting are greater
sensitivity and quantitative measurement of mRNA abundance. It has
been suggested that RNase protection assay is at least tenfold more
sensitive than Northern analysis, being able to detect as little as O.lpg of
target mRNA (Melton et al. 1984). The greater sensitivity of this method
is due to a greater extent of hybridisation that can be achieved. This is a
result of the low hybridisation volume used, compared to membrane
hybridisation methods, allowing much greater probe concentrations to be
used (Hames & Higgins, 1987). Also, RNA in solution is more accessible
to hybridisation than RNA immobilised on a membrane (Sambrook et al.
1989). The problems associated with autoradiography as a detection
method can be circumvented by measuring the amount of probe
protected using liquid scintillation counting. Synthetic sense RNA can be
used to construct a standard curve of known concentration, and quality
control samples can be included in assays, so that quantitative and
reproducible data can be obtained. Because less RNA is required for
analysis by this method, samples can be assayed in duplicate or triplicate,
allowing statistical analysis to be performed.
Probes for analysis of mRNA by RNase protection assay must be
single-stranded, uniformly labelled antisense RNA. In addition,
unlabelled sense RNA is required to act as a standard. RNA probes can be
prepared by transcription in vitro, using the appropriate strand of the
cDNA as a template. In order to do this, the cDNA must be inserted into a
plasmid carrying sequences on either side of the cDNA which act as
promoter elements for commercially available bacteriophage
DNA-dependent RNA polymerases, allowing transcription of RNA from
either strand. Since pUC18, the plasmid into which the inhibin-a cDNA
was supplied, bears no such promoter sequences, it was necessary to
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subclone the cDNA into a suitable vector. The vector which was chosen
was pGEM3Zf(+) (Promega) (Fig.5.2). This plasmid contains sequences on
either side of the multiple cloning site which act as promoters for
bacteriophage SP6 and T7 RNA polymerases, which can therefore be used
to generate RNA transcripts from either strand.
The aims of this section of the project were to subclone the inhibin
a-subunit cDNA into pGEM3Zf(+), to use synthetic RNA derived from
this construct to develop and validate a sensitive and reproducible RNase
protection assay for the quantitative measurement of mRNA encoding
the inhibin a-subunit, and to use this assay to study in detail the
hormonal regulation of inhibin-a gene expression.
2 Materials and Methods
Animals, in vivo hormonal treatments, isolation of granulosa cells,
extraction of RNA, and Northern analysis were all as described in section
2.2. The following methods were also used in the studies described in this
chapter.
2.1 Subcloning of Inhibin a-Subunit cDNA
The a-subunit clone (a7; see Fig.5.3) contains in its 5' end sequences
not confirmed by the other a-subunit clone obtained by the group
supplying the clone. This region contains multiple termination codons
with a putative amino acid coding region (Esch et al. 1987). Therefore, the
Hinfl/Kpnl fragment of the cDNA (1027bp long) was chosen for
subcloning. This fragment contains most of the open reading frame and
none of the untranslated regions of the a-subunit cDNA. The strategy
used for the subcloning of this fragment is summarised in Fig.5.4.
Inhibin-a/pUC18 was digested with Hinfl and KpnI. The resulting
DNA fragments were resolved by electrophoresis in a 0.8% agarose gel,
and the desired fragment was cut from the gel and purified as described in
chapter 2, sections 2.6.3 and 2.6.4. The ends of the a-subunit Hinfl/Kpnl
fragment were filled in by incubation for 30min at room temperature
with 10U Klenow fragment of E. coli DNA polymerase I, in a buffer


































Fig.5.2. Plasmid pGEM3Zf(+) (Promega), showing the LacZ gene, bacteriophage
fl region (fl ori), bacterial origin of replication (ori) and the ampicillin resistance gene
(Ampr). Unique restriction sites are shown. The multiple cloning site and the flanking
promoter regions for bacteriophage T7 and SP6 RNA polymerases are shown on the
right. The size of the plasmid is 3199 base pairs.
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Fig.5.3. Rat inhibin a-subunit cDNA fragments. A: Diagram of the full length
(1336bp) cDNA. The open reading frame is boxed, showing the regions encoding the
pro-, aN and mature aC portions of the inhibin a-subunit protein. Non-coding
regions are shown as lines. B: Clone a7 (Esch et ai, 1987), aligned with the full
length cDNA above. The confirmed inhibin-a sequences are boxed, and the
unconfirmed 5' region is shown as a line. C: Partial restriction map of the 1027bp
Hinfl-Kpnl fragment of clone a7, aligned with the full length cDNA and clone a7
above. Positions of restriction sites are indicated (in bp) with respect to the 5' end of
the full length cDNA. This fragment was subcloned for use as a template for RNA
probe generation.
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Fig.5.4. Strategy adopted for subcloning the rat inhibin a-subunit H infl-Kpnl
1027bp cDNA fragment. Parent plasmid (pUC/inhibin-a), containing clone a7, was
digested with Hinfl and Kpnl, and the 1027bp fragment was purified from an agarose
gel. The ends of this fragment were then filled in with the Klenow fragment of E.coli
DNA polymerase I, to generate blunt ends. The plasmid (pGEM3Zf(+)) into which the
cDNA was to be subcloned was digested with Smal, generating blunt ends. Phosphate
groups (denoted by the letter P circled) were removed from the linearised plasmid by
treatment with calf intestinal alkaline phosphatase, to prevent recircularisation of the
plasmid. The blunt-ended inhibin-a 1027bp cDNA fragment was ligated into the Smal
site of the plasmid using T4 DNA ligase.
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containing 80|iM deoxyribonucleotide triphosphates, 50mM Tris (pH7.5),
lOmM MgS04, lOOpM DTT and 50pg/ml BSA. The reaction was stopped
by the addition of lgl of 0.5M EDTA (pH8.0), the mixture was extracted
once with an equal volume of phenokchloroform (1:1), and the DNA was
purified from unincorporated nucleotides by chromatography on a
Sephadex G-50 column (Nick Column, Pharmacia; see chapter 2, section
2.6.4). DNA was recovered by precipitation at -20C for lh with 0.1 volume
of 3M sodium acetate (pH7.0) and 2 volumes of ethanol. In order to accept
the blunt-ended a-subunit insert, ~10pg of plasmid were digested with
Smal. To prevent recircularization of the plasmid during ligation, 5'
phosphate groups were removed from the linearised plasmid by
incubation for lh at 37C with 1U of calf intestinal alkaline phosphatase,
in a buffer containing 50mMTris (pH9.0), ImM MgCl?, 100pM ZnCl2 and
ImM spermidine. The mixture was extracted once with an equal volume
of phenol:chloroform, and once with an equal volume of chloroform,
and the plasmid DNA was recovered by precipitation at -20C for lh with
0.1 volume of 3M sodium acetate (pH7.0) and 2 volumes of ethanol.
Blunt-ended inhibin a-subunit 1027bp cDNA fragment was ligated
into the Smal-digested, alkaline phosphatase-treated plasmid as follows,
lpg of plasmid and a twofold molar excess of insert (700ng) were
incubated with 2 Weiss units of T4 DNA ligase, in a buffer containing
50mM Tris (pH7.6), lOmM MgCl2, ImM ATP, ImM DTT and 5% (w/v)
polyethylene glycol-8000. Ligation reactions were incubated at 4C
overnight. Whole ligation reactions were used to transfect competent
JM109 cells by the method described in chapter 2, section 2.6.3. Mini
plasmid preparations were made from selected clones (see chapter 2,
section 2.6.3) and plasmids were digested with EcoRI, Sal I, and a
combination of the two. These enzymes cleave the plasmid on either side
of the Smal site, into which the insert was ligated. Therefore, a
recombinant plasmid of the expected construction would be linearized by
digestion with either enzyme, and the insert liberated by digestion with
both. Restriction digests and undigested plasmids were then analysed by
Southern blotting. DNA was resolved by electrophoresis in a 0.8% agarose
gel (see chapter 2, section 2.6.3). After electrophoresis, the gel was soaked
for 45min in denaturing solution (1.5M NaCl, 0.5M NaOH) to separate
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the DNA strands, rinsed in distilled water, and then soaked for 45min in
two changes of neutralizing solution (1.5M NaCl, 1M Tris pH7.4). DNA
was transferred to a nylon membrane (Hybond-N, Amersham) by
capillary blotting, using lOxSSC as the transfer buffer, essentially as
described for Northern blotting in chapter 2, section 2.6.2. After transfer,
DNA was fixed to the membrane by exposure to 254nm UV light for
6min. The blot was probed with a random primed inhibin-a cDNA probe,
as described for Northern blot hybridisation in chapter 2, sections 2.6.4
and 2.6.6, to identify positive clones. The orientation of the insert in a
positive clone was determined by digestion with EcoRI and Bglll. In order
to confirm the orientation of the insert, unlabelled RNA was transcribed
with SP6 and T7 RNA polymerases using plasmid linearised with Bglll as
a template. To act as a sense RNA standard, unlabelled RNA was also
transcribed from the entire insert with SP6 RNA polymerase using
plasmid linearised with EcoRI as a template. Transcription of unlabelled
RNA was carried out as described for transcription of 32P-labelled RNA
probes (chapter 2, section 2.6.5), except that all ribonucleotide
triphosphates were present at a concentration of 500jiM, and no labelled
nucleotide was present. The sizes of transcripts obtained from each
reaction were determined by polyacrylamide gel electrophoresis as
described below. The concentration of synthetic sense RNA was
determined by spectrophotometry.
In order to demonstrate detection of native inhibin-a mRNA using
the presumptive probe, identical Northern blots were probed with 32P-
labelled RNA probes transcribed from plasmid linearised with Bglll using
SP6 and T7 RNA polymerases, as described in chapter 2, section 2.6.6.
2.2 Polyacrylamide Gel Electrophoresis of RNA
Acrylamide monomer stock solution was obtained as a 40% (w/v)
solution of acrylamide and bisacrylamide in a ratio of 19:1 (IBI). Gel stock
solution consisted of 4% or 6% acrylamide/bisaerylamide containing 7M
urea and IxTBE. Gels were prepared by the addition of TEMED and APS
to the gel stock to a final concentration of 0.08% (v/v and w/v,
respectively). Gels were poured between glass plates, using a commercial
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polyacrylamide gel apparatus (BioRad), and allowed to polymerize for lh
at room temperature.
Loading buffer (80% [v/v] formamide, ImM EDTA, 0.1% [w/v]
xylene cyanol and 0.1% [w/v] bromophenol blue) was added to 2gl of each
sample, which were then heated to 80C for lOmin to denature RNA, and
placed on ice. An equal volume (lOgl) of each sample was then loaded
onto adjacent lanes of gels. Electrophoresis was carried out for
approximately 45min at 200V.
Unlabelled RNA was visualized by ethidium bromide staining. Gels
were stained by soaking for 30min in lxTBE containing 0.5|ig/ml
ethidium bromide, and photographed under UV light. Radiolabeled
RNA fragments were detected by autoradiography. Gels were fixed by
soaking in 10% (v/v) methanol, 10% (v/v) acetic acid for 30min, and then
dried onto Whatman 3MM paper, using a commercial gel dryer (BioRad).
Dried gels were exposed to Kodak X-Omat AR-5 film overnight at -70C
with two intensifying screens.
2.3 RNase Protection Assay
Complementary 32P-labelled RNA probe was transcribed in vitro
and incorporation of radioactivity and yield of labelled probe were
calculated as described in chapter 2, section 2.6.4. Specific activity of probe
was l-2xl08cpm/gg. Probe was precipitated with 0.1 volume of 3M
sodium acetate (pH5.5) and 2.5 volumes of ethanol at -70C for 30min.
Probe was redissolved in hybridisation buffer to a final concentration of
104cpm/|il. In all cases, hybridisation buffer contained 0.05% (w/y) SDS,
10mMTris(pH7.4), 0.6M NaCl, and 2mM EDTA, after Leung et al. (1987).
Because RNA may suffer non-enzymatic hydrolysis in solution at high
temperatures (Tenhunen, 1989; ITames & Higgins, 1987), many protocols
for RNase protection assays include 50-80% formamide in the buffer
(Melton etiil. 1984; Hernandez et al. 1991; Lynn et al. 1983), so that lower
hybridisation temperatures can be used. Therefore, assays were carried
out using this buffer without formamide, and also with 50% or 80%
formamide. Probes were used in hybridisation reactions on the day of
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their synthesis, since high specific activity 32P-labelled probes rapidly
break down due to radiochemical damage (Zinn et al. 1983).
Samples, standards and controls were placed in microcentrifuge
tubes and the mass of RNA was adjusted to 20pg with yeast transfer RNA
(tRNA). 2.5 volumes of ethanol and 0.1 volume of 3M sodium acetate
(pH5.5) were added and the RNA was allowed to precipitate at -20C for at
least lh. All assays included one or two background control tubes, which
contained only the tRNA. Samples were centrifuged and the pellets
washed with 70% ethanol and dried under vacuum.
The samples were then dissolved in 20|il of the probe solution by
gentle vortexing and heating to 65C for lOmin. The same volume of
probe solution was also added to a tube containing no RNA, to act as an
input control. The samples were then brought to the bottom of the tubes
by brief centrifugation and covered with two drops of mineral oil (Sigma).
RNA was denatured by heating the tubes to 90C for 5min before being
transferred to a water bath at the appropriate hybridization temperature.
A range of different hybridisation temperatures were tested; 75C, 80C and
85C for hybridisation in the absence of formamide; 60C, 65C and 70C for
hybridisation in 50% formamide; 45C, 50C and 55C for hybridisation in
80% formamide, based on hybridisation temperatures used by other
workers (Leung et al. 1987; Lynn et al. 1983; Melton et al. 1984).
Hybridization was allowed to take place for at least 12h.
After hybridization, RNases A and T\, in 300pl of an ice-cold
solution containing lOmM Tris (pLI7.5), 300mM NaCl and 5mM EDTA
were added to all tubes except the input controls. Many published
protocols have used concentrations of 40gg/ml RNase A and 2pg/ml
RNase Ti (Melton et al. 1984; Zinn et al. 1983). Therefore, the following
concentrations of RNase were tested for their effect on the efficiency of
the assay:
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Tubes were incubated at 32C for lh. In order to destroy the RNase,
lOOpg of proteinase K and lOgl 20% SDS were added to all tubes except
input controls, and tubes were incubated for a further 15min at 37C. The
input controls were adjusted to 320pl, all samples were extracted once
with phenobchloroform (1:1), and 300|il of the aqueous phases transferred
to fresh tubes. Samples were precipitated at -20C for at least Ih with 30pl
3M sodium acetate (pH5.5) and 750pl cold ethanol, in the presence of 20|j.g
carrier yeast transfer RNA. RNA was pelleted and redissolved in 20pl
sterile water. To visualise protected probe, samples were analysed by
polyacrylamide gel electrophoresis and autoradiography as described
above. Only one tenth of the input control samples were loaded on gels.
To measure the amount of probe protected by increasing amounts of
synthetic sense RNA, duplicate 5gl aliquots of each sample were spotted
onto DE81 filters, washed and subjected to liquid scintillation counting as
described in chapter 2, section 2.6.4.
3 Results
3.1 Subcloning
Fig.5.5 shows a Southern blot of plasmid prepared from a clone of
E. coli transfected with a product of the ligation described above.
Digestion with either EcoRI or Sail yielded a single band, as expected, and
digestion with both enzymes liberated an insert of approximately lkb
from a plasmid migrating at the expected molecular weight of ~3.2kb. The
insert hybridised strongly to the inhibin-a cDNA probe, and it was
concluded that this insert consisted of the 1027bp inhibin a-subunit
cDNA fragment, plus 33bp of the multiple cloning site of the plasmid.
Although some hybridisation of the probe to the ~3.21<b band was
observed, it was of much lower intensity than that seen to the insert, and
was therefore considered to be non-specific. Further analysis of this clone
confirmed that digestion with EcoRI and Sail liberated the expected
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Fig.5.5. Southern analysis of a positive clone containing the 1027bp fragment of the
inhibin-a cDNA. Plasmid and restriction digests were separated by electrophoresis in
a 0.8% agarose gel, and DNA was transferred to a nylon membrane. The blot was
probed with a 32P-labelled rat inhibin a-subunit cDNA probe, washed at 65C, and
exposed to x-ray film for 30min. Lane 1: undigested plasmid. Lane 2: plasmid
digested with EcoKl. Lane 3: plasmid digested with Sail. Lane 4: plasmid digested
with both EcoRl and Sail. Positions of molecular weight standards are marked on the
left.
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1060bp insert, and also revealed that digestion with EcoRI and Bglll
excised a 622bp fragment of the insert (Fig.5.6), indicating that the insert
was cloned into the multiple cloning site of the plasmid in the
orientation shown in Fig.5.7. Preparation of unlabelled RNA from
plasmid linearised with Bglll generated a 630 base transcript using T7
RNA polymerase, and a 466 base transcript using SP6 RNA polymerase
(Fig.5.8). The sizes of these transcripts are consistent with the orientation
of the insert as shown in Fig.5.7. Transcription of RNA from plasmid
linearised with EcoRI using SP6 RNA polymerase yielded a transcript
1091 nucleotides in length, as expected. These results showed that the
subcloning of the 1027bp fragment of the rat inhibin a-subunit cDNA was
successful, and that the orientation of the insert in this construct was
such that antisense RNA probes could be generated using T7 RNA
polymerase, and sense (standard) RNA could be prepared using SP6 RNA
polymerase. Flybridisation of presumptive antisense RNA prepared using
T7 polymerase to granulosa cell RNA is shown in Fig.5.9A. The probe
detected a major mRNA species of ~1.7kb, the levels of which were
highest in granulosa cells from animals which had received FSH in vivo,
and reduced in the granulosa cells of those which had received hCG
following FSF1 treatment. The molecular weight and pattern of
expression of this species are entirely consistent with those of inhibin-a
mRNA as detected using cDNA probes (see previous chapter, Fig.4.2). A
considerable amount of non-specific binding of this probe to the 28s
ribosomal RNA band was observed in this case, although the intensity of
hybridisation was far less great than to the inhibin a-subunit mRNA. As
expected, a probe synthesised from the opposite strand did not hybridise
to inhibin-a mRNA under the same conditions (Fig.5.9B). Flowever, and
most unexpectedly, this probe did hybridise to a low molecular weight
species (-600 bases), the abundance of which was markedly stimulated by
treatment of animals with hCG in vivo, and unaffected by treatment with
FSH.
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Fig.5.6. Restriction analysis of the positive clone shown in Fig.5.5. Plasmid was
digested with fcoRI (lane 2), EcoRI and Sail (lane3) and with fcoRI and Bg/II (lane
4). Lane 1 contains undigested plasmid. DNA was resolved by electrophoresis in a
0.8% agarose gel containing ethidium bromide. Positions of molecular weight
standards are marked on the left.
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Fig.5.7. Map of the positive clone shown in Figs.5.5 and 5.6. The 1027bp rat
inhibin a-subunit insert is marked in black, and its orientation with respect to the
sense strand (5'-3') is marked with an arrow below. Plasmid features are marked as in
Fig.5.2, except the SP6 and T7 promoters, which are marked as unfilled arrows, and
only selected restriction sites in the multiple cloning site are shown.
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Fig.5.8. Transcription in vitro using subeloned inhibin-a cDNA as a template. Lane
1: RNA molecular weight markers, the sizes of which (in kb) are marked on the left.
Lane 2: RNA transcribed from plasmid digested with BglU, using T7 RNA
polymerase. Lane 3: RNA transcribed from plasmid digested with BglU, using SP6
RNA polymerase. Lane 4: RNA transcribed from plasmid digested with EcoK\, using
SP6 RNA polymerase. RNA was resolved by electrophoresis in a 4% denaturing
polyacrylamide gel, and stained with ethidium bromide.
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Fig.5.9. Northern hybridization of 3-P-labelled RNA probes to total RNA from rat
granulosa cells. Probes were transcribed from plasmid containing the 1027bp
fragment of the inhibin-a cDNA, linearized with BglU, using T7 (panel A) or SP6
(panel B) RNA polymerases. Probes were hybridized to identical Northern blots
bearing 20|ig of total RNA per lane from granulosa cells of untreated rats (lane 1), or
rats treated in vivo with 20IU hCG (lane 2), 4 injections of 40|ig oFSH (lane 3), or
both FSH and hCG (lane 4). Blots were washed twice for 3()min at 65C, and exposed
to x-ray film for lOh at -70C.
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3.2 Factors Affecting the Efficiency of RNase Protection
The results of an experiment to determine the effect of different
concentrations of formamide and different hybridisation temperatures on
the efficiency of hybridisation in this assay are shown in Fig.5.10. In all
three hybridisation buffers used (0%, 50% and 80% formamide)
hybridisation temperature did not appear to affect greatly the efficiency of
hybridisation across the narrow range tested. However, the concentration
of formamide in the buffer used did have a marked effect. In a buffer
containing no formamide, probe protected by hybridisation with sense
RNA was readily detected by overnight exposure of gels. Some low
molecular weight smearing was present, although this was also present
in the probe preparation, and was probably due to radiochemical
breakdown products of the probe (Zinn et al. 1983). No RNase-resistant
probe was present in the absence of sense RNA. However, where the
hybridisation buffer contained 50% formamide, protected probe was only
adequately detected after exposure of gels for 8 days. The degree of low
molecular weight smearing was greater than that present in the probe
preparation, indicating incomplete protection, and some probe was
detected in the background controls after this exposure time. In a buffer
containing 80% formamide, the amount of probe protected was barely
above background. The effect of different concentrations of RNase in the
digestion mixture on yield of protected probe was also investigated
(Fig.5.11). It was found that the yield of protected RNA was greatest at the
lowest concentration of RNase used (8|ig/ml RNase A, 0.4gg/ml RNase
Ti), which is much lower than that used in most published protocols
(Leung et al. 1987; Melton et al. 1984; Sambrook et al. 1989). At this
concentration of RNase, no probe was detected in background controls
after overnight exposure of gels.
The method adopted for subsequent RNase protection assays was
therefore to hybridise in a buffer containing no formamide at a
temperature of 75C, and to digest unhybridised probe in a buffer
containing 8|ig/ml RNase A and 0.4|ig/ml RNase Tj.
Known amounts (25-100pg) of synthetic sense RNA were hybridised
to a 32P-labelled probe using the method described above. After digestion
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Fig.5.10. Influence of hybridization temperature and formamide concentration on
RNase protection of 32P-labelled inhibin-a cRNA probe by synthetic sense RNA.
Formamide concentrations in the hybridization buffers were as follows. Panel A: no
formamide; panel B: 50% formamide; panel C: 80% formamide. Hybridization
temperatures were as follows. Panel A, lanes 3, 4 and 5: 75, 80 and 85C,
respectively; panel B, lanes 3, 4 and 5: 60, 65 and 70C, respectively; panel C, lanes 3,
4 and 5: 45, 50 and 55C, respectively. In each panel, an input control (probe only, no
RNase treatment; lane 1) and a background control (probe only, digested with RNase;
lane 2). Probe (2xl05cpm; ~lng) was allowed to hybridise to lOOpg synthetic sense
RNA for 16h, and unhybridised probe was digested with 40p.g/ml RNase A and
2p.g/ml RNase Tj. Protected fragments were analyzed by electrophoresis in 4%
(panels A and B) or 6% (panel C) polyacrylamide gels containing 7M urea, followed
by autoradiography. Exposure times were: panel A, 24h; panel B, 8d; panel C, 17d.
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Fig.5.11. Resistance of RNA hybrids to different concentrations of RNase. 2x10^
cpm of 32P-labelled cRNA probe was hybridized to lOOpg of synthetic sense RNA for
16h at 75C in a formamide-free buffer. Samples were treated with the following
concentrations of RNases: lane 3, 200(ig/ml RNase A, 10|ig/ml RNase Ti; lane 4,
80|ig/ml RNase A, 4|ig/ml RNase Tj; lane 5, 40)1g/ml RNase A, 2[ig/ml RNase Ti;
lane 6, 20|ig/ml RNase A, ljig/ml RNase Ti; lane 7, 8p.g/ml RNase A, 0.4|ig/ml
RNase Ti. An input control (probe only, no RNase treatment; lane 1) and a
background control (probe only, digested with 8 fig/ml RNase A and 0.4(1g/ml RNase
Ti; lane 2) were also included. Resistant fragments were visualized by electrophoresis
in 4% polyacrylamide gels containing 7M urea, followed by autoradiography.
Exposure was for 24h.
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with RNases, protected probe in duplicate aliquots of each sample was
adsorbed to DE81 filters and measured by liquid scintillation counting.
The resulting standard curve is shown in Fig.5.12. It was found that
detectable protection was achieved by the lowest amount (25pg) of
standard RNA used in this assay. Therefore, another standard curve was
constructed, using a wider range of standards (4-125pg). In the same assay,
probe was also hybridised to lOpg of total ovarian RNA from control
animals and from animals treated with FSH in vivo. Protection of probe
was assessed by electrophoresis and autoradiography (Fig.5.13). It was
found that 8pg of synthetic sense RNA was detected after overnight
exposure of the gels (Fig.5.13A), and that, by comparison with standards,
ovaries from control animals contained inhibin-a mRNA levels
equivalent to approximately 60pg standard. Ovarian RNA from FSH-
treated animals contained approximately twice that amount.
Unfortunately, in that experiment, the background of radioactivity,
visible on the gels as a dark smear, was very high, so that scintillation
counting of samples did not reveal any differences between the samples.
This background did not indicate incomplete protection of probe, since it
was of both higher and lower molecular weight than the probe, and was
present in equal amounts in samples and controls.
4 Discussion
The aim of the part of the project described in this chapter was to
develop and validate a sensitive, quantitative and reproducible RNase
protection assay for the measurement of inhibin a-subunit mRNA, and
to use this assay to study in detail the control of expression of this
mRNA. To this end a portion of the rat inhibin a-subunit cDNA was
successfully subcloned into a suitable vector, and synthetic RNA probes
and sense standards transcribed from this construct were used to perform
the preliminary stages of the development of an RNase protection assay.
It was confirmed that specific RNA levels can be quantified by
scintillation counting of protected probe bound to charged paper filters,
and a linear relationship appeared to exist between the counts of probe
detected by this method and the amount of sense RNA to which the
Chapter 5 RNase Protection Assay 259
Input of standard RNA (pg)
Fig.5.12. Quantitation by liquid scintillation counting of inhibin-a cRNA probe
protected by increasing amounts of synthetic sense RNA. 2xl05cpm 32P-labelled
probe was hybridized with 25, 50 or lOOpg of sense RNA for 16h at 75C in
formamide-free hybridization buffer, before digestion with 8pg/ml RNase A and
0.4|ig/ml RNase Tj. Duplicate 5|il aliquots of each samples were applied to DE81
filters, washed four times with 0.5M Na2HP04 (pH7), rinsed in 70% ethanol and
dried. Filters were placed in scintillation vials with 4ml scintillation fluid, and
emissions counted on the 32P channel of a scintillation counter.
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Fig.5.13. Visualisation of inhibin-a cRNA probe protected by increasing amounts
of synthetic sense RNA, and by inhibin-a mRNA in rat ovarian RNA samples. Panel
A: lane 1, input control; lane 2, background control; lanes 3-8, 2xl05cpm of ^2P-
labelled antisense inhibin-a probe was hybridized to 4 (lane 3), 8 (lane 4), 16 (lane 5),
31 (lane 6), 62 (lane 7) or 125pg (lane 8) sense RNA. Panel B: 2.xl()5cpm of
inhibin-a cRNA probe was hybridized to its target mRNA in 1 Oglg of total RNA
extracted from ovaries of immature untreated rats (lane 1), or rats treated in vivo with
4 injections of 20jj.g oFSH (lane 2). Samples were digested with 8|ig/ml RNase A and
0.4|ig/ml RNase T]. RNase-resistant hybrids were detected by electrophoresis and
autoradiography.
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probe had been hybridised. The sensitivity of the assay as determined by
autoradiography of protected probe appeared to be less than 8pg, although
the background level of non-specific radioactivity in the assay from
which that estimate was obtained was very high, so that differences in
probe protection between samples were difficult to detect. This is much
below the level of sensitivity claimed for this type of assay by other
workers (Hames & Higgins, 1987; Melton et at. 1984), and it is not clear
whether the assay described in the foregoing section is any more sensitive
than Northern analysis, since no direct comparison was made. However,
apparent levels of rnRNA encoding inhibin a-subunit detected using this
method suggest that the assay would be capable of detecting this message
in less than lpg of total ovarian RNA.
Clearly, for the successful application of this assay, more rigorous
studies of the effects of hybridisation temperature, buffer, RNase
concentration and length and specific activity of probes on the sensitivity
of the assay would be required, as well as a direct comparison between
RNase protection and Northern analysis. However, due to constraints of
time, this work was beyond the scope of the present thesis.
An interesting finding to emerge from the work described in this
chapter was the detection of an RNA species abundantly expressed in
granulosa cells which hybridised strongly to the sense RNA probe.
Because the blot was washed at a high stringency, this RNA appeared to
share considerable homology with the non-coding strand of the inhibin-a
cDNA. However, this molecule was not detected using double-stranded
cDNA probes (see previous chapter), suggesting that this sequence
homology is not complete.
The function of such a molecule is unknown, although functions
for antisense RNA have been proposed in other systems. Antisense RNA
has been most closely studied in prokaryotic systems, including plasmids,
bacteriophages, transposons and bacteria, where they inhibit translation,
lead to termination of transcription, or affect the stability of specific
mRNAs (for reviews, see Eguchi, et at., 1991, and Simons & Kleckner,
1988 ). A few cases of naturally occuring antisense RNA expression in
eukaryotes have recently been reported (Simons, 1988; Mol et al. 1990).
Most strikingly, a gene encoding a novel member of the nuclear
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hormone receptor superfamily, similar to the receptors for retinoic acid
and thyroid hormones, was recently cloned. Although the protein
encoded by this gene exhibits some binding affinity for triiodothyronine
(Miyajima et al. 1989), its true ligand has not yet been identified.
Remarkably, this gene was found to overlap the c-erbA gene, which
encodes the thyroid hormone receptor, but its mRNA is transcribed from
V yj
the opposite strand (Lazar et al. 1989; Miyajima et al. 1989). Similarly, both
strands of parts of the N-rayc (Krystal et al. 1990) and c-myc (Piechaczyk et
al. 1988; Nepveu et al. 1987) genes are transcribed. In the case of N-myc, at
least, the antisense RNA hybridises to the mRNA in vivo, preventing
splicing of the first intron (Krystal et al. 1990). Antisense transcription
from the IGF-II gene has also been demonstrated in chicks (Taylor et al.
1991). In all these cases, levels of antisense RNA were of the same order
as levels of the corresponding mRNA. Strong evidence of regulation of
mRNA processing by antisense RNA has also been found in the case of
bFGF expression in Xenopus oocytes. An antisense transcript of this gene
has been cloned, which encodes an unknown protein, and is also
complementary to the coding region of the bFGF mRNA (Volk et al.
1989). Furthermore, during maturation of the oocyte, this antisense RNA
binds to the bFGF mRNA, leading to conversion of adenine residues to
inosine in the region of hybridisation (Kimelman & Kirschner, 1989). The
authors postulate a role for this mechanism in the regulation of bFGF
mRNA stability. Also, genetic myelin deficiency in mice has been
attributed to inhibition of myelin basic protein mRNA translation by
antisense RNA transcribed at a high rate from an inverted tandemJ
duplication of part of this gene (Tosic et al. 1990).
An inhibitory role for naturally occuring antisense RNA is
supported by the applicability of transfected or microinjected antisense
nucleic acids in the inhibition of translation of specific mRNA (Green et
al. 1986; van der Krol et al. 1988). However, another intriguing possibility
is that antisense RNA may encode proteins with properties related to
those of the corresponding product of the sense mRNA. It has been
shown that, in some cases, peptides translated from complementary RNA
sequences exhibit high affinity binding for one another (Blalock, 1990),
suggesting profound implications for the molecular basis of ligand-
Chapter 5 RNase Protection Assay 264
/
receptor interactions (Blalock & Bost, 1988). The observation that RNA
complementary to angiotensin II mRNA encodes a specific angiotensin II
receptor antagonist (Moore et at. 1989) is consistent with this hypothesis.
Therefore, the interesting possibility arises that the species detected with
the inhibin-a sense probe could encode an inhibin binding protein,
antagonist, or even receptor. However, this seems unlikely, since the
sense probe used here was generated from a part of the cDNA encoding
the pro- and aN regions of the inhibin a-subunit precursor protein (see
Fig.5.3), which are not present in the mature subunit. Since the region of
homology between the probe and this species has not been determined,
this does not mean that the "antisense" RNA is not complementary to
other portions of the inhibin-a mRNA.
Based on the sequence similarity between the coding strands of a
number of receptor genes and the antisense strands of other genes, it has
been proposed that one mechanism whereby new proteins evolve is by
utilisation of the noncoding strands of preexisting genes (Kunisawa &
Otsuka, 1987). This hypothesis implies that apparent antisense
transcription from a particular gene may not have any relevance to the
control of expression of that gene, but may simply indicate expression of a
distinct gene which arose from the use of sequences already existent in
the noncoding strand of that gene. The protein product of a gene arising
in this way need not be related in any other way to the product of the
parent gene.
Based purely on the weight of literature suggesting that antisense
RNA functions directly to interfere with the processing of the
corresponding mRNA, rather than the two latter explanations discussed
above, the most likely interpretation of the detection of "antisense"
inhibin-a RNA is that it acts to suppress inhibin-a production at some
level of RNA processing. If this is the case, it adds another level of
complexity to the already confusing subject of the control of inhibin
synthesis. The hormonal regulation of the expression of this species was
also interesting. FSH treatment in vivo had no effect on levels of this
transcript in granulosa cells, but hCG, with or without prior FSH
treatment, caused a substantial increase in its abundance. Since hCG
causes a drop in levels of inhibin-a mRNA after prior FSFI treatment (see
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chapter 4, Figs. 4.2 and 4.6), and an increase in levels of "antisense"
inhibin-a RNA, this may constitute a dual mechanism to explain the fall
in inhibin production by large follicles which occurs at the LH surge
(Yohkaichiya et al. 1991; Rivier et al. 1989; Watanabe et al. 1990). This
absence of effect of FSH, either on the levels of this transcript or on the
effect of hCG thereon, strongly suggests that the expression of this
molecule is under the control of a thecal cell product, whose production
is stimulated by hCG. The most obvious, although by no means only,
candidate for such a role is androgen. It would be very interesting to study
the effects of gonadotrophins and theca-derived steroids and growth
factors on the levels of this "antisense" RNA under the defined
conditions of the in vitro system used in this thesis.
Further characterisation of this "antisense" RNA species will be
required before its significance is revealed. The region of homology
shared by this transcript and the inhibin a-subunit mRNA could easily be
determined by the use of probes transcribed from different regions of the
inhibin-a cDNA, and the degree of this homology could be determined by
measuring the temperature at which cross-hybridising inhibin-a sense
probes are dissociated from the "antisense" RNA. However, in order to
ascertain the nature of this molecule, it would be necessary to isolate its
cDNA. It would also be necessary to test the hypothesis that it is capable of
binding to inhibin-a mRNA in vivo. Of course, it would also be
interesting to investigate whether equivalent antisense RNAs exist for
the inhibin (3-subunit messages. Such aims are, unfortunately, beyond the
scope of the current project.
Chapter 6 General Discussion
1 Value of the DES-Primed Rat Granulosa Cell Model
In order to study the control of a biological system at any level, a
simplified model must be employed. Such a model must be simplified to
the extent that any observations can be unequivocally ascribed to the
influence of the test treatment, and so in determining the role of one
factor, many other factors inevitably have to be ignored. No in vitro
model can mimic perfectly the conditions present in vivo, and it is useful
only if it retains some similarity to those conditions. The rat granulosa
cell culture model used throughout the experiments described in this
thesis was designed to provide a convenient means of studying the role
of sex steroids in the paracrine control of protein synthesis and gene
expression which accompany granulosa cell differentiation. Because the
cells were isolated from their normal environment, some hormonal and
physical factors, which are certain to affect the function of granulosa cells
in vivo, could not be evaluated. However, since similar model systems
have been widely used in the past in the study of the local control of
follicular development and function (Dorrington et al. 1975; Sanders &
Midgley, 1982; Hsueh et al. 1984), it was considered to be suitable for
studies of the intraovarian role of sex steroids. It has long been known
that administration of oestrogen to rats in vivo causes increased ovarian
weight as a result of the development of large numbers of large preantral
/
and small antral follicles (Simpson et al. 1941) due to proliferation of the
granulosa cells (Goldenberg et al. 1972). It is this property which has been
exploited in this culture model to provide a convenient means of
isolating large numbers of relatively undifferentiated granulosa cells
which can be induced to differentiate in culture in response to FSH. It is
still not known how oestrogen exerts this effect, and it is interesting that
oestrogen treatment in vivo stimulates granulosa cell IGF-I, IGF-I
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receptor and TGF-(3 mRNA expression (Hernandez et al. 1990b;
Hernandez et al. 1991; Mulheron & Schomberg, 1992), and the production
of a thecal cell factor which is mitogenic for granulosa cells (Bley et al.
1991).
Since the aim of the studies described in this thesis was to study the
roles of steroids in granulosa cell differentiation, it was important that
pretreatment of cells with oestrogen did not compromise their
subsequent responsiveness to steroids. Several studies have shown that
pretreatment of animals with oestrogen increases the subsequent effects
of FSH in vitro on cAMP formation (Jonassen et al. 1982), RIIJ3 expression
(Hedin et al. 1987a), aromatase activity and gene expression (Bogovich &
\J
Richards, 1984; Fitzpatrick & Richards, 1991), side-chain cleavage
expression (Goldring et al. 1987) and LH receptor formation (Richards et
al. 1976; Segaloff et al. 1990). It has also been suggested that prolonged
exposure to high levels of oestrogen in vivo can reduce the capacity of
granulosa cells to proliferate in vitro (Chakravorty et al. 1991). However,
data presented in Figs.2.24, 3.6 and 4.12 showed no marked effect of DPS
pretreatment on the semi-quantitative end-points of patterns of protein
synthesis and gene expression. Some enhancement by DES of the effect of
FSH and testosterone on progesterone production was observed (Fig.2.23),
but the overall pattern of hormonal responsiveness was unaffected.
The major potential artefact of using this culture model identified in
the results presented here was the apparent morphological differentiation
of granulosa cells cultured on plastic dishes. The most striking differences
observed between cultured and freshly isolated granulosa cells were in
their patterns of protein synthesis, which appeared to change with time
and plating density in culture (Chapter 2). One of the proteins most
markedly dependent upon time and cell density in culture was
fibronectin (see Chapter 3), which is involved in cell spreading and
attachment. Since this protein was not synthesised by freshly isolated
cells, it is likely that at least some of the changes in protein synthesis
observed during culture reflected structural adaptations of the cells to
culture. Therefore, some of the observed effects of FSH on protein
synthesis by cultured granulosa cells probably reflected a reversal of these
adaptations necessary for the expression of the functional effects of FSH.
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The relatively slower time-course of stimulation by FSH of functional
markers of granulosa cell differentiation (see Figs.2.12, 4.8 and 4.9), when
compared to that of the suppression of actin mRNA levels by FSH (see
Fig.3.7), also supports this interpretation. A similar inverse relationship
between synthesis of cytoskeletal and extracellular matrix proteins and
markers of differentiated function has been shown before (Skinner et al.
1985; Ben Ze'ev & Amsterdam, 1986). Similarly, the absence of any effect
of gonadotrophins on actin expression in vivo argues strongly against a
physiological role for these morphological changes in vivo. The very low
basal level of expression of inhibin-a mRNA in culture (see Fig.4.6),
when compared to freshly isolated cells (see Fig.4.2), may also be due to
constraints imposed by structural adaptation of these cells to culture.
These observations suggest that this model is not suitable for the study of
structural aspects of granulosa cell differentiation.
In order to determine the extent to which granulosa cells in culture
behave functionally as they do in vivo, the responses of granulosa cells to
gonadolrophins were evaluated both in vitro and in vivo. The effects of
gonadotrophins on the expression of mRNA encoding the functional
markers of differentiation studied (i.e. inhibin subunits, the LH receptor,
P450arom and P450scc, see Chapter 4) were qualitatively the same in vivo
and in vitro. The exception to this was the effect of hCG alone. In
cultured cells, hCG was never observed to have any effect on expression
of any of the genes studied, and did not affect progesterone production in
vitro. However, when administered in vivo, hCG had a slight
stimulatory effect on expression of P450arom, P450scc and LH receptor,
and a strong stimulatory effect on the expression of the inhibin subunits.
It could be argued that this effect of hCG was mediated via the theca,
which would be expected to have LH receptors in all follicles. The absence
of any effect of hCG alone on cultured cells would seem to support this
interpretation. However, this effect was variable between experiments.
This implies that the granulosa cells of the animals were not as
immature as one might expect, having some degree of LH
responsiveness, and that the state of maturity of cells obtained using this
model is not always the same. This may be due to variable levels of
pituitary function between individuals, or variable efficacy of DES
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capsules, allowing some gonadotropin stimulation to reach the ovary.
The obvious solution to this problem would be to use
hypophysectomised animals, but the cost of routinely using
hypophysectomised animals is unjustifiable.
Although cultured granulosa cells are morphologically different
from those in a follicle, and respond relatively slowly to hormonal
stimuli, these cells can be induced to differentiate functionally, as
indicated by increased progesterone production and expression of inhibin,
P450arom, P450scc and LH receptor mRNA. Therefore, with some caution
in the interpretation of results, the use of this model appears to be
justified for investigating the influence of specific factors on this process.
2 Steroid Action in the Ovary
Prior to the studies described in this thesis, few comparative studies
on the effects of androgens and oestrogens on granulosa cells had been
carried out. In those which had, the results implied that these classes of
sex steroid have very similar effects, with androgens being the more
potent, suggesting a similar mechanism of action (Armstrong &
Dorrington, 1976; Hillier et al. 1985; Hudson et al. 1987; Wang & Leung,
1987a; Armstrong & Dorrington, 1976). Indeed, this does appear to be the
case for many of the end-points studied in these experiments, such as the
effects on patterns of protein synthesis and progesterone production (see
Chapters 2 and 3). However, some results described in this thesis suggest
that there are differences between the actions of androgens and
oestrogens on granulosa cells.
The demonstration of expression of androgen receptor mRNA in rat
granulosa cells provided strong evidence that the observed effects of
androgens are mediated by the conventional receptor. Expression of
androgen receptor mRNA did not appear to be greatly affected by
gonadotrophin treatment, suggesting that androgen responsiveness may
be independent of the stage of differentiation of the cells. Authentic
oestrogen receptor mRNA was detected in RNA extracted from whole rat
ovaries by Northern blotting, but none was found in granulosa cell RNA.
This does not rule out the possibility that this message is expressed in
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granulosa cells, but if so, it is at a very low level. The fact that the
oestrogen receptor probe used was transcribed from the mouse cDNA,
whereas a rat cDNA was used to detect androgen receptor mRNA, is not
likely to account for the failure to detect oestrogen receptor mRNA in rat
granulosa cells, since this probe did hybridise to an mRNA of the
expected size in rat uterus and ovary RNA samples, albeit less strongly
than in mouse tissue. Also, a previous study also failed to detect
oestrogen receptor mRNA in mouse granulosa cells using the same probe
(Hillier et al. 1989a). Since granulosa cells respond so strongly to
oestrogen, and since specific nuclear uptake of oestrogen by granulosa
cells has been demonstrated (Kudolo et al. "1984b; Wolfson et al. 1990), it is
highly probable that granulosa cells contain conventional oestrogen
receptors. Based on these observations, the difference in potency between
androgens and oestrogens could be explained in terms of receptor
numbers.
If granulosa cells do not express conventional oestrogen receptors, it
is difficult to explain the evident effects of oestrogens in these cells. It is
unlikely that oestrogens act by binding to the androgen receptor, since it
has very low affinity fop oestrogens (Schreiber et al. 1976; Trapman et al.
1988; Lubahn et al. 1988), and also because antiandrogens do not
antagonise the effects of oestrogens in granulosa cells (although they do
block the action of catecholoestrogens) (Hudson & Hillier, 1985; Hudson
et al. 1987; Spicer & Hammond, 1988b). Mechanisms of steroid action
have been proposed which do not involve binding to conventional
nuclear receptors. Binding of steroids, and other factors which normally
are thought to act via nuclear receptors, to membrane components has
been demonstrated, resulting in signal transduction through an
intracellular second messenger (Bomsel-Helmreich et al. 1979; Farach-
Carson et al. 1991). This mechanism has not yet been studied in great
detail, and current concepts still favour binding of steroids to nuclear
receptors, leading to transcriptional activation (O'Malley & Tsai, 1992).
The oestrogen receptor probe did hybridise to a smaller (~1.5kb) transcript
present in rat granulosa cells, and so it is possible (although not very
likely) that this oestrogen receptor-related transcript may be involved in
oestrogen action via a mechanism distinct from the conventional
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receptor-mediated process. However, it is more likely that this molecule
is an intracellular oestrogen-binding protein, which may act to protect the
granulosa cell from chronic oestrogen stimulation when the cell is
steroidogenically active (Hillier et al. 1989a). Certainly, the expression of
this message is highest after FSH treatment, when oestrogen synthesis
would be at its highest, and declines after hCG treatment following FSH
treatment, when oestrogen synthesis would also decrease. If this
molecule is involved in oestrogen action, one would expect this to result
in increased oestrogen responsiveness with increased maturity.
Conversely, if it is a binding protein, one would expect oestrogen
responsiveness to decrease with increasing maturity. Therefore, some
circumstantial evidence for the function of this factor could be obtained
by investigating the relative oestrogen sensitivities of granulosa cells at
different stages of differentiation. The true function of the protein
encoded by this RNA will probably not be determined until its cDNA is
cloned and sequenced.
The significance of the greater potency of androgen compared to
oestrogen is not known, but intuitively it seems probable that, since
androgen has to diffuse from the theca layer and across the basement
membrane before reaching the granulosa cells, its concentration upon
reaching those cells will be far lower than that of oestrogen. Oestrogen, on
the other hand, can act within the cell in which it is synthesised.
Moreover, after being taken up by steroidogenically active granulosa cells,
much of the androgen will be rapidly aromatised to oestrogen in the
cytoplasm before it can reach the nucleus. Therefore, greater sensitivity to
androgen than to oestrogen would seem to be necessary for any response
to androgen to occur on one hand, and to prevent hyperstimulation by
locally high concentrations of oestrogen on the other. Such a difference in
sensitivity to these two classes of steroid would be consistent with a
common mode of action for androgens and oestrogens (perhaps by
sensitising cells to the FSH-induced elevation of intracellular cAMP
levels), with androgens being the more potent simply because they have
to be in order to exert the same effect. This implies that the importance of
androgen may not be as great as its potency may predict.
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Since androgens have been shown to be more potent than
oestrogens in augmenting the action of FSH on end-points such as
production of progesterone and oestradiol, it was somewhat surprising to
find that the opposite may be the case for inhibin gene expression. Where
a marked augmentation of inhibin gene expression by steroids was
observed, oestradiol appeared to be more potent in this respect than DHT.
Moreover, whereas no effect of androgen was observed in the absence of
FSH, oestradiol alone consistently stimulated the expression of inhibin-a
and -J3b mRNA. These results strongly imply some difference between
the modes of action of androgens and oestrogens.
It is not known at what level or levels steroids modulate the
transduction of gonadotrophic signals, or whether they have effects
which are independent of cAMP. Greater or more prolonged increases in
cAMP levels have been shown in granulosa cells stimulated by FSH in
the presence of oestrogen or androgen (Goff et al. 1979; Hillier & deZwart,
1982; Knecht et al. 1985; Fitzpatrick & Richards, 1991), although not all
studies have shown any effect on adenylate cyclase or phosphodiesterases
(Nimrod, 1977b). Steroids are also capable of augmenting the action of
cAMP analogues on granulosa cells (Hillier & deZwart, 1982; Nimrod,
1977b; Knecht et al. 1984; Knecht et al. 1985), suggesting that, at least in
part, their action is exerted at a site distal to the generation of cAMP. A
number of intracellular events are involved in the cAMP response
between the binding of hormone to its membrane receptor and changes
in gene expression and protein phosphorylation events (Montminy et al.
1990). Assuming that conventional receptors for androgens and
oestrogens are present in granulosa cells, which are considered to exert
/ V
their effects primarily at the level of transcription (Beato, 1989; O'Malley
& Tsai, 1992), it is not inconceivable that the two receptors exert the same
effects on the expression of some genes, but different effects on others.
According to this hypothesis, where the effects of androgens and
oestrogens on cAMP-induced events are qualitatively the same (e.g.
steroid production), one would be led to conclude that they affect the
same genes (encoding components of the cAMP-response system,
perhaps), and differences in potency could be explained in terms of
relative receptor numbers. Where there is a basic difference between the
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effects of these factors (e.g. inhibin-a and -(3b gene expression), one would
conclude that the target genes for the two receptors were different. Until
the specific genes in question (which may encode generic components of
signal transduction pathways, rather than cell-specific factors such as
inhibin subunits or steroidogenic enzymes) are identified and their
regulatory regions inspected for steroid response elements, this
hypothesis will remain speculative.
3 Inhibin and Activin in Granulosa Cell Differentiation
Before the studies described here were carried out, it was already
known that FSH stimulates production of inhibin (Bicsak et al. 1986;
Suzuki et al. 1987; Bicsak et al. 1988; Hillier et al. 1989b) and expression of
inhibin a-subunit mRNA (Woodruff et al. 1987) by rat granulosa cells,
and in situ hybridisation studies had established that the expression of a-
and (3-subunit proteins and their mRNA increases with the size of the
follicle (Meunier et al. 1988a; Woodruff et al. 1988). After the LH surge,
the expression of these genes falls in the ovulatory follicles (which are the
only ones which would be expected to contain LH-responsive granulosa
cells), with some residual expression of the a-subunit in the newly
z J
formed corpus luteum (Cuevas et al. 1987; Meunier et al. 1988a). The
results of the experiments described in Chapter 4 confirmed that the
expression of the a-subunit is stimulated by FSH, and also showed, as one
would expect, that expression of the other two subunits is also stimulated
by FSH. Consistent with the fall in inhibin subunit gene expression in the
granulosa cells of large follicles after the LH surge, they also showed that
administration of hCG to animals which had been treated with FSH
caused a marked fall in levels of inhibin subunit mRNA. All three
inhibin subunits seemed to be regulated by gonadotrophins in
qualitatively the same way. The expression of P450arom and the LH
receptor, and also the oestrogen receptor-related transcript all followed
roughly the same pattern, as one might expect if the effects of
gonadotrophins on granulosa cell function are mediated primarily
through elevation of intracellular cAMP levels. It was not shown
whether cAMP was responsible for the fall in LFI receptor mRNA in
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granulosa cells following hCG treatment, since ligand-induced down-
regulation could account for these results (as it probably did in residual
ovarian tissue containing theca cells). On the other hand, where hCG was
found to affect LH receptor expression in granulosa cells which had not
been treated with FSH, it was stimulatory rather than inhibitory. Also, as
discussed above, the effects of gonadotrophins on the expression of the
oestrogen receptor-related transcript could be indirect, being a response to
changing levels of oestrogen within the cell. Despite a common second
messenger for gonadotrophins, there are qualitative and quantitative
differences not only in the effects of the two hormones, but also in their
effects on the expression of different genes. The clearest example of
such a difference is the expression of P450scc mRNA, which was
stimulated to only a modest degree by FSH, and much more strongly
stimulated by hCG in FSH-treated cells, rather than being suppressed, as
the expression of the inhibin subunits, P450arom and LH receptor
mRNAs were. A less obvious, but certainly distinct difference between
regulation by gonadotrophins of the expression of the different genes
studied was the effect of hCG administered in vivo on granulosa cells
which had not been treated with FSH. This treatment was only found to
increase the levels of P450scc, P450arom and LFI receptor mRNA on one
occasion and the effect was very slight, especially on P450scc mRNA
levels. However, hCG administered in vivo consistently stimulated
expression of mRNA encoding all three inhibin subunits in granulosa
cells which had not been treated with FSH, in one experiment to an equal
or greater degree than FSH (although the dose of hCG was very high in
order to mimic an LH surge). This effect was not seen in vitro, which may
indicate that this effect was due to a thecal product whose production was
stimulated by hCG (other possible reasons for this are discussed above).
Also, expression of mRNA encoding all three subunits was detectable in
freshly isolated granulosa cells from control animals, especially the
a-subunit mRNA, which was present at such high levels in untreated
cells that gonadotrophins had only slight effects on its abundance. In
contrast, no mRNA encoding P450arom, P450scc or LH receptor was
detected in cells from control animals. This is consistent with
immunocytochemical and in situ hybridisation studies in the rat which
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have shown widespread expression of a-subunit mRNA even in
preantral follicles (Meunier et al. 1988a; Meunier et al. 1989; Dykema et al.
1991), whereas expression of P450scc (Rodgers et al. 1986a; Zlotkin et al.
1986; Le Goascogne et al. 1989), P450arom (Milwidsky et al. 1980; Ishimura
et al. 1989; Sasano et al. 1989b) and LH receptor (Oxberry & Greenwald,
1982; Richards et al. 1976; Peng et al. 1991) have only been found in large
antral follicles. Circulating levels of inhibin in the rat increase gradually
from early in the follicular phase (Watanabe et al. 1990; Hasegawa et al.
1989; Fujii et al. 1983), whereas oestradiol levels are low until soon before
ovulation, at which point they rise sharply (Brandt et al. 1990; Dupon &
Kim, 1973). These results suggest that expression of the inhibin subunit
genes is associated with an earlier stage of follicle development than the
other ones studied, and may be due to greater sensitivity to
gonadotrophin, or that their expression is under the control of different
factors.
An attractive hypothesis has recently been put forward to explain
the different effects of FSH and LH despite signal transduction via the
same second messenger. It has been shown that FSH is capable of
stimulating oestrogen synthesis maximally and progesterone synthesis
moderately in cultured human granulosa cells from large follicles, while
permitting proliferation to occur, whereas LH maximally stimulates
synthesis of both oestrogen and progesterone, and inhibits proliferation
(Yong et al. 1991b). These effects of FSH could be mimicked by low doses
of dibutyryl cAMP, and those of LH by high doses (Yong et al. 1991a),
suggesting that the different effects of FSFI and LH are due to different
capacities for generating intracellular cAMP concentrations. The authors
suggested that there are fewer receptors for FSH than for LH on mature
granulosa cells, resulting in a greater increase in intracellular cAMP
levels in response to LH. This theory also explains how low
concentrations of LFI can mimic the effects of FSH on immature
granulosa cells, since those cells would be expected to have fewer LH
receptors. These observations are consistent with the proposal that
different gonadotrophin-responsive genes have different cAMP dose-
response characteristics (Richards et al. 1987; Richards & Hedin, 1988). For
example, in rat granulosa cells, the expression of P450arom in response to
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cAMP would be expected to be biphasic, with stimulation at low doses,
and inhibition at high doses, whereas P450scc expression would be
expected to be less sensitive to cAMP, and not to be inhibited at high
doses. However, it is not known whether this means that gonadotrophin-
responsive genes fall into two categories (low and high cAMP threshold),
or whether these different genes all have different sensitivities to cAMP.
Since expression of the inhibin subunit genes appears to be more
sensitive to gonadotrophins than that of the other markers of granulosa
cell differentiation studied (see above), it seems probable that the latter is
the case. This would imply that the process of granulosa cell
differentiation is a gradual one, with expression of genes being
sequentially induced as the follicle develops. In situ hybridisation studies
have shown that granulosa cell LPI receptor mRNA is predominantly
expressed in those cells closest to the basement membrane (Camp et al.
1991; Peng et al. 1991), whereas inhibin subunit mRNA is expressed in all
\y ^
granulosa cells, including the cumulus cells (Meunier et al. 1988a; Rivier
et al. 1989; Dykema et al. 1991). Since those granulosa cells closest to the
basement membrane are thought to be the most highly differentiated
(Zoller & Weisz, 1978; Zoller & Weisz, 1980; Hsueh et al. 1984), this
pattern of expression is consistent with inhibin expression being
associated with an earlier stage of differentiation than other markers such
as the LH receptor.
Since inhibin and activin have opposite functions one would expect
the control of synthesis of the a- and [3-subunits to differ, so it was
somewhat surprising to find that expression of the a- and [3-subunit
genes is regulated in the same way by gonadotrophins. The only
difference in the regulation of expression of these genes was the
stimulation of expression of a- and Pe-subunit mRNAs by oestradiol, but
nor would this provide a mechanism for the preferential production of
activin. Because inhibin a-subunit mRNA appears to be more abundant
and widely expressed in the ovary than those of the P-subunits (Meunier
et al. 1988b; LaPolt et al. 1989; Penschow et al. 1990), one might be led to
assume that when P-subunits are produced, the secreted product would
be inhibin rather than activin, due to the excess of a-subunits. Of course,
the levels of mRNA and its protein product are not necessarily directly
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related, since control of production of a protein can be exerted at several
levels, so caution must be exercised in extrapolating from mRNA levels
to protein production. If activin is produced by granulosa cells in any
significant amounts, the control of its synthesis must be at a level other
than gene expression, or else its control at that level must be extremely
subtle. It is possible that the stimulation of a- and pg-subunit mRNA by
oestradiol is part of a mechanism regulating the different forms of
inhibin or activin produced under different conditions, but this result
must be interpreted with caution since it was not conclusively shown
that the expression of PA_subunit mRNA is not affected by oestradiol. The
most likely explanation for stimulation of inhibin gene expression by
oestradiol alone, and for its greater potency than androgen in augmenting
the effects of FSH or cAMP, is that inhibin (which stimulates thecal
androgen production (Hsueh et al. 1987; Hillier et al. 1991b)) must be
produced in tandem with oestradiol (which inhibits androgen production
(Leung & Armstrong, 1979; Magoffin & Erickson, 1982)) to ensure a
continued supply of subslrale for oestrogen synthesis. Since unstimulated
cells contain very low levels of cAMP (Richards et al. 1979; Hillier &
deZwart, 1982), and since inhibin gene expression is under the control of
factors operating through mechanisms distinct from the cAMP pathway
(LaPolt et al. 1989), it is quite plausible that this action of oestrogen is
independent of the cAMP signalling system. Control of inhibin gene
expression by multiple signalling pathways could account for the
difference between it and those other markers of differentiated function
studied, and would suggest that inhibin and activin are produced and act
under different conditions from those other factors.
Control of inhibin expression by an "antisense" inhibin a-subunit
transcript would add another level of complexity to this subject.
However, the nature of the RNA species detected using the inhibin-a
sense probe is unknown, and expression of "antisense" [3-subunit
transcripts was not investigated, so the detection of this molecule must be
considered a preliminary finding.
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4 Future Prospects
Although the studies described in Chapter 4 showed beyond doubt
that the expression of the mRNA encoding all three inhibin subunits is
stimulated by FSH both in vivo and in vitro, the effects of sex steroids
and gonadotrophins must be studied in greater detail before the
regulation of expression of these genes is fully understood. It would
appear from the results that steroids do augment the action of FSH on
inhibin subunit gene expression, and that hCG may be stimulatory in
immature cells and inhibitory in mature cells, but the effects were
variable and were not quantified. Detailed studies of the dose-response
characteristics of the expression of these genes in response to
gonadotrophins, cAMP and steroids at different stages of maturity would
undoubtedly resolve the regulation of the control of these messages, and
would also establish the relative roles of androgens and oestrogens in the
control of granulosa cell function at different stages of follicle
development. In order that meaningful conclusions may be drawn from
such data about the role of inhibin and steroids in granulosa cell
differentiation, and the sensitivities of different genes to hormonal
signals, the expression of the inhibin subunits should be compared to that
of other genes under the same conditions. Since Northern blotting is not
a quantitative technique, and requires large amounts of RNA for analysis,
no attempt was made to use this technique for such studies. Instead, an
RNase protection assay was developed for use in these experiments, so
that quantitative results could be obtained using a minimum of material.
This approach could also have yielded information not available by
Northern blotting, such as the direct measurement of the absolute levels
of mRNA encoding each inhibin subunit, the detection of any effect of
androgen alone on any inhibin subunit mRNA, and the detection of any
effect of oestrogen alone on the expression of |3A~subunit mRNA. With
this information, conclusions about the production of different forms of
inhibin and activin could be drawn. Unfortunately, due to constraints of
time available for the completion of this project, the assay was never fully
developed and validated, and so it was not possible to carry out any of
these studies.
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Expression of androgen receptor mRNA was detected in granulosa
cells, which did not appear to be regulated by gonadotrophins. However,
the control of expression of this message would have to be studied in
greater detail before its implications for granulosa cell androgen
responsiveness could be inferred. In contrast, no expression of oestrogen
receptor mRNA was found. However, it could not be ruled out that this
was due to the sensitivity of the method employed in its detection. If
these cells do not possess conventional oestrogen receptors, the
mechanism of the undoubted effects of oestrogens is a mystery.
Therefore, it would be worthwhile to use a more sensitive assay such as
RNase protection assay, or even reverse transcriptase-PCR, to establish
conclusively whether granulosa cells express this message. Also in
relation to oestrogen action in granulosa cells, it would also be interesting
to find out what protein (if any) is encoded by the oestrogen receptor-
related transcript, and what the significance of its hormonal regulation
might be.
Two other observations of unknown significance were made in this
project. Firstly, the synthesis of a prominent ~241<Da secreted granulosa
cell protein is increased after exposure of cells to FSH. Because this
protein is so abundant, and the effect of FSH was seen both in vivo and in
vitro, it seems likely that this protein is involved in the process of
granulosa cell differentiation. Therefore, another interesting extension of
the work presented in this thesis would be the identification of this
protein. Secondly, the detection of a putative "antisense" inhibin
a-subunit RNA, and the control of its expression by hCG, has
implications for the control by gonadotrophins of inhibin production in
granulosa cells. It would be very interesting to characterise this transcript,
and to determine its role in the control of inhibin production.
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Appendix Publications
The data published in the following paper are described in Chapter 4
(presented in a slightly different form in Fig.4.11). This work was also
presented at the 180th meeting of the Society for Endocrinology, London,
November 1989 (/. Endocrinol. 123 Suppl., abstract 90).
The data presented in Fig.3.4 was presented at the Society for the
Study of Fertility Annual Conference, Sheffield, July 1990 (/. Reprod.
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Regulation of Inhibin Subunit Gene Expression by FSH and Estradiol in Cultured Rat Granulosa Cells.
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Abstract. Roles of follicle-stimulating hormone (FSH) and sex steroids in regulating the expression of mRNA species encoding the a-, Pa- and Pb-
subunits of inhibin were studied in cultured granulosa cells from immature rat ovaries. Inhibin subunit mRNAs were detected by Northern biot analysis
of total RNA extracted from granulosa cell monolayers which had been incubated for 48 h in serum-free medium containing FSH (100 ng/ml) and/or a
steroid (10"® M): estradiol (E), testosterone (T) or 5a-dihydrotestosterone (DHT). Levels of mRNA encoding each inhibin subunit in untreated
(control) cultures were low. In cultures treated with FSH alone, levels of inhibin a-, Pa- and Pe-subunit mRNA were approximately 60-fold, 70-fold and
66-fold greater than control, respectively. In cultures treated with E alone, levels of inhibin a- and Pe-subunit mRNA were elevated approximately
4-fold and 2-fold, respectively, but the level of inhibin pA-subunit mRNA was not measurably affected. Treatment with T or DHT alone had no
consistent effect on the levels of any inhibin subunit mRNA. The stimulatory effects of FSH were not consistently altered by the presence of either
androgen or estrogen. These results confirm the role of FSH in regulating inhibin a-subunit gene expression and provide direct evidence that both
inhibin p-subunit genes are inducible by FSH in granulosa cells. All three inhibin subunit mRNAs followed the same pattern, suggesting that their
expression is coordinate^ regulated by FSH during granulosa cell differentiation.
Introduction
Two distinct forms of inhibin composed of a common
a-subunit and one of two p-subunits, Pa and Pb, have
been isolated from ovarian follicular fluid (1). The three
inhibin subunits are encoded by separate genes whose
expression in granulosa cells is developmental^
regulated, and therefore likely to be under gonadotropic
control (2, 3). Direct evidence exists that expression of
the inhibin a-subunit gene is controlled by FSH (4) but
there are no equivalent data regarding the control of
Pa- and Pe-subunit gene expression. Here, we present
direct evidence for coordinate regulation of inhibin a-,
Pa- and Pe-subunit mRNA expression by FSH in primary
rat granulosa cell cultures. We also show that the a- and
pe-subunit genes are inducible by estradiol.
Materials and Methods
Female 21-day old Sprague-Dawley rats received a
10-mm silastic capsule containing diethylstilbestrol
placed subcutaneously to stimulate granulosa cell
proliferation. Five days later they were sacrificed by
cervical dislocation, the ovaries removed, and granulosa
cells from preantral-early antral follicles were harvested
in culture medium. The medium was Medium 199
containing 25 mM HEPES buffer, extra (2 mM)
L-glutamine, penicillin (50 lU/ml) and streptomycin (50
mg/ml) (all from Gibco Ltd, Paisley, UK) with 0.1%
(wt/vol) bovine serum albumin (BSA; ICN Biomedicals,
High Wycombe, Bucks, UK). Multiwell plastic
dishes (Linbro Space Savers, Flow Laboratories,
Received in Iowa City September 11, 1989
Rickmansworth, Herts, UK) were precoated with donor
calf serum (Gibco) and washed with Dulbecco's
phosphate buffered saline before use (5). The culture
wells were inoculated with replicate 250 pi portions of
cell suspension containing approximately 2x105 live
granulosa cells (viability >40% determined by trypan blue
exclusion). Human FSH (LER/8-116, 100 ng/ml;
ref 6) and/or 10"6 M steroid (testosterone [T],
5a-dihydrotestosterone [DHT] or estradiol [E], all from
Sigma Chemical Co, Poole, Dorset, UK) were previously
added to give a final incubation volume of 500 pi. The
cultures were incubated at 37 C in a humidified incubator
gassed with 95% air/5% CO2. After 48 h, the medium was
removed and the culture dishes were placed on ice. The
cell monolayers were lysed with a solution (300 pi)
containing 4 M guanidium thiocyanate, 24 mM sodium
citrate, 0.5% (wt/vol) sarcosyl and 0.1 M
P-mercaptoethanol. Lysates were pooled from all wells
receiving the same treatment (n=8-16) and total RNA was
extracted with phenol-chloroform (7). 5pg of total RNA
from cells receiving each treatment were separated by
electrophoresis in 1.5% agarose gels containing 2.2 M
formaldehyde. RNA molecular weight standards (Gibco)
were run alongside samples on each gel and ethidium
bromide staining was used to check the uniformity of
sample loading (Fig. 1). RNA was transferred onto nylon
membranes (Hybond-N, Amersham International pic,
Aylesbury, Bucks, UK) in 20 x SSC, by capillary blotting.
cDNA probes to the a-, Pa- and Ps-subunits of rat inhibin
(clones a7, Pa30 and Pb11, ref 8) were labelled with 32P
by random priming (Multiprime kit, Amersham).
Prehybridization, hybridization and washing were all
carried out at 65 C. Blots were prehybridized for 1-2 h in
0.2 M sodium phosphate (pH 7.2), 1 mM EDTA, 1%
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:ig.1. Ethidium bromide stained 18s ribosomal RNA bands,
lemonstrating uniform gel loading with total RNA. The same gel was
ised to generate the Northern blots shown in Fig. 2
wt/vol) BSA, 7% (wt/vol) sodium dodecyl sulphate (SDS)
tnd 15% (vol/vol) formamide, then hybridized overnight
n the same buffer containing approximately 5 x 105
:pm/ml of probe. The membranes were then washed for
it least 1h in 40 mM sodium phosphate (pH 7.2), 1 mM
:DTA and 1% (wt/vol) SDS with several changes of
cashing solution, and exposed to Kodak XAR-5 film for
-10 days at -70 C using an intensifying screen,
autoradiographic signals were quantified by scanning
lensitometry.
Results
lorthern blots from a representative experiment carried
ut on seven separate occasions are shown in Fig. 2.
evels of the mRNA species encoding each inhibin
ubunit were low or undetectable in untreated control
ultures. Four inhibin subunit mRNA transcripts were
aadily detected in FSH-treated cultures: one a-subunit
iRNA (~1.7 kb), one PA-subunit mRNA (-6.5 kb), and two
B-subunit mRNA species (-4.4 kb and -3.3 kb). Of the
two Pe-subunit transcripts, the larger was the more
abundant, in agreement with previously reported findings
(8, 9, 10). Treatment with FSH alone stimulated the
a-, pA- and PB-subunit mRNA levels on average 60
(range 5-258), 70 (9-242) and 66 (12-187) fold
respectively, relative to control. Treatment with E alone
increased the a- and Pe-subunit mRNA levels 4(2-10)
and 7 (2-25) fold relative to control but had no discernible
effect on the PA-subunit mRNA level. Treatment with T or
DHT alone had no consistent effect on the expression of
any subunit mRNA relative to control. When combined
with FSH, neither androgen nor estrogen consistently
altered the response relative to FSH alone.
Discussion
These results show that expression of inhbin a-, Pa- and
PA-subunit mRNAs in rat granulosa cells is under direct
control by FSH. The a-subunit data confirm previous
evidence that this mRNA is directly inducible by FSH
during granulosa cell differentiation in vitro (4) and
in vivo (11). However, the p-subunit data are novel,
showing that both Pa- and PB-subunit mRNAs are also
directly inducible by FSH in vitro.
The demonstration that granulosa cell inhibin Pa- and PB-
subunit mRNAs are inducible by FSH points to a major
intersexual difference in the hormonal control of gonadal
inhibin production. Sertoli cells, the testicular homologs
of granulosa cells, also express inhibin a, Pa- and Pb-
subunit mRNAs (8, 9, 10, 12). However, whereas both





Fig.2. Northern blot analysis of inhibin subunit
mRNAs in rat granulosa cells. The cells were
cultured for 48 h with or without 100 ng/ml human
FSH, in the presence or absence of 10"6 M steroid:
testosterone (T), 5a-dihydrotestosterone (DHT) or
estradiol (E). Total RNA (5 pg) from cells receiving
each treatment was separated by electrophoresis
on an agarose-formaldehyde gel and transferred to
a nylon membrane, which was sequentially
hybridised with each 32P-labelled rat inhibin subunit
cDNA probe: left panel, a-subunit; centre panel,
pA-subunit; right panel, PB-subunit.
Key: 1, control; 2, E alone ; 3, DHT alone ; 4, FSH
alone ; 5, FSH plus E ; 6, FSH plus DHT.
Numbers on the left denote approximate molecular
weights (kb).
The lowest molecular weight species in the right-
hand panel is residual inhibin a-subunit probe
which was incompletely stripped from the
membrane before reprobing.
Exposure times were: left panel, 30 h; centre
panel, 8 d; right panel, 10 d. These data are
representative of the results obtained from seven
individual experiments.
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is stimulated directly by FSH, the production of (3a- and
(3A-subunit mRNAs by Sertoli cells is unresponsive to
FSH in vivo and in vitro (10, 12, 13). Thus FSH appears
to cause differential expression of inhibin subunit mRNAs
in Sertoli cells, whereas it effects coordinate induction of
inhibin subunit mRNAs in granulosa cells.
Rapid changes in the expression of all three inhibin
subunit mRNAs occur in granulosa cells throughout the
rat estrous cycle (2). Our results suggest that differential
expression of Pa- and Pb- subunit mRNA could involve
the action of intrafollicular estrogen. Inhibin production,
like other FSH-inducible granulosa cell functions, is
augmented by the presence of sex steroids in vitro (14,
15), consistent with paracrine regulatory functions for
follicular steroids in vivo . In a rat granulosa cell culture
system similar to that used here, FSH-induced inhibin
(measured by RIA directed against the N-terminal
sequence of the porcine inhibin a-subunit) was
increased by androstenedione and estradiol whereas
neither steroid was effective in the absence of FSH (14,
15). Here, we observed direct induction of a- and Pb-
subunit mRNAs by estradiol in the absence of FSH, with
no consistent interaction between FSH and the estrogen.
This could be a mechanism for determining which
dimeric forms of inhibin and activin, and which free
subunits predominate at different stages of follicular
development.
The intraovarian functions of the various forms of inhibin,
activin and free subunits present in follicular fluid are still
unclear (16, 17, 18). However, this study suggests that
the genes which encode all three subunits are under
primary endrocrine control by FSH. A secondary
paracrine level of control, mediated by estrogen, is also
implied. It remains to be seen whether other follicular
factors which influence inhibin production (14, 19) do so
by affecting inhibin subunit gene expression directly.
Acknowledgements
This work was supported by the Wellcome Trust. IMT is
the recipient of a Medical Research Council (UK)
postgraduate research studentship. We are grateful to
Professor LE Reichert of Albany Medical College of
Union University, Albany, NY, USA, for the supply of
human FSH, and to Dr C Goddard and Dr M Hanks
of The Institute of Animal Physiology and Genetics
Research, Roslin, Midlothian, UK, for assistance with
scanning densitometry.
References
1. Ying S-Y 1988 Inhibins, activins, and follistatins: gonadal proteins
modulating the secretion of follicle-stimulating hormone. Endocr
Rev 9:267
2. Meunier H, Cajander SB, Roberts VJ, Rivier C, Sawchenko PE,
Hsueh AJW, Vale.W 1988 Rapid changes in the expression of
inhibin a-, Pa-, and Pa-subunits in ovarian cell types during the rat
estous cycle. Mol Endocrinol 2:1352
3. Woodruff TK, D'Agostino J, Schwartz NB, Mayo KE 1988 Dynamic
changes in inhibin messenger RNAs in rat ovarian follicles during
the reproductive cycle. Science 239:1296
4. Woodruff T, Meunier H, Jones PB, Hsueh AJW, Mayo KE 1987
Rat inhibin: molecular cloning of a- and p-subunit complementary
deoxyribonucleic acids and expression in the ovary. Mol
Endocrinol 1:561
5. Hillier SG, de Zwart FA 1982 Androgen/antiandrogen modulation
of cyclic AMP-induced steroidogenesis during granulosa cell
differentiation in tissue culture. Mol Cell Endocrinol 28:347
6. Reichert LE Jr 1967 Selective inactivation of the luteinizing
hormone contaminant of human pituitary follicle-stimulating
hormone preparations by digestion with a-chymotrypsin. J Clin
Endocrinol Metab 27:1065
7. Chomczynski P, Sacchi N 1987 Single-step method of RNA
isolation by acid guanidium thiocyanate-phenol-chloroform
extraction. Anal Biochem 162:156
8. Esch FS, Shimasaki S, Cooksey K, Mercado M, Mason AJ, Ying S-
Y, Ueno N, Ling N 1987 Complementary deoxyribonucleic acid
(cDNA) cloning and DNA sequence analysis of ovarian inhibins.
Mol Endocrinol 1:388
9. Meunier H, Rivier C, Evans RM, Vale W 1988 Gonadal and
extragonadal expression of inhibin a, Pa, and pB subunits in
various tissues predicts diverse functions. Proc Natl Acad Sci USA
85:247
10. Feng Z-M, Bardin CW, Chen C-LC 1989 Characterization and
regulation of testicular inhibin p-subunit mRNA. Mol Endocrinol
3:939
11. Davis SR, Burger HG, Robertson DM, Farnworth PG, Carson RS,
Krozowski Z 1988 Pregnant mare's serum gonadotropin
stimulates inhibin subunit gene expression in the immature rat
ovary: dose response characteristics and relationships to serum
gonadotropins, inhibin, and ovarian steroid content.
Endocrinology 123:2399
12. Keinan D, Madigan MB, Bardin CW, Chen C-LC 1989 Expression
and regulation of testicular inhibin a-subunit gene in vivo and in
vitro. Mol Endocrinol 3:29
13. Toebosch AMW, Robertson DM, Trapman J, Klaasen P, de Paus
RA, de Jong FH, Grootegoed JA 1988 Effects of FSH and IGF-I
on immature rat Sertoli cells: inhibin a- and p-subunit mRNA levels
and inhibin secretion. Mol Cell Endocrinol 55:101
14. Ying S-Y, Czivik J, Becker A, Ling N, Ueno N, Guillemin R 1987
Secretion of follicle-stimulating hormone and production of inhibin
are reciprocally related. Proc Natl Acad Sci USA 84:4631
15. Bicsak TA, Cajander SB, Vale W, Hsueh AJW 1988 Inhibin:
studies of stored and secreted forms by biosynthetic labelling and
immunodetection in cultured rat granulosa cells. Endocrinology
122:741
16. Hillier SG, Tsonis CG, Wickings EJ, Eidne KA 1987 Inhibition of
FSH-stimulated granulosa cell function by a synthetic fragment of
the porcine inhibin a-subunit: evidence for involvement of GnRH
receptors. J Endocr 113:R3
17. Ying S-Y, Becker A, Ling N, Ueno N, Guillemin R 1986 Inhibin and
beta type transforming growth factor (TGFp) have opposite
modulating effects on the follicle-stimulating hormone (FSH)-
induced aromatase activity of cultured rat granulosa cells.
Biochem Biophys Res Comm 136:969
18. Hsueh AJW, Dahl KD, Vaughan J, Tucker E, Rivier J, Bardin CW,
Vale W 1987 Heterodimers and homodimers of inhibin subunits
hormone-stimulated androgen biosynthesis. Proc Natl Acad Sci
USA 84:5082
19. Bicsak TA, Tucker EM, Cappel S, Vaughan J, Rivier J, Vale W,
Hsueh AJW 1986 Hormonal regulation of granulosa cell inhibin
biosynthesis. Endocrinology 119:2711
